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Résumé 
Les polymères biodégradables façonnés sous fonne de nanoparticules (NPs) ont été 
trés étudiés pour leur capacité à libérer une grande variété de médicaments, protéines et 
peptides de façon contrôlée sur des périodes de plusieurs semaines à plusieurs mois. 
Plusieurs facteurs, tels que les propriétés physico-chimiques des médicaments et des 
polymères ainsi que la structure interne de la matrice polymérique de la particule, 
influencent la libération du médicament. 
La taille nanométrique des NPs limite l'étude de leur structure microporeuse. Ainsi 
l'importance des micropores n'a pas été prise en considération par le passé du fait 
qu'aucune méthode de mesure n'était disponible. Cependant les pores de tailles 
nanométriques augmentent de façon significative le ratio surface interne / volume, qui a son 
tour affecte l 'hydratation des polymères, la pennéabilité et conséquemment la dégradation 
du polymère qui à l'origine insoluble dans l'eau, est transfonné en fragments solubles. Il est 
donc d'une grande importance de mieux comprendre la structure interne microporeuse afin 
de mieux prédire la libération des médicaments des NPs. 
Les techniques d'imagerie n'atteignent pas le niveau de résolution requis pour 
l'analyse de la microporosité. Cependant il existe une méthode par l'adsorption d'azote sur 
matériau poreux qui pennet l'analyse quantitative de l'aire de surface spécifique, la 
microporosité et la distribution de taille des pores à l'échelle nanométrique (micro et 
mésopores). 
La première partie de cette thèse consiste en l'application de la technique 
d'adsorption de gaz à l'étude de la microporosité des NPs polymériques. Les études ont été 
entreprises afin d'évaluer les effets des facteurs de fonnulation comme la charge en 
médicament sur la microporosité de NPs fabriquées à partir du même polymère, le 
poly(ethylene glycol)I%-graft-poly(D,L lactide) ou (PEG1%-g-PLA). Il a été trouvé que bien 
que la quantité de triethylamine et la charge initiale en médicament augmentent tous les 
deux la quantité totale de médicament encapsulé, seul la charge initiale en médicament 
initiale affecte la microporosité des NPs. De façon surprenante ces différences de 
microporosité bien que marginales peuvent expliquer adéquatement les différences 
observées dans les cinétiques de libération de la propafenone chlorhydrate (Prop). Il a été 
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établi qu'une plus grande microporosité entrave les déplacements du médicament dans les 
pores, diminuant son coefficient de diffusion effectif et ralentissant sa libération. 
À partir de ces résultats nous avons été amenés à penser que les changements dans 
la structure moléculaire devraient conduire à des organisations différentes des chaines de 
polymère durant la formation des NPs et donc créer des différences dans leur microporosité 
dépendant des espaces entre chaines et volume libre caractéristiques du type de polymère. 
Pour tester cette hypothèse, des polymères peggylés avec des structures moléculaires 
différentes ont été utilisé afin de préparer des NPs. Les études d'adsorption de gaz révèlent 
des différences dans les isothermes d'adsorption de l'azote, la microporosité et l'aire de 
surface BET. Ces résultats, ainsi que les analyses de surface par XPS et les propriétés 
thermiques des NPs montrent que les chaines de polymères se réorganisent de façon 
distincte et reproductible dans les NPs en fonction de l'architecture moléculaire du 
polymère. Cette structure microporeuse interne des NPs détermine au final leurs propriétés 
de libération de médicament, alors que nous avons confirmé qu'une plus grande 
microporosité ralentissait la libération. 
Dans la deuxième partie de ce travail, nous avons entrepris une évaluation détaillée 
des propriétés de surface des NPs préparées à partir de polymères ayant des architectures 
différentes. Ces études démontrent que la structure moléculaire du polymère non seulement 
change la morphologie interne des NPs mais également altère significativement leurs 
propriétés de surface. En particulier, l'effet des différences chimiques de surface de ces 
NPs a été étudié en fonction de leur capacité à prévenir l'adsorption de protéines. 
Également nous avons montré que les taux d'internalisation des NPs sur une lignée de 
macrophage sont corrélés avec leurs propriétés de surface. Néanmoins toutes les NPs 
testées montrent une internalisation principalement par le biais d'un processus 
d'endocytose dépendant de la clathrine. 
En bref, ce travail démontre que les NPs polymériques ont une structure interne bien 
précise et reproductible déterminée par les propriétés des polymères la composant. La 
structure moléculaire des polymères affecte non seulement l'intérieur de la matrice mais 
également la morphologie de surface des NPs, qui conséquemment décide de leur 
performance globale tant au niveau de la libération de médicament que de leurs propriétés 
biologiques. 
Mots clés: Nanoparticules polymériques, adsorption de gaz, structure microporeuse, 
adsorption de protéines, internalisation intracellulaire, 
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Abstract 
Biodegradable polymers have been investigated extensively for their ability of 
releasing a wide variety of drug molecules, proteins and peptides in a controlled way over a 
period of several weeks or months. Factors affecting the drug release rate include 
physicochemical properties of both, pol ymer & drug, formulation factors and the internaI 
structure of matrix. However, the nanometric size of nanoparticles (NPs) limits 
investigation of their internaI microporous structure. Nevertheless, nitrogen adsorption 
provides a means for quantitative analysis of specific surface area, microporosity and pore 
size distribution in the nanometer range (micropores and mesopores), where imaging 
techniques have yet to achieve sufficient resolution in this range. The importance of 
micropores in release kinetics has not been considered in the past due to the absence of 
adequate measurement methods. However, small pores in the nanometer size range increase 
the internaI surface-to-volume ratio significantly, which affects polymer hydration, 
permeability and consequently, degradation of the originally water-insoluble polymer into 
water-soluble fragments. Hence, it is of great importance to gain a better understanding of 
the internaI microporous structure which may permit a more precise prediction of drug 
release from NPs. 
Objective of the present work was to bridge the existing knowledge gap between 
microporosity of NPs and their drug release kinetics using nitrogen gas adsorption. The 
first part of the thesis consists of the application of gas adsorption technique to probe the 
microporosity of polymeric NPs. Studies were undertaken to evaluate the effect of 
formulation factors like drug loading levels on the microporosity of NPs fabricated from 
poly(ethylene glycol)l%-graft-poly(D,L lactide) (PEG1%-g-PLA). It was found that both, the 
amount of triethylamine and initial drug loading level increased the total encapsulated drug 
in the polymeric matrix. However, only initial drug loading levels affected the 
miCroporosity of the NPs. Surprisingly, these differences in microporosity, although 
marginal, could adequately explain the differences in the release kinetics of propafenone 
hydrochloride (Prop). It was established that higher microporosity can hinder the drug 
movement through such small pores, decreasing its effective diffusion coefficient and 
consequently, the drug release rate. 
v 
From these results, it was concluded that changes in the molecular structure of the 
polymer would lead to different chain organization during NP formation. This would create 
greater differences in their microporosity depending on interchain spacing and free volume, 
characteristic of polymer type etc. Hence, pegylated polymers of different molecular 
structure were used for preparation of NPs. Gas adsorption studies revealed differences in 
their nitrogen adsorption isotherms, microporosity and BET surface areas. These results 
along with XPS surface analysis and thermal properties of NPs pointed out that polymer 
chains reorganized distinctively inside the NPs depending on molecular structure of the 
polymer. This internaI microporous structure of the NPs determined their drug release 
properties. Once again, it was confirmed that higher microporosity slows down the release. 
The second part of this thesis undertook detailed evaluation of surface properties of 
NPs fabricated from different polymer architectures. These studies demonstrated that 
molecular structure of polymer did not only change the bulk morphology of NPs, but 
significantly altered their surface properties. Further, effect of different surface chemistry 
of NPs on their ability to prevent protein adsorption was studied. AIso, these NPs showed 
different cellular uptake in macrophage cell line, which was correlated to their surface 
properties. AlI these NPs showed clathrin-dependent endocytosis as the main mechanism of 
their cellular uptake. 
ln a nutshelI, this thesis demonstrates that polymeric NPs have definite and 
reproducible internal structure determined by the properties of individual polymer. 
Molecular structure of polymer affects bulk as well as surface morphology of NPs, which 
consequently determines their overall performance in terms of drug release and biological 
properties. 
Keywords: Polymeric nanoparticles, Gas adsorption, Microporosity, Protein adsorption, 
Intracellular uptake 
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\\ My Inspiration" 
l was there standing on the aisle 
Looking beyond the horizon 
The horizon where the Sun and the Moon meet 
The sky and the ocean greet 
Suddenly l felt weak, 
l saw a cloud that was dark, floating on my moon 
It was hazy, l tried to look beyond, l couldn't. 
Foes disabled me, Friends asked me to be brave 
l thought, 
Do l have courage account in the bank of bravery? 
Or am l too lazy to draw a chaque? 
l was still on the aisle, 
The breeze whipsered, 
Look at the cloud once again dear, 
It has a silver lining, 
It said, the night is adrker just before dawn 
The dawn is breaking 
l am looking at the sun 
l hear the sun whispering to me 
The only thing that makes you strong 
Is seeing sombody like you 
Achieving something great. 
Then you know, how much is possible 
& you reach out further 
Than you ever thought you cou Id. 
XX! 
You reach out for the Stars & Sun; 
Look at the sky 
It says, don't look back. 
l give you my clouds, 
The clouds give you the wings, 
AI/ you have todo is 
To Fly! Fly 1 Fly 1 ............. .. 
...................... Author unknown 
l will love the light for it shows me the way 
Yet, l will endure the darkness for it shows me the stars 
...................... Author unknown 
It is the hour of 'Trial' 
That makes men Great 
Not the hour of 'Triumph' 
...................... Author unknown 
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Review of Literature 
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1.1 Generaloverview 
According to the report by the Royal Society of London in July 2004, 
nanotechnologies are the design, characterization, production and application of structures, 
devices and systems by controlling shape and size at nanometric scale [1]. 
Nanotechnologies are not new and have been studied for many decades. However, only in 
recent years, scientists have gained an in depth understanding of nanostructured substances 
by using sophisticated tools such as the atomic force microscope. It is reported from 
different sources that the global market of nanotechnology will expend very fast. This year, 
it should reach $1 trillion [2]. Its applications in pharmacology are included in this action, 
and the National Institutes of Health estimated that more than 50% of aIl biomedical 
advances will be in the nanotechnological sector by the year 2010 [2]. 
Nobel laureate and immunologist, Paul Ehrlich, proposed the concept of the so-
caIled "magic buIlets" for the drugs that might be selectively directed to their site of action 
[3]. This dream is fast turning into reality, thanks to the recent milestones achieved in the 
field of 'polymer therapeutics' viz. polymeric drugs, polymer drug-conjugates and 
polymeric nanoparticles (NPs). This breakthrough was achieved by multidisciplinary 
approach encompassing physics, chemistry, cellular & molecular biology and 
biotechnology. 
Various steps have been recognized in the development of successful drug delivery 
device; the first and foremost of which is the availability of well-characterized, 
biodegradable, biocompatible polymers with potential of controlled release and drug 
targeting to specific tissue/cells. Biodegradable polymers have had a remarkable impact in 
the field of controlled drug delivery. Over past two decades, Poly (L-lactide) (PLLA) and 
other copolymers based on D-lactide or glycolic acid or poly(s-caprolactone) (peL) or 
polyethylene glycol (PEG) have been extensively studied as controlled drug delivery 
carriers. Such carriers offer various advantages such as controlled drug release rate, 
improved therapeutic efficacy, prolonged biological activity and decreased administration 
frequency [4]. Block and graft copolymers ofpolylactide (PLA) and PEG have opened new 
avenues in the field of targeted drug delivery by prolonging the circulation time of the 
polymeric colloidal drug carriers in vivo. However, with in-depth understanding of 
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pathophysiology and cellular mechanisms of the disease, targeted or cell specific drug 
delivery is becoming the focus of the CUITent research. Presence of specific ligands on the 
surface of colloidal carriers is necessary to target specific cell type in the body (as in case 
of tumour cells). This can reduce systemic si de effects of the drug by improving receptor-
mediated uptake by the targeted cells. For instance, targeted doxorubicin delivery could be 
achieved by folate conjugated mixed micelles of PLGA-b-PEG-folate polymer [5]. Thus, 
targeted drug delivery has generated a great need for biomaterials with bioadhesive and/or 
specific recognition properties. The ability to impart bioadhesivity, cell specificity or other 
specific characteristics to the existing biocompatible polymers represents an important 
synthetic challenge. Indeed, availability of functional pendant groups is highly desirable for 
fine-tuning of above mentioned properties. Various efforts are directed towards achieving 
this goal [6, 7]. However, chemistry involved in the synthesis of functional monomers is 
complex and/or tedious. For example, Bizzarri et al [6] have synthesized functionalized 
malolactonate polymers and copolymers, where the synthesis of monomers itself was long 
with low yields (12-45 %) and polymerization reactions required over 4-30 days. Similarly, 
Ouchi et al [8] have reported the synthesis of PLA-grafted polysaccharides; however, their 
method involved protection and deprotection. Thus, there are very few reports on the 
efficient and easy synthesis of functionalized polyesters. Amongst them, Finne et al [9] 
. have reported very efficient synthesis method for functionalized peL and PLLA with 
controlled molecular weight and low polydispersity. 
The next goal is formulation of drug delivery vehic1e like NPs, liposomes, micelles 
etc. providing protection to the encapsulated therapeutic agent and optimizing its 
formulation factors to obtain desired release kinetics. The recent advances in 
nanotechnologies, especially nanopartic1es (NPs) make them very promising in the drug 
delivery and diagnostics. NPs were first developed around 1970 and are defined as solid 
colloidal partic1es, less than 1 !lm in size [10]. They can be made from inorganic and 
polymeric materials, however, polymeric NPs are more desirable because they can be 
chemically designed to be degradable and biocompatible, the first and foremost 
requirement of any system for biological application. Despite of their own disadvantages 
such as low drug-Ioading capacity and wide size distribution [11], NPs offer numerous 
advantages over conventional dosage forms, including the ability to protect drugs from 
enzymatic degradation, target the drug to specific tissues, cells & cell compartments and 
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reduce the side-effects of chemotherapy. Rence, over past few decades, there has been 
considerable interest in developing biodegradable NPs as effective drug delivery devices [4, 
12-16]. 
Various polymers have been investigated for preparation of NPs including 
polylactide (PLA) [17-20]; poly(lactide-co-glycolide) (PLGA)[II, 16, 21-27]; poly(c-
caprolactone) (peL) [28,29] and pegylated polymers [29-40]. NPs have also been prepared 
using polyalkylcyanoacrylate polymers [41-45]. The drug of interest is dissolved, 
entrapped, adsorbed or attached to the nanoparticle matrix. Depending on the method of 
preparation, nanospheres or nanocapsules can be obtained with different properties and 
release characteristics. Nanocapsules are vesicular systems in which the drug is confined to 
a cavity surrounded by a unique polymeric membrane, whereas nanospheres are matrix 
systems in which the drug is physically and uniformly dispersed [33, 46-49]. A drug can be 
loaded into NPs by oil-in-water emulsion method if the drug is water insoluble [25, 50] or 
water-in-oil-in-water double emulsion [11, 19, 30, 50, 51] if the drug is water soluble. 
Other methods reported for preparation of NPs include nanoprecipitation [17, 52] and 
electrospraying [20]. Drug loading efficiency of NPs depends on the properties of the drug 
and polymer as weIl as formulation parameters. 
1.2 Characterization of NPs 
The therapeutic success of any smart drug delivery system requires it to i) be non-
toxic, non-immunogenic and stable in the biological fluids, especially during circulation ii) 
protect the encapsulated moiety from premature degradation, iii) overcome biological 
barriers that it will encounter once administered in vivo, iv) be recognized efficiently and 
selectively by the target cells and tissues, v) be able to penetrate the target cell membranes 
and gain access to the intracellular structure and of course, vi) release the encapsulated 
therapeutic moiety in a controlled and/or sustained manner depending on the need of the 
application. In short, innovative and successful developments in the se drug delivery 
systems will require a multidisciplinary approach encompassing engineering, physical 
chemistry and biological sciences. Fine-tuning of various physicochemical properties is 
equally necessary to obtain biologically successful therapeutic system. Behavior of NPs 
within the biological microenvironment, stability, extracellular and cellular distribution 
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varies with their chemical makeup, morphology, and size. The following section gives the 
brief summary of these properties. 
1.2.1 Size and size distribution 
Most widely studied parameter in case of particulate carriers is the size. The size 
and size distribution are important parameters in determining their release kinetics as weIl 
as the interaction of NPs with the cells and penetration through biological barri ers such as 
gastrointestinal barrier for oral chemotherapy and blood brain barrier for the treatment of 
brain cancers or Alzheimer' s disease. It has been confirmed with repetitive studies that 
generally larger particles are rapidly cleared by mononuclear phagocytic system (MPS) 
than smaller particles [13, 53, 54]. Complement activation is also suggested to be 
dependent on the size [53, 54]. Even in case oflong-circulating colloidai particles, optimum 
size is proposed to be 150-200 nm [14, 55, 56]. 
1.2.2 Surface and bulk morphology 
The surface and bulk morphology are important in determining the drug release 
kinetics from NPs. NPs are too small to be visualized under the light microscope. As a 
result of the rapid progress in high-resolution microscopies such as scanning electron 
microscopy (SEM), atomic force microscopy (AFM) , NPs can be visualized with a 
resolution of few nanometers. AFM provides a higher resolution than SEM. Both contact 
and non-contact modes can be employed. Tapping mode AFM (TM-AFM) is more 
preferred than the contact-mode and the non-contact mode because of its ability to probe 
soft sampI es such as biological and polymeric materials under ambient conditions [57, 58]. 
In tapping mode, the cantilever oscillates close to its bending mode resonance frequency so 
that tip makes contact with the sample only for a short duration in each oscillation cycle. As 
the tip approaches the sample, the tip-sample interactions alter the amplitude, resonance 
frequency, and the phase angle of oscillating cantilever. During scanning, the amplitude at 
the operating frequency is maintained at the constant level, called the set-point amplitude, 
by adjusting the relative position of the tip with respect to the sample. This operating 
method results in lower surface forces, particularly lateral forces, causing less surface 
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damage [57]. One recent approach in TM-AFM is the use of the changes in the phase angle 
of the cantilever probe to produce phase image. This image often provides more contrast 
than the topographic image and has been shown to be sensitive to material surface 
properties such as stiffness, viscoelasticity and chemical composition [57-60]. 
It is possible to observe the bulk morphology of NPs by cross-section; however, 
their small size makes this difficult. This may be the reason of lack of such investigations in 
the literature, except that reported by Rizkalla et al [61]. Using this technique, authors 
could successfully demonstrate co-existence nanocapsules having large central cavity along 
with nanospheres with solid core. 
Another possible technique to study the internaI morphology of NPs is physical gas 
adsorption. The next section will give brief synopsis of basic principles of gas adsorption in 
general and summary of methods used for microporosity analysis in specific. 
1.2.2.1 Physical Gas Adsorption: Basic Principles [62] 
Gas adsorption is one of the many experimental techniques available for the 
surface and pore size characterization of porous materials. Other techniques include small 
angle X-ray and neutron scattering, mercury porosimetry, electron microscopy, 
thermoporometry and NMR-methods. Each method has limited length scale applicability 
for pore size analysis. Among these methods, gas adsorption is the most popular method 
because it allows assessment of wide range of pore sizes (from 3.5 A up to > 1000 A), 
including the complete range of micropores (0 to 20 A), mesopores (20 to 500 A) and even 
macropores (500 to 5000 A). In addition, gas adsorption techniques are convenient to use 
and are not that co st intensive as compared to sorne of the other methods. Adsorption can 
be divided into chemical and physical adsorption, depending on the strength of the 
interaction. Physical adsorption is a general phenomenon and occurs whenever adsorbable 
gas is in contact with the surface of solid adsorbent. Physisorption exhibits characteristics 
which make it most suitable for surface area measurements as indicated 
1. Physisorption is accompanied by low heats of adsorption with no disruptive 
surface structural changes during the measurement. 
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2. Pores can be filled completely by the adsorptive gas for pore volume 
measurements. Such pore condensation phenomena can be used to calculate 
pore size and size distribution. 
3. Physisorption is completely reversible, enabling both the adsorption and 
desorption to be studied. 
4. Physically adsorbed molecules are not restricted to specific sites but, can coyer 
the entire surface, enabling calculation of surface areas rather than number of 
sites. 
1.2.2.2 Classification of adsorption isotherms [62-64] 
As per IUPAC classification [63], adsorption isotherms are divided into 6 types as 
shown below. 
The reversible type 1 isotherm is concave to PlPo axis and amount approaches a 
limiting value as PlPo - 1. This type of isotherm is generally encountered in case of 
adsorption on microporous materials. Micropore filing and therefore, high uptakes are 
observed at re1atively low pressures. The strong increase in the adsorbed amount close to 
the saturation pressure results from the pore condensation into large meso- and macropores 
or interparticulate space. 
Type Il isotherms are typically obtained in case of macroporous or non-porous 
adsorbent, where monolyer-multilayer adsorption can occur. The inflection point (B) 
indicates the stage at which mono layer is complete. 
The reversible type III adsorption isotherm is convex to the PlPo axis and is very 
uncommon, but an example includes nitrogen adsorption on polyethylene. 
Type IV isotherms are typical of mesoporous materials and exhibit characteristic 
hysteresis loop associated with the pore condensation. 
Type V isotherms also show pore condensation and hysteresis phenomenon, 
however, initial part ofthis isotherm is related to the type III isotherm. 
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Type VI isotherm is a special case showing multilayer adsorption on a uniform, 
non-porous surface. 
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Figure 1.1. IUP AC classification of adsorption isotherms 
1.2.2.3 Adsorption in micropores 
As defined earlier, pores are classified as macropores (pore widths greater than 500 
Â), mesopores (pore widths from 20-500 Â) and micropores (pore widths less than 20 Â). 
For NPs of size 200 nm, micropores will be more important. The mechanism of pore filling 
is different in meso- and micropores. Mesopores fill via pore condensation, representing a 
first order gas-liquid phase transition. In contrast, the filling of micropores represents a 
continuous process, in most cases. The micropores are further subdivided into those smaller 
than 7 Â (ultramicropores) and those in the range of 7-20 Â (supermicropores). The filling 
of ultramicropores occurs at very low relative pressures and is entirely govemed by the 
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enhanced gas-solid interactions. The relative pressure where micropore filling occurs is 
dependent on a number of factors such as the size and nature of adsorptive gas molecules, 
the pore shape and the effective pore width. The pore filling capacity depends on the pore 
accessibility to the probe molecules which in tum, is detennined by the size of the probe 
molecule. In an ideal case, pure microporous materials exhibit type 1 isothenn as IUP AC 
classification. Various methods and theories have been developed for micropore 
characterization, which include Polyani, Dubinin including most recent approaches by 
Horvath-Kawazoe [65, 66] known as HK method. It should be noted that this method 
cannot be applied to mesopore size analysis. The following equation is used for micropore 
analysis using HK method: 
{ P} NA NsAs + NaAa cr4 cr 10 cr4 cr lO ln Po = RT x cr4 (l-2do) x 3(1- dol 9(1- dol 3(1- dol + 9(dol 
...................................................................................................................... (1) 
Where, 
da + ds 
do = .................................................................................................... (2) 
2 
cr {~r .do ........................................................................................ (3) 
As = ................................................................................... (4) 
3 
Aa= 
2 ' 
- mec Ua b ... ................................................................................. (5) 
2 
Aa = Kirkwood-Mueller constant of adsorbate 
As = Kirkwood-Mueller constant of adsorbent 
do = distance between adsorptive and adsorbent molecules 
da = diameter of an adsorbate molecule 
ds = diameter of an adsorbent molecule 
Na = number of atoms per unit area (m2) of adsorbent 
NA= nurnber of adsorptive molecules per unit area (m2) of adsorbent 
me = mass of an electron 
c = speed of light 
Ua = polarizability of adsorbate 
Us = polarizability of adsorbent 
cr = distance between two molecules at zero interaction energy 
'X;t = magnetic susceptibility of adsorbate 
'XJ; = magnetic susceptibility of adsorbent 
1 = the separation between nuclei oftwo layers 
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According to this equation, the filling of micropores of a given size and shape takes 
place at a characteristic relative pressure. 
1.2.2.4 Specifie surface area 
Gas adsorption technique also serves in the analysis of specific surface area of the 
sample. Specific surface area depends on size, shape and porosity. The BET-nitrogen 
adsorption method continues to be a universally employed method for detennining the 
surface area of adsorbents, catalysts and other materials [67]. It is based on a simple model 
of monolayer-multilayer adsorption and given by the following equation: 
1 1 +t::~} :0 ......................................... (6) 
W [PlPo - 1] 
Where, 
W = weight of the adsorbed molecules 
W m =: weight of the adsorbed molecules at mono layer coverage 
C = BET constant 
P6 = saturation pressure 
A plot of 1/ W [PlPo - 1] versus PlPo gives a straight line in the range of 0.05 ::; PlPo 
::;0.35. 
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1.2.2.5 Nitrogen as a standard adsorptive for surface area 
measurements [62] 
The unique properties and the availability of liquid nitrogen have led to the 
univers al acceptance of nitrogen as the standard BET adsorptive. The fact that nitrogen has 
a permanent quadrupole moment is important, because it is responsible for the formation of 
a well-defined monolayer on most of the surfaces. However, quadrupole moment of 
nitrogen affects its adsorption on highly polar surfaces due to specific interactions between 
these polar groups and its quadrupole moment. Thus, nitrogen in not completely inert and 
this may result in overestimation ofBET surface area in case of polar surfaces. 
In contrast to nitrogen, argon has no quadrupole moment. Argon is much more 
sensitive to the details ofthe surface structure ifused at liquid nitrogen temperature (77 K). 
For accurate measurement of surface areas as low as 0.5 - 1 m2, number of 
molecules trapped in the void volume of the sample ceIl needs to be reduced. This can be 
achieved by using krypton adsorption at liquid nitrogen temperature for the surface area 
analysis. Krypton has a much smaller saturation pressure (1.63 Torrs i.e. 217.25 Pa) 
compared to nitrogen (270 torrs) at 77.35 K and hence, the amount of krypton remaining in 
the void volume will be much less as compared to that of nitrogen. This increases the 
sensitivity of the manometric adsorption measurements significantly thereby, allowing 
accurate surface area measurements for materials with small specific surface areas « 0.05 
m
2/g), or if only a very small amount of sample is available. 
1.2.3 Physical state of drug within NPs 
It is important to know whether the drug is present in crystalline or amorphous form 
within the matrix. This provides certain information about the rate of drug release. The first 
step in the release requires dissolution of drug in the release medium followed by its 
diffusion. Drug dispersed in the matrix in crystallihe form will dissolve slowly than its 
amorphous or molecularly dispersed form affecting the release kinetics. DifferentiaI 
scanning calorimetry (DSC) can be used to gain information about physical state of the 
drug as well as polymer-drug interaction. For instance, Mu et al [68] have detected no 
melting endotherm of paclitaxel in PLGA nanospheres, attributing it to the molecular 
dispersion of pac1itaxeJ in the poJymeric matrix. On the other hand, Okada et aJ [69J have 
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shown an increase in the glass transition temperature (Tg) of leuprorelin-Ioaded PLA 
microspheres due to ionic interaction between the drug and the polymer. 
1.2.4 In vitro drug release kinetics 
In vitro release studies are important in the characterization of any drug de li very 
system. Although in vivo release could be different, the in vitro release experiments provide 
sorne guidance for prediction of possible effects of the drug delivery system. It also gives 
an insight to the possible burst effect, which should be avoided to prevent toxic 
concentration in the body. It is weIl established that drug release from polymeric matrices is 
govemed by both diffusion and degradation depending on the polymer type [70]. This 
release phenomenon is a complex interplay ofvarious factors such as properties of the drug 
and polymer, their compatibility with each other, type Qf emulsifier used, drug loading 
level, physical state of the drug inside the matrix and various other formulation parameters. 
The Higuchi square root model has been successfully applied to model the kinetics 
of drug release from matrix system. Equation 9 was derived from Fick's first law of 
diffusion and applied to porous hydrophobic polymeric drug delivery systems in 
homogenous matrices [71]. 
Q(t) = J Ds x fIt x Ca x (2Co - f:Ca)t.. ........................................................................ (7) 
= V DappCa x (2Co - f:Ca)t ..................................................................................... (8) 
= k ft ........................................................................................ (9) 
Where, 
Q(t) :Cumulative amount of drug released in time t per unit surface area 
Ds : Drug diffusion coefficient in the release medium 
Co : Total amount of drug in the matrix 
Ca: Solubility of drug in the release medium 
f: : Porosity of the matrix 
't : Tortuosity of the matrix 
Dapp = DsEh : Apparent observed diffusion coefficient 
k : Dissolution rate constant 
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Thus, drug release from such a system will depend on the initial concentration of the 
drug in the matrix, porosity, tortuosity, properties of the polymer system forming matrix 
and the solubility of the drug. Drug release from hydrophobic polymeric drug delivery 
system will occur when the drug cornes into contact with the release media, subsequently 
dissolves and diffuses through the media filled pores. Thus, geometry and structure of pores 
is important in this process. 
1.2.5 Surface charge 
Surface charge is important in determining the in vivo stability as weIl as cellular 
interaction capability of NPs. Zeta potential measurements can give idea of surface charge 
of particles. Generally, surface charge should be near neutral to avoid non-specific cell 
sticking or uptake of NPs. This is discussed along with the properties of long-circulating 
polymers. 
1.2.6 Surface chemistry 
Once the release properties are tailor-made for particular application, the next 
milestone to be achieved in the development of drug delivery device is suitability of the 
surface properties of such polymeric colloidal carrier in terms of its in vivo stability, 
compatibility and cellular interaction capabilities. Physicochemical surface characteristics 
also give clear evidence of the effect of coatings and residual emulsifiers on the NP surface. 
The amount of emulsifier on the surface has significant effect on various physicochemical 
and biological properties of the NPs. Polyvinyl alcohol (PV A) is the most commonly used 
emulsifier in the formulation of polymeric NPs. It has been proven that a fraction of PV A 
remains associated with the NPs despite repeated washing and has been proposed that this 
is due to formation of an interconnected network with the pol ymer through hydrophobic 
interactions at the interface. Sahoo et al [23] have systematically shown that this residual 
PV A, in tum, affected different pharmaceutical properties of NPs such as particle size, zeta 
potential, polydispersity index, surface hydrophobicity, protein loading and also slightly 
influenced in vitro release of the encapsulated protein. Importantly, NPs with higher 
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amount of residual PV A had relatively lower cellular uptake despite their smaller particle 
size. It was proposed that lower intracellular uptake of NPs with higher amount of residual 
PV A could be related to higher hydrophilicity of NP surface. 
Various efforts have been directed to create particles with precise surface chemistry, 
especially for their long-circulating properties. Their summary and properties required for 
long-circulating polymers/carriers will be described in the next section. 
1.3 Optimization of surface chemistry of NPs: Essence 
for their long-circulating behavior and biological 
activity 
Amongst various physicochemical properties, surface properties of any system are 
thought to play a crucial role in interactions with the cells and their intracellular transport 
machinery, and can significantly affect the efficacy of the encapsulated drugs [72]. Hence, 
it is critical in targeted gene and drug delivery to carefully design and control the surface 
properties of such systems. A prerequisite to selective targeting is particle stability in vivo 
and the minimization of nonspecific uptake. This can be done by designing surfaces with 
no or little protein adsorption. In particular, the adsorption of biological proteins onto 
biomaterials plays an important role in determining their fate. Hence, elimination of prote in 
adsorption onto biomaterials is one of the key elements in preventing thrombosis, platelet 
activation and immunological responses [73]. Similarly, this phenomenon of adsorption of 
proteins and opsonins on polymeric drug delivery systems leads to their recognition and 
rapid elimination from systemic circulation by Mononuclear Phagocytic System (MPS). To 
avoid this, the concept of long-circulating polymers has been emerged [12, 30, 74]. In the 
past two decades, we have witnessed a surge in the development of long circulating 
vehicles. Among the various polymers studied, poly (ethylene glycol) (PEG) has been the 
most extensively investigated pol ymer. PEG is an uncharged hydrophilic and non-
immunogenic polymer that can be physically adsorbed onto or preferably, covalently 
attached to the surface of colloidal systems [75, 76]. Various pioneering studies and 
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especially, the entry of pegylated or so-called "sterically stabilized" liposomal doxorubicin 
(Doxil™, CaelyxTM) into the market signify the importance of the stealth technology. 
1.3.1 Approaches used for prolonged circulation 
Since the past two decades, various approaches have been used for imparting the 
stealth behavior to the polymerie carriers, which include: 
• Adsorption of hydrophilic polymers containing hydrophobie substituents 
onto the surface via hydrophobie interactions, e. g. surfactants such as 
poloxamers, poloxamines [12, 74]. 
• Covalent bonding of hydrophilic polymers onto the surface e.g. surface-
grafted polymers or use of PEGylated copolymers with sorne other biodegradable 
polymer such as PLA, PLGA, PCL [16, 30, 31, 33, 34,39,47, 77-83]. 
It is proposed that in both these cases, the hydrophilic parts protrude out in aqueous 
milieu forming "molecular cloud" on the surface of the carrier, thus protecting the carrier 
from recognition by MPS [13, 46, 76]. However, in the first approach, possibility of rapid 
desorption of the adsorbed coat may deceive the true purpose, as observed in case of NPs 
[74]. Covalently linking PEG to the surface of the polymer has sorne disadvantages as weIl. 
It is sometimes difficult to ensure that covalently bound PEG cornes out on the surface and 
does not penetrate in the bulk of the material. This will affect PEG surface coverage and 
conformation. At the same time, presence of covalently bound PEG chains throughout the 
particle may be advantageous for degradable particles, ensuring availability of surface 
exposed PEG during the entire degradation and erosion process. Hence, copolymers of PEG 
with other polymers were used; nevertheless, this does not assure presence of aH PEG 
chains on the surface of particles prepared from these polymers. 
1.3.2 Physicochemical properties of long-circulating 
. 
carrIers 
Several theories have been proposed to explain the apparent protein binding and 
long-circulating properties of pegylated carriers. Sorne authors correlated long-circulating 
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behavior of pegylated carriers to the results of overloading the clearance system in the body 
thereby giving false stealthy appearance to particles [13]. Nonetheless, most widely 
accepted theory is the one based on ability of PEG to impart protein resistant properties to 
the particles [84, 85]. This theory makes the argument that the hydrophilic and flexible 
nature of surface PEG chains allows them to have more extended conformation when free 
in solution. Therefore, when opsonins or other proteins are attracted towards the particle 
surface by van der Waals and other electrostatic forces, they encounter the extended PEG 
cloud and begin to compress them, which forces the PEG chains into more condensed and 
hence, high energy conformation. This creates an opposing repulsive force which, if great 
enough can completely balance or overpower the attractive forces between the protein and 
the particle surface. High (optimal) surface density and long chain length (degree of 
polymerization) was suggested to be desirable for prote in resistance [84, 85]. The most 
important physicochemical properties required for long-circulating polymers and polymeric 
carriers are summarized below with the relevant experimental evidence wherever possible. 
1.3.2.1 Solubility and Hydrophilicity: 
In general, the surface grafted polymer should be soluble and hydrophilic. Along 
with this, it was also proposed by Jeon et al [84, 85] that the composition of terminally 
attached polymer chain affects the refractive index and static dielectric constant of the 
polymer layer. Lower the refractive index, lower are the van der Waals interactions and 
thus, greater would be the steric barrier for approaching prote in. According to Jeon et al, 
PEG of relatively low molecular weight has the lowest refractive index as compared to any 
common water-soluble synthetic polymers and that may be one of the reasons of its 
excellent protein resistant property. Lot of studies carried out on the surface hydrophobicity 
and protein adsorption clearly indicate that decreasing hydrophobicity of the particle 
surface leads to decreased protein adsorption [86-88]. 
1.3.2.2 Molecular weight (Mw) and Polymer layer thickness: 
It has been demonstrated in various studies [89, 90] that increasing PEG Mw from 6-
20 kDa increased PEG layer thickness and chain flexibility and subsequently enhanced 
circulation half-life. On the other hand, it is important to note that there is a maxima after 
which, increasing molecular weight or polymer layer thickness may not have any effect 
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[89, 90]. This can be illustrated by the following example. When protective effect of 
phosphatidylethanolamine (PE) having 1 or 2 attached PEG molecules was compared in 
liposomes, at a concentration of 3 mole %, the circulation half-life of these liposomes was 
found to be 140 vs 80 min, respectively. However, when used in the concentration of 7 
mole %, both of these liposomes showed the same half-life of about 230 min [91], showing 
that maximum surface density had reached. AIso, it should be stressed that components of 
any molecular brush cannot be completely inert. Very long polymer chains and dense 
brushes are more capable of forming co-operative weak association due to presence of a 
greater number of groups forming, weak bonds. In fact, there are reports that excessively 
long PEG chain (> 5 kDa) was inferior as long-circulating polymer [91]. 
1.3.2.3 Grafting density and conformation: 
Grafting density may be defined as the moles of grafted polymer per unit area of the 
surface. Increased grafting density me ans better steric protection as confirmed by Michel et 
al [82]. They showed that increasing PEG grafting density resulted in less prote in 
adsorption of small as weIl as large proteins. 
Grafting density and conformation are inter-related. For instance, at low grafting 
density, PEG chains will have larger range of motion and will take on a "mushroom" 
conformation, where they will be located near the surface of the particle. On the other hand, 
at higher grafting density, the motion of PEG chains is highly restricted and they will 
exhibit "brush" configuration. The term 'mushroom' relates to the semi-spherical volume 
occupied by a single flexible elongated molecule whereas 'brushes' are long-chain polymer 
molecules attached onto the one end of surface with the density of attachment high enough 
so that the chains are obliged to stretch away from the interface (Fig. 1.2) [92]. 
Very low surface grafting density will also lead to gaps or unprotected surfaces 
where proteins can easily bind to the particle surface. On the other hand, although a high 
grafting density ensures a complete surface coverage, it decreases PEG chain mobility and 
its steric hindrance properties. Therefore, the optimal surface coverage is located between 
"brush" and "mushroom" configurations where the surface density should be high enough 
to coyer the whole surface without compromising the chain flexibility [53]. 
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Figure 1.2. Mushroom and brush regime []Upper: Mushroom (low density.); Lower: 
Brush (High density), AL: Area of particle surface; D: Distance between 
grafting points; L: Length of the pol ymer segment (Np); Xp: mole 
fraction of polymer 
1.3.2.4 Charge and charge density: 
Charge on the surface of biomaterial is a very important factor, playing role in its 
interaction with any living cellltissue as proposed by Dan [93]. It is well-established that 
positively and negatively charged particles are cleared from the body faster than those with 
near-neutral charge [15, 38, 94, 95]. Positively charged particles cause non-specifie cell 
sticking to the negatively charged ceU surfaces whereas, negatively charged NPs are 
efficiently taken up by scavenger endothelial ceUs or Kupffer ceUs in the liver [15, 95]. 
Thus, near-neutral and hydrophilic NPs are needed to avoid undesirable protein and cellular 
interactions. Similarly, Gessner et al. [96], have synthesized a range of model latex 
particles having constant particle parameters except charge density and confirmed that 
increasing surface charge density led to increased protein adsorption (Fig. 1.3). 
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Figure 1.3. Physicochemical properties and total protein amounts adsorbed on lattices 
1-5 expressed in arbitrary units (cpm). The values are the mean of three 
experiments; error bars represent the standard deviation [96]. 
1.3.2.5 Flexibility of the polymer chain: 
This is another important factor for PEG being so popular as a protective polymer. 
In general, more flexible the molecule, the larger the total number of its conformations and 
higher the rate of transition from one conformation to other leading to formation of "high 
probability cloud" occupying lot of place and squeezing the water out of them. Due to 
water exclusion effect, it apparently hinders the permeability of the approaching proteins 
[76]. In case of rigid polymer, unit motion is hindered and even its high solubility and 
hydrophilicity may not provide sufficient protection [97]. This was established as a reason 
why small quantities of PEG could show protection to liposomes however, rigid dextran 
failed to do so [98]. 
1.3.2.6 Presence of side group on the protective polymer: 
Metselaar et al. [90] have studied novel family of polymers, namely, lipid 
conjugated poly(hydroxyalkyl L-aspargine/L-glutamine) and studied effect of various 
variables like type oflipid anchor, grafting density, lipid dose as weil as side group present 
in the poly (L-Amino acid) which was used as protective polymer instead of PEG. lt was 
observed that substitution of longer hydroxyalkyl groups in place of polyhydroxyethyl, 
(viz., polyhydroxy -propyl or -but yI) in their glutamine chain reduced the circulation half-
life (Fig. 1.4). This was attributed to reduced chain flexibility, thus, compromising the size 
of conformational cloud. 
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Figure 1.4. Pharmacokinetics and distribution to the MPS of different 
poly(hydroxyalkyl L-glutamine)s incorporated with a grafting density of 
7.5% in 150 nm DPPC-cholesterol liposomes. (A) %-injected dose in 
blood-curves of PEG2000-Distearoyl phosphatidylethanolamine (closed 
circles), PHEG (poly(hydroxyethyl L-glutamine))4000-DODASuc (gray 
squares), PHPG (poly(hydroxypropyl L-glutamine))5000-DODASuc 
(gray diamonds), PHBG poly(hydroxybutyl L-glutamine))5000-
DODASuc (gray triangles), and bare liposomes without polymer-lipid 
conjugate (open circles). (B) Distribution to spleen (open bars), liver (gray 
bars) and total distribution to the MPS (liver and spleen) (black bars). 
Results are expressed as the mean percentage of the injected dose of four 
rats ± SD. (Taken from Ref [90]) 
1.4 Biological consequences of long-circulating carriers 
The most important biological consequence of long-circulating polymers is their 
effect on pharmacokinetics of the macromolecu1es/particulate carrier systems. Indeed, there 
is accumulating body of evidence for various liposomal [99], nanoparticulate [14] and 
micellar systems [100]. As discussed throughout this section, this is assumed to be due 
suppression of surface opsonization by serum or plasma proteins and in tum, decreased 
uptake by MPS [12]. 
The altered pharmacokinetic parameters show delayed drug absorption, restricted 
drug biodistribution, delayed drug clearance and retarded drug metabolism. These effects 
are due to hindered interstitial drug penetration and restricted drug accessibility to the 
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biological milieu due to encapsulation in the polymerie carrier [53]. While unprotected, 
conventional carriers show non-linear saturable pharmacokinetics, long circulating carriers 
show dose-independent, non-saturable, and log-linear pharmacokinetics [55, 101]. This is 
explained by significant decrease in the first phase of particulate clearance into a high 
affinity and relatively low capacity system, such as MPS. 
1.5 Nanoparticle Targeting 
NPs can be targeted to specifie tissues especially tumor cells through a physical 
sieving mechanism based on their size (passive targeting) or through specifie molecular 
binding interactions (active targeting). 
1.5.1 Passive Targeting 
Passive targeting ofNPs takes advantage oftheir inherent size and unique properties 
of the tumor vasculature. In contrast to normal endothelium, tumor vessels are lined by a 
simple layer of endothelium with few pericytes and smooth muscle cells. Tumor blood 
vessels are distinct from normal vessels, in that the tumor endothelial cells have wide 
fenestrations, ranging from 200 nm to 1.2 Ilm (Fig. 1.5) [102-105]. This increased 
permeability of tumor vascular tissue combined with impaired lymphatic drainage from 
tumor interstitium is known as Enhanced Permeability and Retention (EPR) effect. This has 
been exploited to improve drug delivery to tumors and other sites including inflammation 
and infarcts possessing similar pathological characteristics. Thus, due to the presence of 
leaky vasculature and compromised lymphatic drainage, small colloidal particles (100-200 
nm) can extravasate in the pathological sites such as tumor, infection, inflammation. In 
addition, long-circulating character of these particles makes them circulate for longer time, 
thus, enhancing their capture by tumor cells. This leads to increased local drug 
concentration improving the therapeutic efficacy, and at the same time, reducing no-
specifie accumulation of the drug in the healthy tissues, decreasing their toxicity [33, 103-
109]. A significant drawback of using the EPR effect is that it works oruy in solid tumors. 
However, the therapy for spreading tumors and metastases presents the great challenge for 
the chemotherapy as these tumors do not develop EPR effect and therefore, their therapy 
requires active targeting strategies. 
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Figure 1.5. EPR effect, taken from reference [110] 
1.5.2 Active targeting 
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Active targeting is achieved by conjugating the carrier system to sorne ligands 
unique to the cells/tissues to be targeted (Fig. 1.6). An ideal targeting ligand should be 
abundant, with a high affinity and specificity for binding to the cell surface receptors and 
shou1d be compatible to chemical modification by conjugation. The tumor endothelium 
provides many targets for cancer therapy including tumor growth factor-a, matrix 
metalloproteinases, integrins etc. (reviewed in [2, Ill, 112]). Other targeting moieties used 
so far include RGD-peptide [113, 114], folie acid [37], and monoclonal antibodies. 
Figure 1.6. Active targeting 
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1.5.3 Intracellular transport mechanisms 
Once the colloidal carrier remains in circulation by escaping opsonization and 
components of MPS, it should reach the target cell populations to exhibit its activity. 
Intracellular organelles, such as mitochondria, nucleus etc. form the site of actions of many 
therapeutic agents [72]. The cytoplasm itself is the target for certain drugs like 
glucocorticoids, the receptors of which are cytoplasmic. Hence, the efficient intracellular 
delivery of NPs is crucial in enhancing the efficacy of encapsulated therapeutic agent. To 
develop such a system, it is indispensable to learn intracellular transport mechanisms. 
Most colloidal drug delivery devices gain entry inside the cell through the process 
of endocytosis. Endocytosis is divided into phagocytosis and pinocytosis. Phagocytosis is 
the ingestion of relatively large particulates by specialized cell types (i. e. macrophages, 
neutrophils and dendritic cells) that adhere to the particle and generate membrane 
extensions around the particle. Eventually, these membrane extensions fuse together to 
enclose the particle within an membrane bound compartment called 'Phagosome'. InternaI 
fusion of phagosome with lysosome generates 'phagolysosome' where particle is degraded 
by action of various enzymes like proteases and nucleases. 
In contrast to phagocytosis, essentially all the cells undertake pinocytosis which 
refers to the internalization or invagination of plasma membrane domains. With 
invagination and internaI budding of such domains any bound molecules and associated 
extracellular fluid are also taken into the cell. Pinocytosis begins at specialized plasma 
membrane domains including clathrin- coated pits, caveolae and non-coated lipid rafts. The 
invaginated plasma membrane gives rise to the membrane-enclosed vesicles within the 
cytoplasm termed 'endosomes'. 
Cells will endocytose materials from their extracellular environment through 
one of the following processes: 
Receptor-mediated endocytosis: Here, particle will bind to its cognate receptor and 
the receptor-ligand pair is internalized through plasma membrane invaginations to form 
endosomes. Broadly, receptor-mediated endocytosis can be constitutive (class I) or ligand-
stimualted (Class II). Constitutive endocytosis results from continuaI plasma membrane 
turnover. This type of internalization occurs for receptors for transferring and low density 
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lipoprotein. In ligand-stimulated endocytosis, ligand binding to its receptor triggers the 
internalization. Examples include inulin and epidermal growth factor binding to their 
receptors. 
Adsorptive endocytosis: The material to be endocytosed binds to the cell surface not 
through specifie receptor-ligand pairing but through non-specifie mechanisms like 
electrostatic interactions. Saturation of non-specifie membrane binding sites is less likely 
than with receptor-mediated process. 
Fluid-phase endocytosis: The material to be endocytosed is simply present within 
the extracellular fluid bathing the cell surface and as the plasma membrane invaginates to 
form endocytic vesicle, sorne of the extracellular fluid is captured within the lumen of the 
budding vesicle. The examples include horseradish peroxidase or dextarns which are 
referred to as fluid-phase markers. This is associated with the slowest rates of 
internalization. 
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2.1 Hypotheses 
2.1.1 Hypothesis 1 
Formulation factors like initial drug loading levels will affect microporosity and 
hence, the drug release kinetics of polymerie nanoparticles. Nitrogen gas adsorption 
technique can be used to probe the microporosity of nanoparticles. 
2.1.1.1 Justification for studying drug release kinetics 
Polymerie nanoparticles (NPs) offer suitable me ans for delivering various 
therapeutic agents by either localized or targeted delivery to the tissue of interest [1-9] at a 
therapeutically optimal rate. Various therapeutic agents such as antibiotics, anti-
inflammatory drugs, anticancer agents, proteins and peptides have been encapsulated in 
polymerie NPs. Since pharmacokinetic properties of these agents are different, drug release 
rate should be tailored in order to achieve optimum plasma drug concentration and 
therapeutic . effect as per the need. AIso, the issue of drug release from nanocarriers still 
remains central to cancer chemotherapy. It has been shown that stealth liposomes of 
entrapped cisplatin lack antitumor activity despite of its accumulation in tumor interstitium. 
This was attributed to the poor and extremely slow release of cisplatin from extavasated 
liposomes [10]. This underlines the importance of optimizing drug release kinetics from 
various drug delivery systems. 
Drug release from polymerie matrix systems is governed by diffusion of the drug in 
the matrix as weIl as the matrix erosion resulting from degradation and dissolution of 
smaller weight pol ymer. These processes are affected by physicochemical properties of the 
drug, polymer and the drug delivery system along with various formulation factors. The 
pharmaceutical properties of NPs include carrier nature, particle size and size distribution, 
surface and bulk morphology, surface chemistry, charge, encapsulation efficiency and in 
vitro drug release kinetics. AIso, another important issue is the influence of formulation 
factors including nature and concentration of polymer/s used, type and concentration of 
emulsifiers, ratio of oil to water phase, effect of centrifugation, lyophilization etc. on the 
final properties of NPs. Although many of these factors have been investigated in detail to 
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improve above-mentioned phannaceutical properties ofNPs [11-17], very few studies have 
undertaken detailed investigation of mechanism of release from NPs [18-26]. 
Unfortunately, the experiments in this field can only observe the macroscopic behavior of 
drug release, and the information on the drug diffusion mechanism in pol ymer at molecular 
level is still very limited. Knowledge on the diffusion mechanism of drug molecules in 
polymer matrix and the intermolecular interactions of drug molecules with the polymer 
chains would help us to understand the diffusion of drug molecules in polymeric 
nanocarriers and finally, it would guide us to design a controlled release material for a 
specified drug. Research in this area is still lacking probably due to unavailability of high 
resolution methods to probe into internaI microporous structure of these nanosized 
materials. 
2.1.1.2 Gas adsorption and microstructure of NPs 
It is very weIl known that bulk and surface morphology can have profound effect on 
release properties on NPs [27]. Although surface morphology of NPs has been studied 
qualitatively by scanning electron microscope (SEM) [28-30], atomic force microscope 
(AFM) [28, 29, 31] and transmission electron microscroscope (TEM) [30-32], there are no 
reports on the elucidation of bulk morphology of NPs, especially relating to their 
microporous structure. Since sm ail pores in few nanometer range can affect matrix 
hydration, drug diffusion into release medium as weil as polymer degradation [33J, it is 
of great importance to gain insight into these small pores (micropores) during NP 
formation. ln the first part of this thesis, we propose to undertake extensive investigation 
of effect of various formulation variables studied so far on the microstructure of NPs and 
in turn, on their release kinetics. We hypothesize that formulation factors (e.g. drug 
loading) will affect the internai structure, especially microporosity of NPs and this will 
have global effect on release profiles of the encapsulated drugs. We also hypothesize that 
these changes in microporosity (in few angstroms) will be more important in determining 
the rate of release from NPs than changes in bigger mesopores. Here, micro pores are 
defined as the pores sm aller than 2 nm and mesopores are in the size range of 2-50 nm. 
lt is quite logical to assume that bigger mesopores will either be absent or rarely present 
in NPs of size 200 nm. lnterestingly, in parallel with our studies, there is a recent report 
on pore size distribution measured by NMR cryporometry, where Petrov et al [33J have 
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correlated pore size distribution in 30-70 nm to the swelling and drug release kinetics. 
However, if should be noted that the study was carried out on microparticles and not on 
nanoparticles. 
In this regards, we propose application of gas adsorption technique to investigate 
microporosity of NPs of 200 nm in size. This technique allows assessment of a wide range 
of pore sizes (from 0.35 nm to 100 nm), which includes the complete range of micro- and 
mesopores, and even (partia11y) macropores. The analysis of a nitrogen isotherm allows one 
to obtain parameters such as total pore volume, micropore volume, BET surface area, pore 
size distribution (PSD) as weIl as surface fractal dimension. These param~ters are 
commonly used for characterization of zeolites, clays and various catalysts [34-37]. 
Although the se parameters can prove to be very useful in understanding the surface 
morphology as weIl as microstructure of NPs, their use in the area of drug delivery is not 
reported so far. Rence, the initial investigation was planned to verify the usefulness of this 
technique for characterization ofNPs for the first time in the field ofNPs, and establish the 
relationship between microporosity and drug release kinetics. 
2.1.2 Hypothesis 2 
Molecular architecture (block or graft) of the polymer will define the internaI 
structure as well as the microporosity of nanoparticles during their formation through 
definite reorganization of different chains. This, in turn, will affect drug release rate. 
2.1.2.1 Justification of studying effect of polymer architecture 
on release kinetics 
To further confirm the first hypothesis, PLA homopolymer, and its pegylated 
copolymers with different molecular architecture (graft or linear block copolymer) were 
used to prepare NPs. It was hypothesized that polymers wouldrearrange differently during 
NP formation depending on their architecture, leading to important change in the internaI 
NP structure, which will consequently affect drug release kinetics. 
A poor correlation exists between effect of PEG incorporation into NPs and their 
release properties. Sorne authors have reported increased drug release with increased PEG 
content [14, 20, 21], whereas others reported the reverse trend [38] and sorne others have 
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reported no or only slight effect of PEG incorporation on the release rate [39, 40]. It is 
worthy to mention that various polymer architectures are being synthesized recently for 
controlled and targeted drug delivery; however, very few studies compare different polymer 
architectures for their in vitro properties [41, 42]. One such recent study includes 
comparison of diblock, triblock and star-shaped copolymer of PLA and PEG indicating 
clear differences in their morphology and release properties [41]. This demands further 
studies on polymer architecture to elucidate differences in properties of drug delivery 
systems, and more importantly, it would also offer a valuable feedback to properly tune and 
optimize biopolymers of a new generation for high-quality drug products. 
2.1.3 Hypothesis 3 
Molecular architecture of the polymer will also affect the surface properties of the 
NPs due to chain reorganization during nanoparticle formation. This will influence the 
protein binding ability and cellular interactions of these nanoparticles. 
2.1.3.1 Justification for studying surface properties 
Today the concept of drug delivery is not limited to prolonging the duration of drug 
release; instead, it implies at least two strategies for realizing temporal (predetermined drug 
release kinetics) and spatial distribution control (precisely directing the drug vehicle to the 
desired site of action) in the body. To achieve this, various nanosystems have been 
developed using a multidisciplinary approach based on chemistry, material science, 
bioengineering, biology and medicine. This approach has brought to notice the significance 
of polymer architecture-property relationships. Polymer architecture markedly influences 
not only the physicochemical properties of the polymer, but also various aspects of the drug 
delivery system including drug release rate, biodistribution and even interaction with 
specific tissues or cells in vivo [43]. Thus, optimizing polymer architecture is an intelligent 
strategy to develop desired pharmaceutical product. Such studies would offer valuable 
feedback to tune properties ofpolymer-based drug delivery systems. 
In the area of colloidal drug delivery systems, it is a major concem how particles 
interact when they come in contact with the physiological fluids or tissues. Bence, surface 
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properties of NPs must be properly designed to maximize the potential for favorable and 
minimize for unfavorable interactions. 
Once the long-circulating carrier reaches the desired tissue, the next step is its 
intracellular entry. Intracellular trafficking of macromolecules is a very complex 
phenomenon and has been reviewed recently [44]. It involves different pathways like 
phagocytosis (for large particles and by specialized cells like macrophges, neutrophils and 
dendritic cells) and pinocytosis (generally common to all cells) as discussed before in the 
introduction. Which of these pathways are involved in the uptake mechanism of the carrier 
will be dependent on its surface properties and will decide the extent of uptake into the 
cells. White severa/ studies corre/ate various physicochemica/ properties to protein 
adsorption and/or in vitro phagocytosis of these partie/es in macrophages, reports 
focusing on their uptake mechanisms are stilliacking in the literature. Indeed, cellular 
uptake mechanisms have been studied in detail for various other cell lines including 
epithelial and cancer celllines whereas their role in macrophage uptake was seldom studied 
except few studies like Raynal et al . [45]. They have demonstrated scavenger receptor 
mediated endocytosis of superparamagnetic iron oxide NPs by mouse peritoneal 
macrophages. It is reported that phagocytosis takes place for particles larger than 500 nm in 
size; however, it is not yet clear why and how smaller particles are then taken up by 
macrophages. It is possible that macrophages can effectively take up these 200 nm or 
smaller particles by mechanisms other than phagocytosis. Although it is shown that 
presence of PEG on the surface of these NPs reduces their macrophage uptake, whether it is 
really by reduced phagocytosis or by other mechanisms like endocytosis, macropinocytosis 
or fluid phase pinocytosis still remains a topic of research. Further, if this reduced 
macrophage uptake of small size NPs is by reduced endocytosis, the same rule will 
definitely be extended to other non-phagocytic cells in the body, thus seriously hampering 
the efficacy of intracellular distribution of pegylated NPs. In fact, incorporation of PEG has 
demonstrated usefulness in controlling pharmacokinetics of the carriers on one hand while 
hampering their interaction with the targeted cells and thus, therapeutic efficiency, 
especially in gene delivery [46-50]. Hence, in the second part of this thesis, work was 
undertaken to evaluate effect of diverse molecular architecture of formulated pegylated 
NPs on their surface properties. Further, efforts were made to find out correlation 
hetween these physicochemical properties with their protein adsorption and in vitro 
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macrophage uptake. A/so, detaUed investigation was carried out to shed some light on 
their uptake mechanismls by macrophages. 
2.2 Objectives 
The challenge of modem drug delivery systems is optimization of the activity of 
drug coupled with the reduction of its si de effects in vivo. One approach is the use of 
colloidal drug carriers like nanopartic1es (NPs) that can provide site-specific drug delivery 
combined with optimal drug release profiles. Release kinetics of drug from NPs can be 
influenced by various factors such as size, drug-polymer interaction, internaI structure of 
the matrix etc. Although majority of factors have been studied previously, the reports on 
importance of micropores and porosity of NPs are still lacking probably due to the 
availability of methods with high resolution. Thus, first goal of this study was to gain 
insight into microporosity of NPs and establish a correlation between microporosity and 
drug release kinetics. An important objective was to establish whether polymeric NPs 
possess definite/reproducible internaI structure during their formation by emulsion-solvent 
evaporation method. It was sought to find out the effect of formulation factors like drug 
loading and polymer architecture on their internaI structure and subsequently, on the release 
kinetics. After optimizing the release rate from NPs, it is equally important to pay attention 
to properties such as charge, surface chemistry, protein resistant capacity and 
cytocompatibility for their stability and use in vivo. Thus, the second goal was complete 
characterization of their physicochemical and biological properties along with the study of 
mechanism of their intracellular uptake to test the feasibility of their use in vivo for any 
therapeutic application. 
Thus major objectives were: 
1. Synthesis and characterization of biodegradable polyester-based polymers like 
poly(D,L-Lactide) (PLA), polyethylene glycol grafted on the backbone of PLA 
(PEG-g-PLA) and multiblock copolymer of PLA and PEG (PLA-PEG-PLA)n. 
2. Optimize the preparation ofNPs using these polymers and Propafenone.HCI (Prop), 
a model drug. 
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3. Physicochemical characterization of prepared NPs for particle size, drug loading 
efficiency, differential scanning calorimetry, drug release kinetics, surface 
morphology by Atomic force microscopy etc. 
4. Porosimetry (microporosity, fractal dimension, total pore volume, BET surface area 
etc.) of prepared NPs and effect of different parameters like polymer type, polymer 
molecular weight, effect of solvent evaporation method, effect of drug loading etc. 
on porosimetry of these NPs. 
5. Establishment of correlation between microporosity and drug release kinetics of 
NPs. 
6. Chemical surface characterization ofNPs using XPS technique 
7. Zeta potential measurement and plasma protein adsorption studies using SDS-
PAGE on pegylated and non-pegylated NPs 
8. Characterization of prepared NPs for their cytotoxicity (along with the safety of 
blank nanoparticles) and mechanism of their intracellular uptake using murine 
macrophage cellline (RA W 264.7) 
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3.1 Abstract 
Nanopartic1e preparation by emulsification-solvent evaporation method is a 
complex phenomenon. Various fonnulation factors can affect the internaI structure and 
release of drug from nanopartic1es (NPs). Aim of the present study is to optimize NPs of 
PEG-g-PLA polymer and study the effect of various factors on the porosity as well as 
release profile of drug-Ioaded NPs. Propafenone hydrochloride (Prop. HCI), a model drug, 
was encapsulated in the NPs using different amounts of triethylamine (TEA) and initial 
drug loading levels. NPs were also prepared without TEA by using propafenone base 
(Prop). AlI the fonnulations were characterized for surface morphology, size and size 
distribution, encapsulation efficiency, thennal analysis, porosimetry and in vitro release 
studies. Encapsulation efficiency of Prop ranged between 10-43 % and was dependent on 
initial drug loading as well as amount of TEA added. Porosity studies revealed that use of 
TEA altered the pore size distribution compared to fonnulations without TEA. 
Fonnulations with higher drug loading showed greater volume contribution of small pores, 
higher fractal dimension suggesting more complex pore structure and slower drug release, 
probably due to decrease in the effective diffusion coefficient of Prop. Results suggest that 
fonnulation factors play an important role affecting the porosity and release rate of NPs. 
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AIso, fractal dimension could be one of the most important factors in determining the 
release behavior ofNPs. 
Keywords: Nanoparticles, Porosity, Fractal dimension, Release, Grafted polymer 
3.2 Introduction 
In recent years, issues in targeted drug delivery are gaining importance with the 
availability of more potent and specific drugs and in-depth understanding of 
pathophysiology and cellular mechanisms underlying the disease conditions. AlI the 
therapeutic agents could be benefited by targeting to specific tissues without reducing their 
therapeutic efficacy. Nanoparticles(NPs), because of their versatility, sustained release 
properties, sub-cellular size and biocompatibility appear to be a promising system to 
achieve these important objectives. Nanoparticulate systems have great potential, being 
able to convert poorly soluble, poorly absorbed and labile biologically active substances 
into promising drugs. However, uptake of conventional NPs by reticuloendothelial systems 
after intravascular administration limits their use [1]. Therefore, the concept of long-
circulating NPs using amphiphilic copolymers has emerged. Such carriers can provide a 
long circulating drug reservoir from which the drug can be released into a vascular 
compartment in a continuo us and controlled manner [1-3]. 
Drug release from NPs is interplay of various factors including nature of polymer, 
physicochemical properties of drug and formulation factors. Although release of bioactive 
molecules from nano- or microparticles has been the focus of many investigations [4-13], 
effect of these factors on the microstructure of NPs remains to be explored. It has to be 
pointed out that the composition and manufacturing procedure of nano- or microparticles 
can strongly affect the underlying release mechanisms [14]. Additives used in the 
formulation may change the characteristics of the final drug delivery system. It is weIl 
known that the NP preparation by o/w emulsion-solvent evaporation is a complex process 
in which, the organic solvent generates pores in the structure during its evaporation. This 
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may lead to changes in the microstructure of NPs significant enough to affect their physical 
properties, especially the release kinetics. 
The porous structure of a material is important in both natural phenomena and 
practical applications such as dissolution, adsorption and diffusion of drugs [15]. Lemaire 
et al suggested that, during release, a drug mole cule located inside a pore would naturally 
diffuse towards one of the end-points of the pore and eventually reach outside. If a drug 
molecule is present within the network of micropores, it will have to diffuse towards the 
closest pore to be released outside. The movement of such molecule in the micropore 
network is highly restricted due to the limited space available [16]. Thus, in other words, 
the effective pore diffusion coefficient will be smaller than the diffusivity in a straight 
cylindrical pore as a result of the random orientation of pores leading to longer diffusion 
path. This effective restricted diffusion coefficient of the drug in the porous media is a 
function of the diffusivity of drug, porosity (E) and tortuosity (t) of the matrix. The 
tortuosity in tum depends on the pore structure, pore size and shape distributions [17]. 
Pore size measurements can provide information about pore diameter and volume. It 
can be determined by gas adsorption and mercury porosimetry. From nitrogen adsorption 
isotherms, sorne basic structural information such as BET surface area, mean pore size, 
pore size distribution and total pore volume can be obtained. Additional information can be 
obtained about fractal geometry, which suggests that the surfaces of most materials are 
fractal at molecular level due to atom packing arrangements and defects. This surface 
fractal dimension (D) can be calculated from the adsorption and desorption data [18]. The 
value of D for solid surfaces can vary from 2 (smooth, regular surface) to 3 (very rough 
surface). Recently, Neimark et al [19, 20] proposed a thermodynamic method for 
calculating surface fractal dimension from adsorption isotherm data based on the 
relationship between the surface area of the adsorbed film and the average pore radius. Use 
of fractal dimensions in pharmaceutical sciences has been proposed since more than a 
de cade [21], however, it has been used mostly to study dissolution behavior of granules and 
powders [22-26]. The authors have used surface fractal dimension suggesting that the 
dissolution would be faster for high value of D due to rougher surface of particles. In 
addition to the surface heterogeneity, the structural heterogeneity of the given solid, 
generated by the existence of pores of different sizes (i.e. micro and mesopores), can 
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contribute significantly to D [27]. Greater the value of D suggests more complex pore 
structure and restricted diffusion of the drug molecule within the pore network. 
The aim of the present study was to optimize stealth NPs of a novel polymer, PEG-
g-PLA encapsulating a model drug, propafenone hydrochloride. The second objective was 
to study the effect of triethylamine (TEA) and drug loading on the physicochemical 
properties of NPs including porosity and surface morphology. In this article, we also 
address the effect of these different variables on the microstructure and thus, on the release 
kinetics ofNPs by introducing fractal dimension as a new parameter. 
3.3 Materials and Methods 
3.3.1. Materials 
D,L- Lactide, poly( ethylene glycol) methyl ether (2,000 Da), Allyl glycidyl ether, 
tetraphenyltin, Polyvinyl alcohol (PV A, average Mw 9,000-10,000 Da, 80% hydrolyzed) 
and triethylamine (TEA, 99.5%) were purchased from Aldrich chemical company Inc., 
Milwaukee, USA. Propafenone hydrochloride (Prop.HCl) was obtained from Sigma 
chemical company, St. Louis, USA. Sodium hydroxide pellets were purchased from 
Anachemia Canada Inc. and dichloromethane (DCM) was purchased from Laboratoire Mat 
Inc., Montreal, Quebec, Canada. 
Propafenone base (Prop) was obtained from Prop.HCl by addition of TEA. Briefly, 
excess TEA was added to 100 mg of Prop.HCl in DCM. The TEA.HCl was removed by 
extraction into water and Prop was collected after evaporation of the organic layer. 
3.3.2. Synthesis of polymer 
The polymer, polyethylene glycol grafted randomly on poly-(D,L) lactic acid (PEG-
g-PLA) (Mw 29,000 Da, PEG Mw 2,000 Da) was synthesized in our lab as reported earlier 
[28]. Briefly, D,L-lactide (21.5 g, 99 mol %) was polymerized in presence ofallyl glycidyl 
ether (0.343 g, 1 mol %) with tetraphenyltin as a catalyst (1:10,000 moles with regard to 
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lactide) at 180°C for 6 h under argon. Polylactic acid with allyl groups was purified by 
dissolving in ethyl acetate and precipitating in water. The allyl groups were converted to 
hydroxyl group by hydroboration with equimolar quantity of borane in tetrahydrofuran 
followed by oxidation in the presence of hydrogen peroxide under alkaline conditions (1.5 
moles of 3 M sodium hydroxide). Hydroxyl group was oxidized to carboxylic acid group 
using Jones reagent, which was further converted to an acid chloride using thionyl chloride 
(1:1000 M). Finally, methoxy-PEG was grafted onto the polymer backbone by the reaction 
between acid chloride and the hydroxyl group of methoxy-PEG (2,000 Da) in presence of 
pyridine. Subsequently, the final polymer was purified by evaporating pyridine and 
washing with distilled water. 
IH NMR spectra were recorded on Brucker ARX 400 spectrometer. Chemical shift 
(8) was measured in ppm using tetramethylsilane (TMS) as an internaI reference. Size 
exclusion chromatography was performed on Water associate chromatography system with 
a differential refractometer as detector and Phenomenex Phenogel 5 I-! as column. 
Polystyrene standards were used for calibration with chloroform as mobile phase at a flow 
rate of 0.6 mL/min. Chemical structure of polymer and NMR spectrum is shown in figure 
3.1. 
3.3.3. Preparation of Nanoparticles (NPs) 
NPs were prepared by emulsion-solvent evaporation method. PEG-g-PLA polymer 
(300 mg) was dissolved in 10 mL of DCM and emulsified in 50 mL of 0.5 % w/v PV A 
solution as an external aqueous phase using high-pressure homogenizer (Emulsiflex C30, 
Avestin, Ottawa, Canada) at a pressure of 10,000 psi for 3 min. The emulsion was collected 
by washing with another 50 mL of 0.5 % PV A. The DCM was evaporated under reduced 
pressure with constant stirring to obtain nanoparticles. Finally, the particles were collected 
by centrifugation at 35,000 g for 45 min (Sorval® EvolutionRc, Kendro, USA). The PV A 
present in the supernatant was detected by a colorimetric method described in the section 
2.4.4. When no PVA was detected in the supernatant, the nanoparticle suspension was 
lyophilized (Freeze Dry System, Lyph.Lock 4.5, Labconco) and stored at 4°C until further 
use. Drug-Ioaded nanoparticles of either Prop.HCI or Prop were prepared in the similar 
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manner using initialloading levels of 5 or 10% w/w of pol ymer. Prop.HCI was dissolved in 
DCM using different ratios of triethylamine (TE A) whereas for Prop, no TEA was added. 
TEA added in case of Prop.HCI transformed the drug into free base, which dissolved in 
DCM without any precipitation. Summary of different formulations is given in table 3.1. 
For the convenience, formulations are labeled such that the number denotes the loading 
level used and the suffix in italics denotes the ratio of Prop: TEA; for example, 5 J:J me ans 
the batch prepared with 5% initial drug loading and 1: 1 Prop.HCI: TEA ratio and 50 
indicates batch prepared with 5% initialloading with no TEA added. 
3.3.4. Characterization of NPs 
3.3.4.1. Particle size distribution 
Nanoparticle size and size distribution was measured by dynamic light scattering 
(DLS) (N4 Plus, Coulter Electronics, Miami, FL, USA) both before and after 
lyophilization. For aIl the batches, fresh NPs suspensions (0.1 mL) or 1 mg of dry NPs were 
dil uted 10-100 times and size measurements were performed at 25 0 C and 90 0 scattering 
angle for 180 seconds. The mean particle diameter was calculated using differential size 
distribution processor (SDP) intensity analysis program. 
3.3.4.2. Morphology 
Surface morphology of NPs before and after resuspension was studied usmg 
Nanoscope IlIa Dimension 3100 atomic force microscope (Digital Instruments, Santa 
Barbara, CA, USA). Samples were prepared by deposition of particles on freshly cleaved 
mica followed by air-drying. Images were obtained using TappingMode™ etched silicon 
probes (TESP7) with spring constant of 20-100 N/m and resonant frequency of 200-400 
kHz. Cantilever length was 125 !lm. 
3.3.4.3. Encapsulation Efficiency (EE) 
NPs were suspended in IN NaOH for 1 h to which ethanol was added followed by 
acidification with IN HCL Amount of drug entrapped was then measured by 
spectrophotometry at 305 nm (U-2001 UVNisible spectrophotometer, Hitachi). Percent 
encapsulation efficiency (% EE) was calculated as the ratio of amount of drug entrapped to 
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the total amount of drug added initially. For all the fonnulations, % EE is expressed in 
tenns of the propafenone base (Prop). 
3.3.4.4. Determination of Residual PV A 
The amount of PV A remaining in the NPs was detennined by a colorimetric method 
based on the fonnation of a colored complex between two adjacent hydroxyl groups of 
PV A and an iodine molecule [4]. Briefly, 2 mg of lyophilized NPs were dissolved in 1 mL 
of 0.5 N NaOH, neutralized by 1 N HCI and the volume was made up to 5 mL with distilled 
water. To this, 3 mL of saturated solution of boric acid and 0.5 mL of 0.1 N Iodine was 
added, and the volume was made up to 10 mL with distilled water. The absorbance was 
measured at 660 nm on Hitachi 2000 spectrophotometer. The amount of PV A was 
calculated by using the calibration curve of PV A prepared under the same conditions. 
3.3.4.5. Differentiai Scanning Calorimetry (DSC) 
The thennal properties of the polymer and drug in the physical mixture and NPs 
were characterized by DSC analysis (DSC Q1000, V9.0, build 275, Universal 4.1 D, TA 
Instruments, USA). Unless otherwise specified, measurements were done (n=2) on 
polymer, Prop.HCI, Prop (pure base), polymer: Prop.HCI, polymer: Prop physical mixture 
and drug-Ioaded NPs. Physical mixture was prepared by triturating polymer and Prop.HCI 
or Prop in the ratio similar to the highest drug loaded NPs (48: 2 w/w respectively). In 
brief, weighed samples were sealed in crimped aluminum pans with lids and heated at the 
rate of 10°C/min from -40 to 200°C. The samples were purged with pure dry nitrogen at a 
flow rate of 50 mL/min. The DSC was calibrated for tempe rature with indium (Goodfellow, 
99.999% Pure), and tin (NIST SRM 2000). The instrument was calibrated for heat flow 
with indium (Goodfellow, 99.999% Pure). 
3.3.4.6. Porosity measurements 
Total surface area and porosity of the NPs were measured by nitrogen adsorption 
using a porosimeter (Quantachrome instruments, Autosorb-FM, Gas sorption system, ON, 
Canada). Briefly, weighed amounts of NPs were placed in the glass cells and outgassed 
with nitrogen at 25°C for 3 h before analysis. Subsequently, the sample and the reference 
cells were immersed in liquid nitrogen at -196°C and adsorption isothenn was obtained 
53 
from the volume ofnitrogen (cc/g) adsorbed onto the surface ofnanoparticles as a function 
of relative pressure. Total surface area was calculated by Brunauer-Emmette-Teller (BET) 
method using five adsorption points in the PlPo range of 1 - 3. Pore size distribution (PSD) 
was calculated according to Horvath-Kawazoe (HK) method in the pore size range of 0 -20 
A and surface fractal dimension was obtained by Neimark-Kiselev (NK) method using the 
Autosorb-l ™ software. Mathematical details of HK and NK methods could be found in 
details elsewhere [29,30] and [19,27], respectively. 
3.3.4.7. In vitro release study 
AlI the 6 formulations prepared using different amount of TEA and drug loading 
levels were tested for in vitro release in triplicate in PBS, pH 7.4. Fifty mg of NPs were 
suspended in 2.5 mL PBS in a dialysis tubing (Spectra Por 1 membrane, 6-8 kDa cut-off). 
This dialysis tubing was placed in a screw-capped tube containingl0 mL PBS. The tubes 
were shaken at 200 rpm on a horizontal water bath shaker (Orbit Shaker Bath, Labline) 
maintained at 37 ± 1°C. At predetermined time intervals, the whole medium in the tube was 
withdrawn and replaced by fresh PBS to maintain sink conditions. The aliquots were 
assayed for the amount ofProp released by spectrophotometry at 305 nm. 
3.4 Results and Discussion 
3.4.1. Characterization of polymer 
IH NMR spectrum of PEG-g-PLA polymer is shown in fig. 3.1 along with the 
structure. Multiplets corresponding to lactic acid -CH could be observed at 5.17 ppm. 
Overlapping doublets at 1.56 ppm were due to the methyl groups of D- and L-Iactic acid 
repeat units. A peak at 3.64 could be attributed to the methylene groups of polyethylene 
glycol. Molecular weight and molecular weight distribution of the polymer were 
determined by size exclusion chromatography. The number average and weight average 
molecular weights of the polymer were found to be 20,600 and 29,000 Da, respectively. 
Polydispersity was 1.4. Unimodal mass distribution ruled out the possibility of presence of 
unreated methoxy PEG or Poly (D,L-Iactide). 
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3.4.2. Morphology and particle size measurements 
Particle size distribution by DLS showed unimodal distribution for freshly prepared 
as well as resuspended NPs. Different formulations showed similar particle size in the 
range of 178-192 nm (Table 3.1). Thus, drug loading levels as well as amount ofTEA used 
had no apparent effect on the particle size, suggesting that the size was largely controlled 
by the emulsification process during nanoparticle preparation. However, the particle size 
for all the batches was increased almost 1.5 times after resuspension in spite of the use of 
Tween 80 (0.01%) or probe sonication (1-5 min) for resuspended NPs (data not shown). 
AFM revealed that NPs were spherical with smooth surface and displayed their aggregating 
tendency (Fig. 3.2). Therefore, the increase in particle size found by DLS might be due to 
aggregation of the particles. Thus, it should be noted that the results of particle size 
distribution by light scattering method should be supplemented with sorne visual methods 
like AFM. 
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Figure 3.1. Chemical structure and NMR spectrum ofthe polymer, PEG-g-PLA 
55 
)( 0.200 .... /div 
Z 100.000 .... /div 
Figure 3.2. Surface morphology ofNPs (formulation 10/:/)by AFM. 
3.4.3. Encapsulation efficiency (EE) 
As seen from the table 3.1, EE of Prop.HCI was very low (10%) for formulation 
prepared without TEA. However, it increased from 10 % to 43 % with use of TEA. This 
could be due to the fact that TEA scavenges hydrochloride from Prop.HCI, thus, setting 
free the pure hydrophobic base (Prop). This allows efficient physical entrapment of Prop in 
the hydrophobic PLA core of the pol ymer, resulting in the improved encapsulation 
efficiency. To further support this, pure base was isolated from its hydrochloride salt and 
incorporated in NPs. It was observed that EE of formulations prepared with pure base was 
comparable with those prepared with 1: 1 Prop.HCI: TEA ratio at the same loading levels. 
With increase in the amount of TEA, EE further increased by l.5 times. Kohori et al [31] 
also showed increased incorporation of adriamycin (ADR) into micelles with increased 
level ofTEA (1 :2.4 molar ratio of ADR.HCI: TEA) attributing it to the effective removal of 
hydrochloride and more efficient physical entrapment. AIso, EE was always more at 5% 
initial loading than 10% for the same Prop:TEA ratio. It is noteworthy to mention that the 
increase in the EE is not accompanied by any increase in the particle size. However, the 
reason for observed increase in EE with higher molar ratio above 1: 1 is not known. There 
are rnany reports citing the interaction between the carboxylic groups of PLA and amino 
groups of basic drugs like leuprorelin acetate [32, 33]. The authors have reported that 
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degree of interaction between the drug and the polymer determines the entrapment 
efficiency. Thus, we propose that addition of TEA more than stoichiometric ratio probably 
favors removal of hydrochloride more efficiently in situ favoring the ionic interaction 
between the carboxylic groups of PLA and basic amino groups of Prop, which finally 
results in the improved encapsulation efficacy. 
Table 3.1. Summary of different formulations and their characterization 
Fonnulat Fonn of Loading Prop:TEA Size (nm)a PI PVA EE (%)b IOn drug (% w/w) (M) (% w/w) 
50 Prop 5 0 180 ± 20.8 0.235 6.71 ±Oo4l 28.03 ± 6.0 
5/:/ Prop.HCI 5 1:1 188 ± 50.1 0.104 6.38 ± 0.83 29.57 ± 5.3 
5/:2 Prop.HCI 5 1 :2 192 ± 40.8 0.101 6.05 ± 0.53 42.75 ± 3.7 
100 Prop 10 0 190 ± 38.3 0.009 6.81 ± 0.59 23.66 ± 1.0 
10/:/ Prop.HCI 10 1: 1 184 ± 33.8 0.222 7.18 ± 0.60 21.63 ± 0.7 
101:2 Prop.HCl 10 1 :2 178 ± 20.8 0.053 6.78 ± 0044 40.75 ± 2.2 
VII Prop.HCI 10 0 184 ± 45.2 0.143 nd 9.81 ± 1.8 
AlI values indicate ± S. D. for n= 3 independent experiments 
a: Median 
b: Mean 
PI: Polydispersity, EE: Encapsulation efficiency, nd: not determined 
3.4.4. Resid ual PV A 
It is widely reported that surfactant remaining on the surface of the NPs alters their 
properties such as particle size, hydrophilicity, release kinetics, cellular uptake etc. [4]. 
Therefore, it is important to know the amount of surfactant associated with the final 
lyophilized NPs. Our basic purpose to determine the residual PV A was to confirm that the 
difference in release kinetics of NPs was not due to presence of different amount of PV A. It 
was observed that a fixed amount of PV A (6-7 % w/w) remained on the surface of all the 
formulations even after 4-5 washings (Table 3.1). An attempt was made to evaluate 
whether PV A was present either inside the polymeric matrix or on the surface of the 
particles. To determine the surface-associated PV A, NPs were suspended in distilled water 
(data not shown), whereas for total amount of PVA associated with the particles (amount 
entrapped as well as present on the surface), NPs were digested in 0.5 N NaOH. The same 
amount of PV A (6-7 %w/w) was present in the given NP formulation by both assays 
confirming that the amount of PV A was solely associated with the surface of the particles 
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(Table 3.1). This might be the reason of the observed aggregating tendency of NPs. Our 
results are in accordance with other authors. Sahoo et al [4] have reported 6.15% w/w PV A 
remaining with DCM as solvent and 5% PV A solution as external aqueous phase for PLGA 
NPs. Zambaux et al have also reported 5-6 % w/w PV A associated with PLA NPs after 3 
washings when 1 % PV A was used as an external aqueous phase [34]. There was no 
significant difference in the amount of PV A associated with the different formulations 
probably because the same solvent and same polymer was used for the preparation of an 
the formulations. Thus, the possibility of residual PV A playing any role towards difference 
in the release kinetics could be ruled out. 
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Figure 3.3. DSC curves of (1) Prop.HCI; (2) base (Prop); (3) Polymer; (4) Physical 
mixture of Prop.HCI: Polymer; (5) Physical mixture of Prop: Polymer and 
(6) Drug loaded NPs (101:2) 
3.4.5. Thermal analysis 
DSC was used to detect possible drug crystallization inside the NPs as weIl as any 
possible interaction between the drug and the polymeric matrix. As shown in the fig. 3.3, 
DSC curve of PEG-g-PLA showed an endothermic peak corresponding to the glass 
transition (Tg) at - 48°C. The melting peak of the Prop.HCI crystals and Prop (base) 
appeared at - 173 and 91°C respectively. This melting endotherm could also be detected in 
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the drug: polymer physical mixtures (2:48, respectively); however, there was broadening of 
this peak. As seen form fig. 3.3, Tg of polymer was also shifted by 2-3°C in both the 
physical mixtures, indicating sorne interaction between drug and polymer. After 
encapsulation of Prop.HCI in the NPs, Tg of the polymer further shifted to - 54 oC, which 
might be due to the effect of process or formulation variables. AIso, melting point 
endotherm of drug disappeared (Fig. 3.3) indicating presence of drug in the amorphous or 
solid dispersion state in the polymer matrix [35]. Our results are in accordance with 
Miyajima et al [36] who have reported increase in Tg of copoly (lactic/glycolic acid) after 
incorporation of basic drugs. This may be because of interaction between the polymer 
carboxyl residues and amino group of drug as suggested by the authors [36]. 
3.4.6. Surface area, pore size distribution and fractal dimension 
Table 3.2. Porosity measurements for different formulations 
No Prop:TEA Lt Lr Total pore Micropore BETSA D 
(M) (%w/w) (%w/w) vol (cc/g) SA (m2/g) (m2/g) 
50 0 5 1.40±0.3 0.34±0.06 18.2 ± 6.3 25.2±5.3 2.538±0.04 
5/:1 1:1 5 1.48±0.3 0.31±0.09 15.8 ± 5.0 23.2±4.9 2.529±0.05 
5/.2 1:2 5 2.14±0.2 0.33±0.09 16.0 ± 5.4 23.1±4.9 2.516±0.01 
100 0 10 2.37±0.1 0.38±0.03 22.4 ± 0.5 28.4±6.1 2.582±0.1 
10/:1 1:1 io 2.16±0.1 0.37±0.06 18.3± 3.2 24.9±5.3 2.572±0.01 * 
101:2 1:2 10 4.08±0.2 0.35±0.05 18.1 ± 3.1 24.6±4.8 2.577±0.01 * 
All values indicate Mean ± S. D. for n=3 independent observations, 
Lt : Theoreticalloading, Lr: Realloading, SA: surface area, D: fractal dimension, 
*: P < 0.05, Student's paired t-test 
In order to find out the microstructure of the particles, PSD was measured using 
nitrogen adsorption porosimetry. According to IUPAC definition, pores with a diameter 
below 40 A are micropores and that between 40 to 1000 A are mesopores. As seen from 
table 3.2, there was no significant difference between total pore volume, micropore surface 
area and BET surface area for different formulations. PSD also followed the similar pattern 
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above 20 A for aIl the formulations. However, there was difference between the 
formulations depending on the drug loading for PSD below 20 A. 
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Figure 3.4. Pore size distribution for various formulations with (a) or without (b) 
TEA. AU values are mean ± S. D. for n= 3, Inset in fig b shows the pore size 
distribution on the same scale as Fig. 3.4 a. 
As shown in fig. 3.4, formulations with 10 % drug loading had greater volume 
contribution of smaller pores as compared to those with 5 % drug loading. Also, it should 
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be noted that different amount of TEA at the same drug loading level exhibited same PSD. 
It seems logical to assume that if higher amount of drug were initially available to be 
accommodated in the same size of NPs, it would lead to the fonnation of a heterogeneous 
matrix as suggested by Gomer et al [5]. This would lead to more compact internaI structure 
increasing number of smaller pores for fonnulations with 10% loading. 
As shown in fig. 3.4 a, aIl the fonnulations prepared with different amounts of TEA 
had larger pores with peak at around 8-9 A (fonnulations 51:1, 51:2 and 101:1, 101:2) whereas 
those prepared without TEA (fonnulations 50 and 100), showed additional pore population 
towards smaller micropores at around 4.7 A (Fig 3.4 b). This may be a complex effect of 
drug loading and TEA, and could be explained as follows. TEA added during preparation 
of NPs increased the drug loading due to hydrophobic interaction between the drug and 
polymer masking the smaller pores with peak around 4.7 A which was present in the 
fonnulations without TEA. At the same time, escaping TEA.HCI soluble in the aqueous 
external phase would have also contributed to larger pores along with evaporating organic 
solvent, thus shifting the PSD slightly towards larger pores (8 A). In other words, 
fonnulation prepared in the presence of TEA showed only one peak due to escaping 
TEA.HCI whereas those prepared without TEA showed both the peaks. It is noteworthy 
that aIl the four fonnulations with TEA followed similar pattern of PSD emphasizing sorne 
control exercised by TEA in pore fonnation. 
The observed difference in the PSD was also reflected on the surface fractal 
dimension (D), which is related to the surface irregularities created by the pores open at the 
surface. Thus, it can reflect the pore size distribution. GeneraIly, the value of D is high 
when the volume of the small pores is important and decreases when the contribution of 
smaller pores decreases [27, 37]. These pores can be more complex from inside, thus 
creating tortuous matrix. As seen from the table 3.2, D was similar for fonnulations with 
same theoretical drug loading because aIl of them showed similar PSD. Fonnulations with 
10% loading al ways had higher proportion of smaller pores (Fig. 3.4 a and b) and greater 
value for D. Thus, it can be seen that the initialloading level influenced the PSD and fractal 
dimension ofNPs. 
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3.4.7. In vitro Release 
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Figure 3.5. Effect ofTEA (0,1:1,1:2) on the release profile ofNPs at different drug 
loading levels, a; 10 % and b; 5 %. Error bars indicate mean ± S. D. for n= 3 
Drug release from microdisperse system is a complex phenoÎnenon affected by 
various factors including the drug loading, additives and the internaI structure of the NPs. 
There are many reports on the factors affecting the release behavior of the drug from the 
NPs; nevertheless, the effect of porosity on the release behavior of the drug from NPs has 
been rarely addressed. 
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For all the formulations, the initial burst release was 20-30% foIlowed by the 
sustained release over next 28 days. The identieal burst of 20-30% suggests that the same 
amount of drug was present at or near the surface, irrespective of real loading. It was 
observed that TEA added had no apparent effect on release pattern of the different 
formulations with same theoretical drug loading although it changed the realloading inside 
the particles (Table 3.1, Fig 3.5). When different parameters including mean micropore 
width, mieropore volume, micropore surface area, BET surface area, and total surface area 
obtained form the porosimetry of these formulations were compared, there was very smaU 
difference in aIl these parameters (Table 3.2). PSD of the formulations at the same drug 
loading was similar (Fig. 3.4) irrespective ofamount ofTEA used. This could be the reason 
why all these formulations with same theoretieal drug loading but different amount of TEA 
exhibited apparently same release kineties (Fig. 3.5). As shown in fig 3.6, release profiles 
of formulation with different theoretical drug loadings showed difference in their release 
behavior (e. g. 50 Vs 10o, 51:1 Vs 101:1 and 51:2 Vs 101:2). It was found that the release of the 
drug from NPs with 5% theoretical drug loading was always faster than 10% loading 
irrespective of amount of TEA added. From the DSC results, it is clear that the drug was 
present in the form of sol id dispersion even in case of NPs with the highest drug loading. 
Thus, the dissolution of the drug before diffusion into the release media would not be a rate 
limiting step as suggested by Gomer et al [5]. As the same polymer was used for aIl 
formulations, difference in the polymer degradation might not be significant to affect the 
release kineties [8]. This implies that the factors affecting the drug diffusivity from the 
polymerie matrix would then control the release behavior. 
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Figure 3.6. Effect of initial drug loading level on the release profile of NPs in the 
presence (a, 1:2 M Prop: TEA) or absence (b) ofTEA. Error bars indicate mean ± S. 
D. forn=3 
It was observed that PSD and fractal dimension were the most critical parameters 
determining the release behavior, whereas other parameters related to total and external 
surface area played minor roie. Our results are in accordance with the model recently 
proposed by Lemaire et al [16] where authors suggested that the effective diffusion 
coefficient of the drug molecule in the wetted polymer, the average pore length and the 
initial pore diameter are the most critical parameters influencing the release kinetics. The 
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drug molecule located in the network of micropores will first diffuse towards the c10sest 
pore; however, this diffusion in the micropore network is slow due to the limited space 
available. In our study also, fractal dimension (D) seemed to play a key role in determining 
the rate of release. Higher value of D indicates more complex pore structure, lower 
effective diffusion coefficient of the drug due to random orientation of pores and increased 
tortuosity [16] from such a system. As shown in table 3.2, formulations with 5% drug 
loading always showed smaller D and hence, greater effective diffusion coefficient and thus 
faster release profile (Fig. 3.6). AIso, volume contribution of sm aller pores for 100, 101:1 
and 101:2 was always more than 50, 51:1 and 51:2 (Fig. 3.4). This effect was more prominent 
especially in the formulation 50 and 100 (Fig. 3.4 b) and was also reflected in their release 
kinetics (Fig. 3.6 b). As seen from fig. 3.4 b and table 3.2, formulation 50 with lowest 
volume contribution of smaller pores and low value for D showed the faste st release rate 
whereas formulation 100 with highest volume contribution of smaller pores and highest 
value of D exhibited the slowest release. PSD towards smaller pores may mean more 
compact, tortuous internaI structure, thus, decreasing the rate of drug diffusion. 
Presence of higher amounts of drug and/or TEA in the initial polymeric phase 
enhanced actual drug loading. However, the drug loading mechanism for both these factors 
seems to be different as can be seen from the effect on release kinetics and PSD. When 
PSD curves were compared, it was observed that change in drug loading resulted in change 
in PSD and thus, release kinetics. However, different amounts ofTEA at same drug loading 
level did not change the PSD significantly and thus, the release kinetics. Interestingly, 
formulations 51:2 and 101:1 (with same drug levels inside the NPs) did show difference in 
PSD irrespective of the same amount of drug being loaded inside the NPs. This further 
supports our hypothesis that the mechanism by which the drug loading ratio and TEA 
increase the realloading might be different. Further studies will c1arify this issue. 
3.5 Conclusion 
In the present study, stealth NPs of PEG-g-PLA were optimized for their 
encapsulation efficiency using TEA and characterized for porosimetry in addition to other 
conventional physicochemical properties. The results obtained show a correlation between 
the release kinetics and PSD. Higher drug loading ratios led to more compact structure 
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creating smaller pores, showed higher value of fractal dimension and more complex pore 
structure, resulting in slower drug release. On the other hand, TEA apparently did not have 
much effect on the release as it was counteracted by higher drug loading. Although the 
exact mechanism of the effect of drug loading and TEA on PSD and the drug release 
remains to be elucidated, it can be conc1uded that formulation factors certainly affect the 
internaI structure of NPs and may play a major role in influencing the release behavior. 
Further studies are underway to characterize these formulations for their stealth behavior 
inc1uding resistance to protein adsorption and macrophage phagocytosis. 
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LINK BETWEEN FIRST AND SECOND ARTICLE 
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The results of the first article have demonstrated usefulness of gas adsorption 
technique for studying microporosity of NPs. Also, differences in microporosity, although 
marginal, seemed to offer adequate explanation for differences in the release kinetics of 
propafenone hydrochloride (Prop) from NPs of PEG-g-PLA [1], which could not be 
explained otherwise by differences in drug loading or thermal properties of these NPs. It 
was thought that microporosity of NPs reflected the polymer interchain spacing and void 
spaces or free volume. Hence, it was speculated that change in the molecular structure of 
the polymer willlead to significant differences in the internaI microporous structure ofNPs 
fabricated of these polymers. As mentioned in the introduction of this thesis, reports on 
mechanisms of NP formation and their microporosity/microstructure are scarce in the 
literature. Thus, in continuation with this first study, further studies were planned to explore 
effect of polymer architecture as weIl as drug loading on the microporous structure of NPs. 
In this second manuscript, an attempt was made to apply gas adsorption technique to blank 
NPs prepared from 4 different polymers to unravel the mechanism of polymer chain 
organization inside NPs. 
It was also evident from the review of literature that results of the drug release 
profiles from pegylated particulate systems are controversial regardless of many studies 
being conducted in this area. Sorne studies have reported enhanced release rates with 
presence of PEG [2] whereas others have reported the opposite trend [3]. Hence, one can 
safely assume the role of internaI structure of NP matrix to influence drug release behavior. 
In fact, it can be speculated that the microporous structure of these reported systems might 
have been different leading to contradictory results. Thus, the work in the second 
manuscript focuses on the effect of molecular architecture of pegylated polymers on the 
microporous structure and drug release properties ofNPs. 
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4.1 Abstract 
Aim of the present study was to characterize the pegylated nanoparticles (NPs) for 
their microporosity and study its effect on drug release kinetics. Blank and drug-Ioaded NPs 
were prepared from three different pegylated polymers, namely, poly(ethylene glycol)l%-
graft-poly(D,L lactide), poly( ethylene glycol)s%-graft-poly(D,L lactide) and multiblock 
copolymer; (poly(D,L lactide)-block-poly(ethylene glycol)-block-poly(D,L lactide))n. These 
NPs were characterized for their microporosity using nitrogen adsorption isothenn. NPs of 
multiblock copolymer showed least microporosity and BET surface area, and that of 
PEGl%-g-PLA showed the maximum. Based on these results, structural organization of 
PLA and PEG chains inside the NPs was proposed and validated with DSC and XPS 
surface analysis. In vitro drug release study revealed that PEGl%-g-PLA NPs exhibited 
slower release despite oftheir higher surface area and microporosity. This was attributed to 
the presence of increased microporosity fonning tortuous internaI structure, thereby 
hindering drug diffusion from the matrix. Thus, it was concluded that microporous 
structure of NPs, which is affected by molecular architecture of polymers, detennines the 
release rate of the encapsulated drug. 
Keywords: Pegylated Nanoparticles, Nitrogen adsorption, Microporosity, Drug release 
kinetics, InternaI structure 
4.2 Introduction 
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Intensive research has been done in past few decades in the development of 
polymerie nanoparticles (NPs) as an effective drug delivery system for controlled release 
and targeting l -3• The therapeutic success of such a system is determined by its drug release 
kinetics, which is a function of structural and physicochemical properties of the NPs. Thus, 
it is a complex interplay of various factors such as properties of polymer and drug4, their 
interaction with each otherS, drug load6, 7, drug distribution inside the carrier, size and 
morphology of the carrier6, 7. Although majority of above-mentioned factors have been 
studied previously, reports on the importance of microporosity of NPs are lacking due to 
the unavailability of methods with high resolution. Small pores in a few nanometre range 
can affect matrix hydration, drug diffusion into release medium and polymer degradation8• 
It has been documented that macroscopic properties of solid materials, like drug release, 
permeability are closely connected to their microporous structure9-11 . This microstructure is 
usually characterized by density, surface area and porosity. While the evolution of porosity 
during microparticle formation has been a focus of research for many years8, 12, studies on 
underlying mechanisms of NP formation and the factors affecting their microporosity are 
scarce in the literature. Many techniques like pycnometry, gas adsorption, X-ray 
diffraction, calorimetry have been used to characterize porous solids13, 14. Gas adsorption is 
more popular because it allows the assessment of a wide range of pore sizes (from 0.35 nm 
to 100 nm), which includes the complete range of micro- and mesopores, and even 
(partiaIly) macropores. In addition, gas adsorption techniques are convenient to use, and are 
less cost intensive than other methods. 
Analysis of a nitrogen adsorption isotherm allows one to obtain parameters such as 
total pore volume, micropore volume, BET surface are a, pore size distribution (PSD) as 
weIl as the surface fractal dimension. These parameters are commonly used for the 
characterization of zeolites, clays and various catalysts IS-18. Although the se parameters can 
prove to be very useful in understanding the surface morphology as weIl as microporous 
structure of NPs, their use in the area of drug delivery is not reported so far. Recently, we 
73 
have shown that formulation factors affect the internaI structure and fractal dimension of 
NPs and thus, release kinetics of encapsulated drugs l9 . This study is an attempt to 
understand the effect of polymer architecture and drug loading on microporous structure of 
NPs. It is shown that arrangement of polymer chains inside the matrix during NP formation 
is dependent on the molecular architecture of the polymer. 
It was also noted that results of the drug release profiles from pegylated particulate 
systems are controversial regardless of many studies being conducted in this area. Sorne 
studies have reported enhanced release rates with presence of PEG20 whereas others have 
reported the opposite trend21 . Bence, one can safely assume the role of internaI structure of 
NP matrix to influence drug release behavior. In fact, it can be speculated that the 
microporous structure of these reported systems might have been different leading to 
contradictory results. Bence, another purpose of this study was to shed sorne light on the 
role of microporous internaI structure on the diffusion of drug molecules from pegylated 
NPs. 
4.3 Materials and methods 
4.3.1. Materials 
D,L- Lactide, poly( ethylene glycol) methyl ether (MePEG; 2,000 Da), 
poly(ethylene glycol) (PEG, 1500 Da), allyl glycidyl ether, tetraphenyltin, polyvinyl 
alcohol (PVA, average Mw 9,000-10,000 Da, 80% hydrolyzed) and propafenone 
hydrochloride (Prop) were purchased from Aldrich chemical company Inc., Milwaukee, 
USA. Dichloromethane (DCM) was purchased from Laboratoire Mat Inc., Montreal, 
Quebec, Canada. 
4.3.2. Synthesis of the polymers 
Bomopolymer, poly(D,L)lactide (PLA) was synthesized by ring-opening 
polymerization of dilactide in argon atmosphere, using tetraphenyltin as catalyst. Briefly, 
dilactide was crystallized from toluene solution and dried under vacuum before use. 
Weighed amount of purified dilactide was then placed in round bottom flask and purged 
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thoroughly with argon. Bulk polymerization was carried at 180°C for 6 h. The pol ymer thus 
obtained was dissolved in acetone and was purified by precipitating in water. 
Polymers with polyethylene glycol grafted poly-(D,L) lactide (PEG-g-PLA) (PEG 
Mw 2,000 Da) were synthesized in the laboratory and the detailed procedure can be found 
as reported earlier19, 22. PEG grafting was peformed at 2 different grafting densities; viz. 1 % 
and 5 % (mole/mole of lactic acid monomer). D,L-Iactide (21.5 g, 99 mol %) was 
polymerized in presence of allyl glycidyl ether (0.343 g, 1 mol %) with tetraphenyltin as a 
catalyst (1: 1 0,000 moles with regards to D, L-Iactide) at 180°C for 6 h under argon. 
Polylactic acid with allyl groups was purified by dissolving in ethyl acetate and 
precipitating in water. The allyl groups were converted to hydroxyl group by hydroboration 
with equimolar quantities of borane in tetrahydrofuran, followed by oxidation in the 
presence of hydrogen peroxide under alkaline conditions (1.5 moles of 3 M sodium 
hydroxide). Pendent hydroxyl group was oxidized to carboxylic acid group using Jones 
reagent, which was further converted to an acid chloride using thionyl chloride (1: 1 000 M). 
Finally, methoxy-PEG was grafted onto the polymer backbone by the reaction between acid 
chloride and the hydroxyl group of methoxy-PEG (2,000 Da) in presence of pyridine. Final 
polymer was purified by evaporating pyridine and washing with distilled water. For 5% 
PEG-grafted polymer, concentrations of D,L-Lactide and allyl glycidyl ether were 95 mol 
% and 5 mol % respectively, remaining synthesis procedure being the same. 
Multiblock copolymer, (PLA-PEG-PLA)n was synthesized as reported earlier23 
using PEG with Mn of 1500 and succinic acid was used as condensing agent to link the 
triblock copolymers. 
1 H NMR spectra were recorded on Brucker ARX 400 spectrometer (Bruker Biospin, 
Billerica, MA, USA). Chemical shi ft (6) was measured in ppm using tetramethylsilane 
(TMS) as an internaI reference. Size exclusion chromatography (SEC) was performed on 
Water associate chromatography system (Waters, Milford, MA, USA) equipped with 
refractive index detector and Phenomenex Phenogel 5 J.! column. Polystyrene standards 
were used for calibration with chloroform as mobile phase at a flow rate of 0.6 mL/min. 
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4.3.3. Preparation of Nanoparticles (NPs) 
Blank NPs of PLA, PEG1%_g-PLA, PEG5%-g-PLA and (PLA-PEG-PLA)n were 
prepared by emulsion-solvent evaporation method19. NPs could not be prepared using 
multiblock copolymer alone due to its low molecular weight; hence, 1: 1 mixture of PLA 
and multiblock copolymer was used for preparation ofNPs in this case. Each polymer (1 g) 
was dissolved in 10 mL of DCM containing 1:2 M triethylamine (TEA) and emulsified in 
50 mL of 0.5% w/v PV A solution as an external aqueous phase using high-pressure 
homogenizer (Emulsiflex C30, A vestin, Ottawa, Canada) at a pressure of 10,000 psi for 3 
min. The emulsion was collected by washing with additional 50 mL of 0.5% PV A solution. 
Then, DCM was evaporated under reduced pressure with constant stirring to obtain NPs. 
Finally, the particles were collected by centrifugation at 35,000 g for 45 min (Sorvall 
Evolution® RC, Kendro, Newton, CT, USA). NP suspension was then lyophilized (Freeze 
Dry System, Lyph.Lock 4.5, Labconco Corporation, MO, USA) to get dry NPs and stored 
at 4°C until further use. Prop-Ioaded NPs were prepared in similar manner using 1:2 M 
TEA and initialloading level of7.5 % w/w ofpolymer. 
4.3.4. Characterization of NPs 
4.3.4.1 Particle size distribution 
Size and size distribution was measured by photon correlation spectroscopy (PCS) 
(N4 Plus, Coulter Electronics, Miami, FL, USA) at 25°C and 90° scattering angle for 180 
seconds. The mean particle diameter was calculated using differential size distribution 
processor (SDP) intensity analysis program. 
4.3.4.2 Encapsulation efficiency (EE) 
NPs were suspended in IN NaOH for 1 h and ethanol was added followed by 
acidification with IN HCL Amount of Prop entrapped was then measured by 
spectrophotometry at 305 nm (U-2001 UVNisible spectrophotometer, Hitachi, Tokyo, 
Japan). Percent encapsulation efficiency (% EE) was calculated as the ratio of amount of 
drug entrapped to the total amount of drug added initially. 
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4.3.4.3 DifferentiaI scanning calorimetry (DSC) 
The thermal properties of pure pol ymer and blank NPs were characterized by DSC 
analysis (DSC Q1000, V9.0, build 275, Universal 4.1 D, TA Instruments, Grimsby, ON, 
Canada). Weighed samples of pure polymers were sealed in crimped aluminum pans with 
lids and were heated from -50°C to 220°C (2 runs) at the rate of lQ°Clmin, while NP 
samples were heated from -50 to 70°C at the rate of lO°Clmin, held at 70°C for 1 min and 
cooled again to -50°C. This cycle was repeated 3 times to ensure that NP structure was not 
destroyed. The samples were purged with pure dry nitrogen at a flow rate of 50 mL/min. 
The DSC was calibrated for temperature with indium (Goodfellow, 99.999% pure), and tin 
(NIST SRM 2000). The instrument was calibrated for heat flow with indium (Goodfellow, 
99.999% pure). The analyses of the obtained DSC thermograms were done using Universal 
analysis 2000, version 14.0C, TA instruments, Grimsby, ON, Canada. 
4.3.4.4. Porosity measurements 
Nitrogen adsorption experiments and porosity measurements were do ne using 
microporosimeter (Autosorb-1 MP, Quantacbrome Instruments, Boynton Beach, FL, USA) 
as described by Sant et a1 19• Weighed amounts of NPs were placed in glass cells and the 
effect of degassing was studied for upto 68 h. Finally, all the samples were degassed under 
identical conditions before analysis. The sample and reference cells were immersed in 
liquid nitrogen at -196°C and high resolution nitrogen adsorption isotherm (relative 
pressure 10-6 to 1) was obtained from the volume of nitrogen (cc/g) adsorbed onto the 
surface of NPs as a function of relative pressure. Krypton was also used in BET region to 
validate the nitrogen data. 
4.3.4.5. XPS analysis 
XPS analysis of blank NP samples was performed on VG ESCALAB MK II (VG 
Scientific, Crawley, UK) using Mg Ka X-rays (hv 1253.6 eV) and an electron take off 
angle of 0°. A single survey scan spectrum (0-1000 eV) and narrow scans for C1s (210-305 
eV) and Ols (525-550 eV) were recorded for each sample with a pass energy of 1 eV and 
0.5 eV, respectively. Acquisition and data analysis were performed by a VGS 5000 data 
system. Peak fitting of the Cl s envelope was as described by Shakesheff et at24 • Chemical 
shifts were referenced to hydrocarbon at 285 eV. 
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4.3.5 In vitro release study 
Prop-loaded NPs of PEG1%-g-PLA and (PLA-PEG-PLA)n were tested for in vitro 
release in triplicate in phosphate buffered saline (PBS), pH 7.4. Fifty mg NPs were 
suspended in 2.5 mL PBS in a dialysis tubing (6-8 kDa, Spectra Por 1 membrane, Spectrum 
Laboratories, CA, USA). This dialysis tubing was placed in a screw-capped tube containing 
10 mL PBS. The tubes were shaken at 200 rpm on a horizontal water bath shaker (Orbit 
Shaker Bath, Labline) maintained at 37 ± 1°C. At predetermined time intervals, whole 
medium in the tube was withdrawn and replaced by fresh PBS to maintain sink conditions. 
The aliquots were assayed for the amount of Prop released by spectrophotometry at 305 
nm. 
4.4 Results and Discussion 
4.4.1. Characterization of polymers 
IH NMR spectroscopy and size exclusion chromatography (SEC) were used to 
measure molecular number average (Mn) and weight average (Mw) distribution of polymers. 
Polydispersity was calculated by the ratio of Mw to Mn .. The results are summarized in 
Table 4.1. IH NMR spectra and chemical structures of all polymers are shown in Fig. 4.1. 
Typical spectra were obtained with peaks at 5.2 ppm corresponding to the tertiary PLA 
proton (m, -CH), peak at 3.6 ppm for the protons of the repeating units in PEG chain (m, 
OCH2-CH20), peak at 4.3 ppm for the PEG connecting unit to the PLA block (m, CHr 
OCO), and peak at 1.5 ppm for the pendent methyl group of the PLA chain (m, -CH3). For 
the multiblock copolymer, additional peak could be seen at around 2.7 ppm corresponding 
to the protons of succinic acid group (m, CH2-COO). Final PEG grafting percentage was 
close to the feed ratio of PEG as shown in Table 4.1. Multiblock copolymer showed highest 
PEG content of 17.8 mol %. 
In addition to molar mass and polydispersity, the thermal properties ofpolymers are 
influenced by their molecular structure. PLA showed glass transition (Tg) at 41.2°C (Table 
4.1, Fig. 4.2a). Random grafting PEG (1 %) on PLA backbone resulted in increased Tg value 
(by about 6°C) due to enhanced chain rigidity (Fig. 4.2b, Table 4.1). Merino et a125 has 
reported similar increase in Tg for hyperbranched polymers and dendrimers over their linear 
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chain analogues. However, further increasing PEG grafting density to 5% showed a 
decrease in Tg of PEG5%-g-PLA polyrner (Fig. 4.2c, Table 4.1). This can be attributed to 
enhanced segmental mobility of PLA chains caused by plasticization effect of increasing 
PEG concentration, as reported earlier26• Thus, for low PEG grafting percentage, effect of 
branching was predominant whereas increasing PEG concentration led to predominant 
plasticizer effect. Similar effect was seen on Tg of multiblock copolymer (Fig. 4.2d). Very 
low Tg value (~15°C) of multiblock copolymer can be due to their very high PEG content 
(17.8 mol %) and/or low molecular weight as compared to grafted polymers (Table 4.1). At 
the same time, melting peak of PEG was present in PEG5%-g-PLA and multiblock 
copolymer, which could not be seen in PEGl%-g-PLA, possib1y due to its lower PEG 
concentration. 
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Figure 4.1. lH NMR spectra and chemical structures of multiblock copolyrner, 
PEG1%-g-PLA (m = 1) and PEG5%-g-PLA (m = 5). 
Table 4.1. Polymer characterization by IH NMR and Size Exclusion 
Chromatography and DSC 
PEGa 
r,b Polymer Mn Mw Mw/Mn (mol %) g 
Poly(D,L)Lactide 18222 24844 1.36 41.17 
PEG1%-g-PLA 9753 15059 1.54 1.2 47.32 
PEGs%-g-PLA 9245 14363 1.55 7.0 34.82 
(PLA-PEG-PLA)n 5250 6120 1.16 17.8 15.27 
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a: Ca1culated from peak intensity ratios ofPEG (3.6 ppm) and PLA (5.2 ppm) by I H NMR 
b: Glass transition temperature ca1culated as half extrapolated tangents from second run of 
the DSC thermograms of respective polymers 
4.4.2. Particle size distribution and encapsulation efficiency (EE) 
Blank and Prop-loaded NPs were found to be monodispersed having diameter of 
180 to 210 nm as determined by PCS (Supporting information, Fig. S3, Table 4.2 and 4.3). 
Prop loading slightly increased the particle size for each type of polymer (Table 4.3). EE 
was found to be between 40 to 65% w/w depending on the polymer type (Table 4.3). 
Grafted polymers showed better EE than multiblock copolymer, which could be attributed 
to enhanced steric hindrance of PEG chains in case of grafted copolymers, thus reducing 
premature diffusion ofProp into the external aqueous phase during solidification ofNPs. 
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Figure 4.2. DSC thermograrns of 4 different polymers heated at the rate of 10°C/min 
from -50 to 220°C, PLA (a), PEGl%-g-PLA (b), PEGs%-g-PLA (c), and 
(PLA-PEG-PLA)n (d) 
Table 4.2. Characterization of blank NPs 
NP SSET, N2 b TC g 
%PEGd Size (nm) Polydispersity 
(m2/g) Formulation 
PLA-Blank 185 ± 3 0.359 18.47±1.39 51.40 
Peg1-Blank 180 ± 4 0.078 28.29±0.09a 49.21 5.5 
Peg5-Blank 184 ± 8 0.22 14.45±1.50a 43.90 9.1 
rviulti-Blank 192± 7 0.019 7.88±0.69a 33.35 3.7 
rviulti: multiblock copolymer + PLA (1:1), PLA: Poly(D,L-1actide), Peg1: PEG1%-g-PLA, 
Peg5: PEGs%-g-PLA; 
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Blank: Blank NPs, e. g., Multi-Blank: Blank NPs prepared from multiblock copolymer + 
PLA (1:1) 
a: Values are significantly different as compared to PLA-Blank at p < 0.05 by Student's 
paired t-test 
b: SBET, N2: surface area determined by nitrogen gas adsorption 
c: Glass transition temperature calculated as half extrapolated tangents from second run of 
the DSC thermograms of respective NPs 
d: % surface PEG coverage determined by XPS analysis; Relative monomer % was 
calculated taking into consideration areas under the curve for respective Cl s peaks 
An values are mean ± S.D. of n=3 
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Figure 4.3. Second run of DSC thermograms of blank NPs heated at the rate of 
10°C/min from -50 to 70°C, PLA (a), PEG1%-g-PLA (b), PEGs%-g-PLA 
(c), and (PLA-PEG-PLA)n (d) 
4.4.3. Thermal properties of NPs 
The three consecutive DSC sc ans of an the NPs were superimposable except the 
sharp peak of enthalpy of polymer chain relaxation in the first scan was less prominent in 
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the subsequent scans (Supporting information, Fig. S 1). This confirms that the structure of 
NPs was conserved during the experiment. Further, it was noted that aH NPs had higher Tg 
as compared to respective polymers (Table 4.1 and 4.2), elucidating compromised pol ymer 
chain mobility when formulated as NPs. AIso, aH pegylated NPs including PEG1%-g-PLA 
showed reduction in Tg as compared to PLA NPs indicative of presence of sorne PEG 
chains inside the core of PLA. This decrease in Tg (l8 e C) was more important for 
multiblock copolymer NPs. AIso, melting endotherm was evident only in the multiblock 
copolymer NPs at 51.YC in aH three runs (Fig. 4.3d and Supporting information, S 1-D). 
4.4.4. Porosity measurements and XPS analysis of blank NPs 
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Figure 4.4. High resolution nitrogen adsorption isotherms of blank NPs of PEGl%-g-
PLA (0), PLA (.6), PEGs%-g-PLA (*) and (PLA-PEG-PLA)n (0). Inset 
shows magnified region between 0-5 cc/g on y-axis to reveal the detailed 
adsorption behavior of nitrogen in relative pressure range 10-6 to 10-1. 
Fig. 4.4 shows high resolution nitrogen isotherms of blank NPs prepared from 4 
different polymers, in the relative pressure range 10-6 to 1. Logarithmic scale is used to 
reveal the detailed adsorption behaviour in the microporous region. BET surface area was 
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calculated usmg five adsorption points in the relative pressure range of 0.1 - 0.3. 
Cumulative micropore volume was calculated according to Horvath-Kawazoe (HK) 
method27,28 in the relative pressure range of 10-6-0.110.01 to inc1ude the pore size range of 0 
- 20 A. The HK method is based on slit-shaped pore model. Even though this pore model 
may not be appropriate for NPs, it was applied here since it would still allow comparison 
between samples as the measurements were done under identical conditions. NPs of 
PEG1%-g-PLA showed highest nitrogen uptake and that of multiblock copolymer showed 
the lowest. A comparison of cumulative micropore volumes for different NPs is shown in 
Fig. 4.5. It was seen that micropore volume for blank NPs of different polymers were in the 
order of PEG1%-g-PLA > PLA> PEGs%-g-PLA > (PLA-PEG-PLA)n. BET surface area 
followed the same trend (Table 4.2). Thus, differences in isotherms correlated extremely 
well with the changes in BET surface area and micropore volume. These results confirm 
that changes in the BET surface area ofNPs were indeed due to microporosity, and this can 
further be attributed to the molecular structure of the polymers as described below. 
Based on the DSC studies of polymers and blank NPs as well as their microporosity 
data, following hypothesis (Fig. 4.6) is proposed to explain the pol ymer chain organization 
of these structurally diverse polymers during NPs formation. In case of PLA NPs, PLA will 
undergo rapid phase separation into polymer-richlpolymer-poor phase because of its 
hydrophobic nature. This leads to pol ymer gelation and precipitation (Fig. 4.6a) ev en with 
the slightest of organic solvent extraction into external aqueous phase, preventing further 
entry of water inside the embryonic partic1es. In such a case, it is reasonable to refer the 
microporosity to that created due to individual chain folding and/or efficient packing of 
several such chains creating void spaces in a nanopartic1e. Indeed, it has long been 
recognized that polymers can possess large amount of void space, referred to as free 
volume9, 10. It is suggested that above a certain amount of free volume, the voids would be 
interconnected and polymer would behave as a microporous materia19. 
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Figure 4.5. Effect of molecular structure of polymer on microporosity of blank NPs 
of PEGl%-g-PLA (0), PLA (~), PEG5%- g-PLA (*) and (PLA-PEG-
PLA)n (0) 
In case of grafted polymers, hydrophilic PEG chains are covalently linked to 
hydrophobic PLA. The immiscibility of these two blocks should result in microphase 
separation of components, the ease of which would depend on the chemistry of the 
polymer29• It is hypothesized that, due to the peculiar polymer structure, phase separation in 
grafted polymers will be facilitated as PLA backbone can collapse easily in water (non-
solvent for PLA) leaving PEG on the extemal surface of the emulsion droplet facing 
aqueous phase (good solvent for PEG). Thus, grafted copolymers NPs will have 
hydrophobie PLA core surrounded by hydrophilic PEG shell (Fig. 4.6b). Higher Tg value of 
pure PEGl%-g-PLA compared to homopolymer PLA (Table 4.1) signifies higher rigidity of 
the polymer backbone due to random grafting of PEG chains. Similar behaviour has been 
reported for PLA-PEG diblock and triblock copolymers, where these copolymers exhibited 
less flexibility, high Tg value and phase separation due to poor miscibility of PEG and PLA 
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blocks30. Further it should be noted that DSC studies of NPs revealed depression in Tg for 
PEG1%-g-PLA NPs over PLA NPs (Table 4.2). This suggests presence of few PEG chains 
miscible in the PLA core. Thus, higher microporosity of PEG1%-g-PLA NPs can be 
attributed to the rigidity of polymer chain in accordance with Mckeown et ae 1. They have 
recently suggested that highly rigid molecular structure leads to increase in the 
microporosity of polymer. 
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Figure 4.6. Schematic representation of arrangement of polymer chains inside NPs 
and mechanism of drug release; PLA (a), grafted polymers (b) and 
multiblock copolymer (c) 
On the contrary, PEGs%-g-PLA NPs resulted in decrease in microporosity compared 
to PLA homopolymer. Why? It is worthy to note that PEGs%-g-PLA polymer and NPs, 
both resulted in greater decrease in Tg (6-TC) as compared to PLA homopolymer and NPs 
respectively, emphasizing improved flexibility of the polymer backbone and presence of 
more PEG chains in the PLA core of NPs as compared to PEG1%-g-PLA. This additional 
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PEG chains penetrating inside the core of NPs will block sorne of the pores. This explains 
the decreased microporosity ofPEGs%-g-PLA NPs. 
In case of (PLA-PEG-PLA)n multiblock copolymer, although it has both 
hydrophobic PLA and hydrophilic PEG domains, microphase separation of polymer itself 
might not be as easy as grafted copolymers. This is due to the fact that covalent linkage of 
PEG chain with two neighboring PLA chains will significantly hamper its spatial mobility. 
Indeed, Wang et al 30 have shown absence of phase separation in multiblock copolymers of 
PLA and PEG due to enhanced miscibility of two blocks and increased hydrophilicity. 
Very high depression in Tg (25.9°C, Table 4.1) of multiblock copolymer clearly supports 
their enhanced miscibility. Thus, faster gelation of the polymeric phase during solvent 
evaporation will not allow aIl the PEG chains to phase-separate inhibiting their migration to 
the surface. In such a case, higher amount of PEG chains, which could not come out on the 
surface during polymer gelation would be forced to accommodate themselves in between 
PLA chains (Fig. 4.6c). Large shift in Tg of these NPs clearly supports this hypothesis. 
According to this hypothesis, NPs prepared with mixture of multiblock copolymerlPLA 
should result in more important pore blocking effect because of interpenetration of PEG 
chains in the PLA core thereby exhibiting reduced microporosity as is evident from the 
microporosity results. AIso, presence of melting endotherm of PEG in these NPs (Fig. 4.3) 
clearly suggests existence of PEG microdomains which was not the case with any of the 
grafted copolymer NPs. 
Further support to the suggested internaI structure of NPs cornes from XPS analysis 
of surface chemistry of these NPs. Relative PEG concentrations at NP surfaces were found 
to be 5.5%, 9.1 % and 3.7% for PEG1%-g-PLA, PEGs%_g-PLA and multiblock copolymer 
NPs respectively (Table 4.2). It is evident that proportionate enrichment of the surface with 
PEG could not be se en on increasing grafting percentage from 1 % to 5%, further 
supporting penetration of sorne PEG chains inside the core of PEGs%_g-PLA NPs reducing 
their microporosity. NPs of multiblock copolymer showed least amount of PEG present at 
the surface despite its highest total PEG content (Table 4.1). These XPS results confirm 
incorporation of substantial amount of PEG chains in the PLA core of multiblock 
copolymer NPs, rendering higher hydrophilicity to the cores of these NPs. 
4.4.5. Microporosity measurements of Prop-Ioaded NPs 
Table 4.3. Characterization ofProp-loaded NPs 
NP Size Actual loading SBET, N2 c SBET, Kr 
%EE 
(m2/g) (m2/g) Formulation (nm) (%w/w) 
Multi-Prop 211 ± 6 3.01 40.10 3.79±0.62a,b 3.69 
Peg1-Prop 205 ± 10 4.13 55.07 20.4±1.lüa 19.12 
d 
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36.64 
48.14 
Multi: multiblock copolymer + PLA (1 :1), Peg1: PEG1%-g-PLA; Peg5: PEGs%-g-PLA; 
Prop: Propafenone.HCI-loaded NPs of respective polymers, e. g., Multi-Prop: Prop-Ioaded 
NPs of 1: 1 mixture of multiblock copolymer + PLA 
EE: Encapsulation efficiency, calculated by ratio of drug encapsulated in NPs to the initial 
drug added x 100 
Actualloading = mg of drug encapsulated per 100 mg ofNPs 
a: p < 0.05 as compared to respective blank NPs (student's paired t-test) 
b: p < 0.001 as compared to prop-Ioaded PEG 1 %-g-PLA NPs (student's paired t-test) 
c: SBET, N2: surface area measured by nitrogen gas 
d: SBET, Kr: surface area measured by krypton gas 
e:Glass transition temperature calculated as half extrapolated tangents from second run of 
the DSC thermograms of respective NPs 
All values are mean ± S.D. ofn=3 
Above-mentioned results have demonstrated dependence of internaI structure of 
NPs on the molecular structure of polymer. These changes in the microstructure of NPs are 
expected to reflect in their drug release properties. Indeed, extensive studies have shown 
dependence of gas permeability properties of various polymers on their microporosit/' 32. 
Such research was rarely applied to the field of controlled release polymers, to the best of 
our knowledge. It is evident from the literature that drug release profiles from pegylated 
particulate systems are still controversial regardless of many studies being conducted in this 
area. Sorne studies have reported enhanced release rates with presence of PEG20 whereas 
others have reported the opposite trend21 . Hence, one can safely assume the role of 
nanoparticle internaI structure to influence their drug release behaviour. Previously, we 
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have successfully used microporosity to explain release kinetics of propafenone 
hydrochloride (Prop) from NPs of PEG_g_PLAI9, which could not have been otherwise 
explained by their drug loading differences or thermal properties. To further probe into 
release mechanism from pegylated polymers with different molecular structure, drug-
loaded NPs were prepared using Prop as a model drug. 
,Sorne of the properties of Prop-Ioaded NPs are enlisted in Table 4.3. High resolution 
nitrogen isotherms, BET surface area as weU as micropore volume plots of aU Prop-Ioaded 
NPs followed the same trend as blank NPs, with NPs of PEG1%-g-PLA having the highest 
and that of multiblock copolymer having the least microporosity (Supporting information, 
Fig. S2). 
Given the fact that aU NPs showed similar particle size distribution (Fig. S3, 
supporting information), changes in BET surface area would then be due to differences in 
texture, which can be caused by different crystal faces, local crystalline disorder, surface 
roughness or the presence of impurities. However, most frequently it has its source in the 
presence of micropores33• We have confirmed the N2- BET surface area of multiblock 
copolymer and PEG1%-g-PLA polymer NPs by krypton adsorption at -196°C in the relative 
pressure range of 0.05 to 0.3. Krypton has a much smaller saturation pressure (1.63 torrs) 
compared to nitrogen (760 torrs) at -196°C, which allows to increase the sensitivity of the 
manometric adsorption measurements significantlyl4. In other words, krypton adsorption 
allows to obtain accurate surface areas for materials with small specific surface are as « 
0.05 m2jg), or if only a very small amount of sample is available (as is the case here, i.e. the 
total surface area provided for the measurements was for most samples around 0.5 m2). As 
indicated, the specific surface area measured by krypton was found to be in excellent 
agreement with that measured with nitrogen (3.69 Vs 3.79 m2jg for multiblock copolymer 
and 19.12 Vs 20.4 m2jg for PEG1%-g-PLA) (Table 4.3). 
4.4.6. In vitro drug release 
The main purpose of this study was to compare and study the effect of 
microporosity on drug release profiles of pegylated NPs. NPs of PLA and PEGs%-g-PLA 
polymers showed very marginal differences in their microporosity as compared to PEG1%-
g-PLA NPs (Supporting information, Fig. S2). AIso, actual drug loading in PLA NPs was 
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very low (only 0.45% w/w) as compared to NPs of pegylated polymers (3-5% w/w). This 
would also affect the release pattern from PLA NPs. Hence, multiblock copolymer and 
PEG1%-g-PLA NPs showing clear differences in microporosity were selected for in vitro 
release studies (Fig. 4.7). Multiblock copolymer NPs showed the faster drug release than 
PEG1%-g-PLA NPs. It can be clearly seen that NPs followed reverse trend of release 
kinetics (multiblock copolymer > PEG1%-g-PLA) as compared to microporosity (PEG1%-g-
PLA> multiblock copolymer). It is also worthy to mention here that in vitro drug release 
curve ofPEGs%-g-PLA NPs was in between PEG1%-g-PLA and multiblock copolymerNPs 
(Data not shown as no statistical difference was found between the groups) as could be 
predicted from its microporosity data. 
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Figure 4.7. Effect of polymer type on in vitro release profile of Prop-Ioaded NPs; 
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It is well known that diffusion of the drug into the release medium depends on its 
effective diffusion coefficient through polymer matrix, which in turn, depends on the 
porosity and tortuosity of matrix34• It should be borne in mind that we are dealing with 
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nanosized partic1es in the range of 180-200 nm and not micropartic1es which have been 
shown to possess very big pores in the range of few micrometers. Unfortunately, various 
experiments in the field of nanopartic1es have been limited to the macroscopic behaviour of 
drug release, and the information about a molecular-Ievel mechanism underlying the 
diffusion of drug molecules through the polymer matrix is still poorly understood. For 
nanosized partic1es, it is not the big pores, but the micropores (pores smaller than 2 nm) 
will be important in the diffusion process. These micropores having smaller or similar size 
of drug molecules wou1d act differently than the bigger pores, actually restricting the 
diffusion of drug molecules through the polymer matrix. In other words, these small pores 
would create compact structure due to limited cavities for the movement of drug molecules. 
Thus, increased microporosity eventually renders the polymer matrix more compact and 
tortuous unlike the big pores. This would decrease the effective diffusion coefficient of the 
drug and thus, slow down drug release process. Hence, in our case, higher microporosity of 
grafted copolymer NPs hindered movement of big drug molecules like propafenone (1.6 
nm as calculated from Chemoffice 8.0) through the aqueous channels further reducing its 
effective diffusion coefficient and thus, the final rate of release35 . 
Recently, Zhao et ae6, studied the mechanism of diffusion of aspirin molecules in 
polymer matrix by molecular dynamics simulation and again, it is to be emphasized that 
wriggling of the polymer chain and free volume of the pol ymer matrix were proposed to be 
the diffusion mechanisms. In this work, authors have emphasized importance of the size of 
cavities available in polymer matrix for the diffusion of drug molecules. When these 
cavities are small (for instance, micropores in our case), the drug molecules cannot jump 
from one cavity to other and have to depend on the wriggling of the polymer chain (short 
irregular movements ofpolymer chains up and down or from side to side). Surprisingly, in 
accordance with our work, the authors36 also found that diffusion coefficient of aspirin 
increases with increase in the PEG concentration in polymer matrix. If we carefully observe 
our results and schematics in Figure 4.6, multiblock copolymer NPs have more PEG 
entrapped in the polymer matrix and hence, the faster diffusion and consequently, faster 
release of Prop from this polymer matrix. Thus, this work again confirmed the results 
corroborated in our first study19 that microporosity really plays an important role in drug 
release kinetics. In fact, it should be noted that these findings are experimental proof of the 
results obtained by molecular dynamic simulation36• 
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The NPs of PEG1%-g-PLA and multiblock copolymer were also subjected to gel 
permeation chromatography (GPC) during in vitro release study in order to determine the 
polymer degradation rate. The molecular weight reduction of PLA core was much faster in 
case of multiblock copolymer NPs in contrast to the negligible change in case of PEG1%-g-
PLA NPs (Supporting information, Fig. S4). These results emphasize that rapid core 
wetting in multiblock copolymer due to PEG entrapment enhances the polymer degradation 
rate after 21 days and in turn, the porosity increasing drug release rate. 
Above results of in vitro drug release and NP degradation provide additional 
support to the hypothesis of polymer chain organization during NPs formation as proposed 
in fig. 4.6 and pore blocking effect exhibited by multiblock copolymer NPs. It is widely 
established that hydrophilicity of the matrix is one of the major driving forces in its 
hydration and in tum, the drug release kinetics37, 38. In case ofmultiblock copolymer NPs, a 
major portion of PEG is entrapped in the core during NP formation (Fig. 4.6c). In addition 
to enhancing hydrophilicity of core, this PEG will result in pore blocking and reduced 
microporosity of NPs in dry state as measured by gas adsorption. Once the se NPs are 
placed in release medium, hydrophilic PEG chains will draw water and swell rapidly into 
the core leading to formation of water channels. This will also result into opening of the 
blocked pores in the core of multiblock copolymer NPs. This in turn, is translated into rapid 
drug release. Indeed, multiblock copolymers of PEG and PLLA have been reported to be 
more hydrophilic than their PLLA homopolymer resulting in faster drug release39, 40. Core 
of grafted copolymer NPs will be predominantly hydrophobic due to the presence of major 
fraction of PLA in the core (Fig. 4.6b). Thus, the rate limiting factor in drug release from 
the se cores will be amount and accessibility of surface pores, wetting and effective 
diffusion coefficient. Thus, higher microporosity as well as hydrophobicity of the core 
justifies slower drug release from the NPs of grafted copolymers. 
4.5 Conclusion 
In conclusion, the nitrogen adsorption technique has been successfully used to gain 
insight into microporosity at angstrom level. Porosity data thus obtained, also pointed out to 
the fact that the polymers with diverse chemistry and architecture rearranged differently 
during NP formation. This decided the internaI microstructure of NPs and determined the 
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kinetics of drug release. Rate of drug release from NPs correlated well with the changes in 
microporosity. In a nutshell, this study clearly showed the important effect ofmicroporosity 
of nanoparticles on the drug release kinetics. 
4.6 Acknowledgements 
Authors are grateful to Natural Sciences and Engineering Research Council of 
Canada (NSERC) for funding this project and award of Postgraduate Scholarship to Shilpa 
Sant during her Ph. D. Authors wish to thank Dr. Christian Pellerin, Professor Adjoint, 
Department of Chemistry, University of Montreal along with Julie Boivin and Sylvain 
Esseimbre, Research agents, Department of Chemistry, University of Montreal for their 
help in the design and data analysis of DSC experiments. 
4.7 Supporting information available 
Detailed thermal properties, cumulative micropore volume after drug loading, size 
distribution profile and SEC analysis data after degradation of NPs. This additional 
information is available free of charge via the internet at http://pubs.acs.org. 
4.8 References 
1. Panyam, J.; Labhasetwar, v., Adv Drug Deliv Rev 2003,55, (3), 329-47. 
2. Sunderland, C. J.; Steiert, M.; Talmadge, J. E.; Derfus, A. M.; Barry, S. E., Drug 
Dev Res 2006, 67, (1), 70-93. 
3. Brigger, 1.; Dubernet, C.; Couvreur, P., Adv Drug Deliv Rev 2002,54, (5), 631-5l. 
4. Frank, A.; Rath, S. K.; Venkatraman, S. S., J Control Release 2005, 102, (2), 333-
344. 
5. Quellec, P.; Gref, R.; Dellacherie, E.; Sommer, F.; Tran, M. D.; Alonso, M. J., J 
Biomed Mater Res 1999,47, (3), 388-95. 
6. Gomer, T.; Gref, R.; Michenot, D.; Sommer, F.; Tran, M. N.; Dellacherie, E., J 
Control Release 1999,57, (3), 259-68. 
7. Chorny, M.; Fishbein, 1.; Danenberg, H. D.; Golomb, G., J Control Release 2002, 
83, (3), 389-400. 
93 
8. Petrov, O.; Furo, 1.; Schuleit, M.; Domanig, R.; Plunkett, M.; Daicic, J., Int J Pharm 
2006,309, (1-2), 157-162. 
9. McKeown, N. B.; Budd, P. M., Chem Soc Rev 2006,35, (8), 675-683. 
10. Budd, P. M.; McKeown, N. B.; Fritsch, D., J Mater Chem 2005, 15, (20), 1977-
1986. 
11. Wang, D.; Zhu, G.; Zhang, Y.; Yang, W.; Wu, B.; Tang, Y.; Xie, Z., New J Chem 
2005, 29, (2), 272-274. 
12. Yang, Y.-Y.; Chung, T.-S.; Bai, x.-L.; Chan, W.-K., Chem Eng Sei 2000,55, (12), 
2223-2236. 
13. Rouquerol, J.; Avnir, D.; Fairbridge, C. W.; Everett, D. H.; Haynes, J. H.; 
Pernicone, N.; Ramsay, J. D. F.; Sing, K. S. W.; Unger, K. K., Pure Appl Chem 
1994, 66, (8), 1739-1758. 
14. Lowell, S.; Shields, J. E.; Thomas, M. A.; Thommes, M., Characterization of 
Porous Solids and Powders: Surface Area, Pore Size and Density. Kluwer 
Acadamic Publishers: Dordrecht, 2004. 
15. Lee, J. F.; Lee, C. K.; Juang, L. C., J Colloid Interface Sei 1999,217, (1), 172-176. 
16. El Shafei, G. M.; Philip, C. A.; Moussa, N. A., J Colloid Interface Sci 2004, 277, 
(2),410-6. 
17. Wang, C. C.; Juang, L. C.; Lee, C. K.; Hsu, T. C.; Lee, J. F.; Chao, H. P., J Colloid 
Interface Sei 2004,280, (1), 27-35. 
18. Wang, C. C.; Juang, L. C.; Hsu, T. C.; Lee, C. K.; Lee, J. F.; Huang, F. C., J Colloid 
Interface Sei 2004, 273, (1),80-86. 
19. Sant, S.; Nadeau, V.; Hildgen, P., J Control Release 2005, 107, (2), 203-214. 
20. Matsumoto, J.; Nakada, Y.; Sakurai, K.; Nakamura, T.; Takahashi, Y., Int J Pharm 
1999, 185, (1), 93-101. 
21. Peracchia, M. T.; Gref, R; Minamitake, Y.; Domb, A.; Lotan, N.; Langer, R, J 
Control Release 1997, 46, 223-231. 
22. Nadeau, V.; Leclair, G.; Sant, S.; Rabanel, J.-M.; Quesnel, R.; Hildgen, P., Polymer 
2005,46, (25), 11263-11272. 
23. Quesnel, R.; Hildgen, P., Molecules 2005, 10, (1), 98-104. 
24. Shakesheff, K. M.; Evora, C.; Soriano, 1.; Langer, R, J Colloid Interface Sei 1997, 
185, (2), 538. 
94 
25. Merino, S.; Brauge, L.; Caminade, A. M.; Majoral, J. P.; Taton, D.; Gnanou, Y., 
Chem-A Eur J 2001, 7, (14), 3095-3105. 
26. Kulinski, Z.; Piorkowska, E.; Gadzinowska, K.; Stasiak, M., Biomacromolecules 
2006, 7, (7),2128-2135. 
27. Horvath, G.; Kawazoe, K, J Chem Eng Japan 1983, 16, (5), 470-475. 
28. Dombrowski, R. J.; Lastoskie, C. M.; Hyduke, D. R., Colloids Surfaces A 
Physicochem Eng Asp 2001, 187,23-39. 
29. Shin, D.; Shin, K.; Aamer, K. A.; Tew, G. N.; Russell, T. P.; Lee, J. H.; Jho, J. Y., 
Macromolecules 2005,38, (1), 104-109. 
30. Wang, S.; Cui, W.; Bei, J., Anal Bioanal Chem 2005,381, (3), 547-556. 
31. Pakunlu, R. J.; Wang, Y.; Saad, M.; Khandare, J. J.; Starovoytov, V.; Minko, T., J 
Control Release 2006, 114, (2), 153-162. 
32. Ilinitch, O. M.; Fenelonov, V. B.; Lapkin, A. A.; Okkel, L. G.; Terskikh, V. V.; 
Zamaraev, KI., Microporous Mesoporous Mater 1999, 31, (1-2), 97-110. 
33. Cejka, J.; Zilkova, N.; Rathousky, J.; Zukal, A.; Jagiello, J., Langmuir 2004, 20, 
(18), 7532-7539. 
34. Veith, S. R.; Hughes, E.; Vuataz, G.; Pratsinis, S. E., J Colloid Interface Sei 2004, 
274, (1), 216-28. 
35. Lemaire, V.; Belair, J.; Hildgen, P., Int J Pharm 2003, 258, (1-2), 95-107. 
36. Zhao, Z. J.; Wang, Q.; Zhang, L.; Liu, Y. C., Journal of Physical Chemistry B 2007, 
111, (1 7), 4411-4416. 
37. Roy, D. S., Eur J Pharm Sei 2002, 16, (3), 193-199. 
38. Sung, K C.,Int J Pharm 1998, 172, (1-2), 17-25. 
39. Luo, W.; Li, S. M.; Bei, J. Z.; Wang, S. G., J Appl Polym Sei 2002, 84, (9), 1729-
1736. 
40. Chen, W.; Luo, W.; Wang, S.; Bei, J., Polym Adv Technol2003, 14, (3-5), 245-253. 
95 
3.1 Supporting information 
MICROPOROUS STRUCTURE AND DRUG RELEASE KINETICS OF 
POL YMERIC NANOP ARTICLES • 
DSC Studies on blank NPs 
Figure S1 
Three subsequent DSC thennograms of respective NPs heated at the rate of 10°C/min from 
-50 to 70°C, PLA (A), PEG1%-g-PLA (B), PEG50/o-g-PLA (C), and (PLA-PEG-PLA)n (D) 
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Microporosity of Prop-loaded pegylated NPs 
Figure S2 
Microporosity of Prop-loaded NPs of PEG1%-g-PLA (-), PEG5%- g-PLA (+) and (PEG-
PLA-PEG)n (e). 
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Figure 83 
Particle size distribution of prop-loaded NPs 
Particle size distribution for Prop-loaded NPs; PEG1%-g-PLA (0), PEG5%-g-PLA ( ... ), 
(PLA-PEG-PLA)n (x) 
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Figure S4 
Gel permeation chromatography of NPs at various intervals of time during reJease 
studies 
Degradation studies of (A) PE01%-g-PLA and (8) multiblock copolymer NPs by OPC NPs 
were suspended in PBS, pH 7.4 at 3TC in shaking water bath. The study was tenninated at 
0, 1, 7, 21, and 43 days, NPs were lyophilized and molecular weight distribution was 
detennined by gel penneation chromatography using polystyrene standards and 
tetrahydrofuran as mobile phase. The arrows indicate disappearing peak for PLA cores in 
case of multiblock copolymer NPs 
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LINK BETWEEN SECOND AND THIRD ARTICLE 
101 
In the first part of this thesis, we have explored polymer architecture, drug loading 
and other formulation factors affecting the microporosity and internaI structure of NPs. 
This, in turn, had global effect on drug release kinetics. Rowever, just tailoring to the need 
of release properties is not sufficient to achieve the best results with any colloidal drug 
carriers. 
It is well documented that surface properties of vectors are crucial in deciding their 
in vivo behavior. For successful drug delivery vehicle, it should be stable in biological 
milieu and further, reach the target site (e.g. tissue/cell) or even its intracellular target (e.g. 
cytoplasmlnucleus). Thus, to further exploit formulated nanoparticulate system to target to 
various cancers or inflammatory diseases or even to brain, the next important issue was 
their prote in resistant ability, cytocompatibility and cellular interaction properties. The 
major concern was how the polymer architecture affected PEG density at the surface of 
these vectors and whether this surface PEG could be effective in rendering these NPs 
protein-resistant and reduce their uptake by macrophages. Rence, further experiments were 
designed to study the surface properties of these vectors with respect to morphology, charge 
& PEG density. AIso, efforts were directed to understand their impact on protein binding, 
cellular interaction and uptake mechanisms. 
CHAPTER5. 
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5.1 Abstract 
Aim of the present study was to evaluate the cellular interaction of nanoparticles 
(NPs) prepared from different pegylated polymers and elucidate the effect of polymer 
architecture, for instance, grafted versus block copolymer on their cellular uptake. 
Fluorescein-labeled NPs of 4 different polymers, viz., poly(D,L lactide) (PLA), 
poly( ethylene glycol) 1 %-graft-poly(D,L lactide) (PEG1 %-g-PLA), poly( ethylene glycol)s%-
graft-poly(D,L lactide) (PEGs%-g-PLA) and (poly(D,L lactide )-block-poly( ethylene 
glycol)-block-poly(D,L lactide))n multiblock copolymer (PLA-PEG-PLA)n were prepared. 
These NPs were characterized for size, zeta potential and surface morphology. XPS studies 
revealed possibility of chemical interaction between PLA-COOH groups and PV A-OH 
groups, thus making it difficult to be washed off from the NP surface completely. Grafted 
polymer NPs showed more surface PEG coverage than (PLA-PEG-PLA)n despite of their 
comparatively lower PEG content. The results of surface properties were translated into 
prote in binding showing least amount of proteins bound to grafted copolymer NPs as 
against multiblock copolymer NPs. NPs showed no toxicity to RA W 264.7 cells. Cellular 
uptake of NPs was temperature and concentration-dependent as well as involved clathrin-
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mediated processes. Thus, this study confirms the importance of polymer architecture in 
determining the surface properties and hence, prote in binding and cellular interactions of 
NPs. AIso, it was shown that grafted copolymer NPs reduced macrophage uptake as 
compared to multiblock copolymer although mechanisms different than phagocytosis were 
involved. 
Keywords: Polymer architecture, Pegylated polymers, Surface properties, Prote in binding, 
Phagocytosis, AFM phase imaging 
5.2 Introduction 
The ultimate goal of controlled release drug delivery system is to maximize 
therapeutic activity while minimizing the negative si de effects of the drug. In this regard, 
versatile nanoscale delivery vehicles like nanoparticles (NPs) are being designed based on 
novel biomaterials. Once administered intravenously, these NPs are recognized by 
mononuclear phagocytic system (MPS) due to opsonization. Size and surface 
characteristics of NPs both play an important role in the blood opsonization and clearance 
kinetics I-4• Larger particles (200 nm and above) and those with hydrophobic surfaces are 
more efficient in activating human complement system and cleared faster from the b100d 
than their smaller counterparts. Hence, precision surface engineering with synthetic 
polymers is often required to control NP interaction and their fate within the biological 
system. 
Among various approaches described, surface stabilization of NPs and liposomes 
with poly (ethylene glycol) (PEG) has proved to be one of the most successful strategy for 
suppressing macrophage recognition and prolonging circulation times of such colloidal 
particles3,5,6. The efficiency of this process depends on the polymer type, surface stability, 
reactivity and physics (surface density and conformation)7,8. Despite the identification of 
various physicochemical parameters like surface charge, PEG chain length, its molecular 
weight, PEG layer thickness, density and conformation of PEG layer2,9-12, effect of 
molecular architecture of copolymers on their prote in resistance ability remains to be 
adequately addressed. Indeed, polymer architecture markedly influences not only the 
physicochemical properties of the polymer, but also various facets of drug delivery systems 
including drug release rate, biodistribution and even interaction with specific tissues or 
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cells in viva8• Thus, optimizing polymer architecture is an intelligent strategy to develop 
desired phannaceutical product. Such studies would offer valuable feedback to tune 
properties of polymer-based drug delivery systems. 
Once the long-circulating carrier reaches the desired tissue, next step is its 
intracellular entry. Intracellular trafficking of macromolecules is very complex 
phenomenon and has been reviewed recently13. It involves different pathways like 
phagocytosis (for large partic1es and by specialized cells like macrophages, neutrophils and 
dendritic cells) and pinocytosis (generally common to all cells). Pinocytosis can be 
receptorlligand-mediated (e.g. clathrin- and caveole-mediated) or constitutive (e.g. 
adsorptive or fluid phase endocytosis). Now, which of these pathways are involved in the 
uptake mechanism of the carrier will be dependent on its surface properties and will decide 
the extent of uptake into the cells. Several studies have correlated physicochemical 
properties of particles to protein adsorption and/or in vitro phagocytosis in macrophages 14-
18. However, reports focusing on their uptake mechanisms in macrophages are stilliacking 
in literature. Indeed, cellular uptake mechanisms have been studied in detail for various 
epithelial and cancer cell lines whereas their role in macrophages was seldom studied 
according to the best of our knowledge. It is reported that phagocytosis takes place for 
particles larger than 500 nm in size, however, why smaller particles are taken up by 
macrophages and by which mechanisms remains to be addressed. It is possible that 
macrophages can effectively take up these 200 nm or smaller particles by mechanisms 
other than phagocytosis. Although it is shown that presence of PEG on the surface of the se 
NPs reduces their macrophage uptake, whether it is really by reduced phagocytosis or by 
other mechanisms like endocytosis, macropinocytosis or fluid phase pinocytosis still 
remains a topic of research. Further, if this reduced macrophage uptake of small size NPs is 
by reduced endocytosis, the same rule will definitely be extended to other non-phagocytic 
cells in the body, thus seriously hampering the efficacy of intracellular distribution of 
pegylated NPs. In fact, it is already reported that incorporation of PEG was useful in 
controlling phannacokinetics of the nanocarriers on one hand, while hampering their 
interaction with the targeted cells and thus, therapeutic efficiency, especially in gene 
deliveryI9-23. Hence, the present study was undertaken to evaluate effect of diverse 
molecular architecture (block versus graft copolymers) on surface properties and 
macrophage uptake of pegylated NPs. Further, efforts were made to find out correlation 
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between the physicochemical properties of NPs with their surface protein adsorption and in 
vitro macrophage uptake. AIso, detailed investigation was carried out to shed sorne light on 
their uptake mechanismls by macrophages. 
5.3 Materials and methods 
5.3.1 Materials 
D,L- Lactide, poly( ethylene glycol) methyl ether (2,000 Da), allyi glycidyl ether, 
tetraphenyltin, polyvinyl alcohol (PV A, average Mw 9,000-10,000 Da, 80% hydrolyzed), 
fluorescein, and ethyl carbodiimide were purchased from Aldrich chemical company Inc., 
Milwaukee, USA. Dichloromethane (DCM) was purchased from Laboratoire Mat Inc., 
Montreal, QC, Canada. AlI materials for cell culture were purchased from Invitrogen 
(Burlington, ON, Canada). 
5.3.2 Synthesis of polymers 
Poly(D,L )lactide (PLA) homopolymer was synthesized by nng-opemng 
polymerization of dilactide under argon using tetraphenyltin as catalyst. Dilactide was 
crystallized from toluene solution and dried under vacuum before use. Weighed amount of 
purified dilactide was placed in round bottom flask and purged thoroughly with argon to 
displace air present in the sample. Bulk polymerization was carried out under argon at 
180°C for 6 h. The polymer thus obtained was dissolved in acetone and purified by 
precipitation in water. 
Polymers with polyethylene glycol grafted poly-(D,L) lactide (PEG-g-PLA) (PEG 
Mw 2,000 Da) were synthesized in our laboratory as reported earlier24,2s. Multiblock 
copolymer, (PLA-PEG-PLA)n was synthesized as reported26 using PEG with Mn of 1500, 
and succinic acid was used as condensing agent to link triblock copolymers. 
Synthesized polymers were characterized by lH NMR, gel permeation 
chromatography (GPC) and differential scanning calorimetry (DSC). tH NMR spectra were 
recorded on Brucker ARX 400 spectrometer (Bruker Biospin, Billerica, MA, USA). 
107 
Chemical shift (8) was measured in ppm using tetramethylsilane (TMS) as an internaI 
reference. Mole % ofPEG was calculated with respect to PLA from IH NMR data. 
GPC was perfonned on Water Associate Chromatography System (Waters, Milford, 
MA, USA) equipped with refractive index detector and Phenomenex Phenogel 5 g column. 
Polystyrene standards were used for calibration with chlorofonn as mobile phase at a flow 
rate of 0.6 mL/min. 
The thennal properties of pure polymers were characterized by DSC analysis (DSC 
QI000, V9.0, build 275, Universal 4.1 D, TA Instruments, Grimsby, ON, Canada). 
Weighed samples were sealed in crimped aluminum pans with lids and were heated at the 
rate of 10°C/min from -50°C to 220°C (2 runs) The samples were purged with pure dry 
nitrogen at a flow rate of 50 mL/min. The DSC was calibrated for tempe rature with indium 
(Goodfellow, 99.999% pure), and tin (NIST SRM 2000). The instrument was calibrated for 
heat flow with indium (Goodfellow, 99.999% pure). The analyses of the obtained DSC 
thennograms were done using Universal analysis 2000, version 14.0C, TA instruments, 
Grimsby, ON, Canada. Results ofpolymer characterization are enlisted in Table 5.1. 
5.3.3 Preparation of nanoparticles (NPs) 
Blank NPs of PLA, PEGl%_g-PLA, PEG5%-g-PLA and (PLA-PEG-PLA)n were 
prepared by emulsion-solvent evaporation method 25. Each polymer (500 mg) was 
dissolved in 5 mL of DCM and emulsified in 50 mL of 0.5 % w/v PV A solution as an 
external aqueous phase using high-pressure homogenizer (Emulsiflex C30, A vestin, 
Ottawa, Canada) at a pressure of 10,000 psi for 3 min. The emulsion was collected by 
washing with another 50 mL of 0.5% PV A solution. DCM was evaporated under reduced 
pressure with constant stirring to obtain NPs. NPs were collected by centrifugation at 
35,000 g for 45 min (Sorval® EvolutionRc, Kendro, Newton, CT, USA). NP suspension was 
then lyophilized (Freeze Dry System, Lyph.Lock 4.5, Labconco) to get dry NPs and stored 
at 4°C until further use. 1:1 (w/w) mixture of PLA and multiblock copolymer was used for 
preparing multiblock copolymer NPs due to its low molecular weight. 
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5.3.4 Fluorescence labeling of blank NPs 
Blank NPs (100 mg) of PLA, PEG1%-g-PLA, PEG5%-g-PLA and (PLA-PEG-PLA)n 
were suspended in PBS. Fluorescein (5 mg) was added to this suspension followed by ethyl 
carbodiimide and the suspension was stirred for 3 days in dark. Labeled particles were then 
dialysed (6-8 kDa, Spectra Por 1 membrane, Spectrum Laboratories, CA, USA) against 
distilled water for 5 days until no fluorescence was detected in the dialysate. Dry particles 
were obtained by lyophilization. 
5.3.5 Characterization of NPs 
5.3.5.1 Particle size distribution 
NP size and size distribution was measured by photon correlation spectroscopy 
(PCS) (N4 Plus, Coulter Electronics, Miami, FL, USA) at 2YC and 90° scattering angle for 
180 seconds. The mean particle diameter was calculated using differential size distribution 
processor (SDP) intensity analysis pro gram. 
5.3.5.2 Zeta potential measurement 
NPs were suspended in 0.22 ~m filtered 0.25% w/v saline solution and zeta 
potential was measured in triplicate on Malvem ZetaSizer Nanoseries ZS (Malvem 
Instruments, Worcestershire, UK). 
5.3.5.3 Surface morphology and phage image analysis 
Freshly cleaved mica surface was dipped in poly-I-Iysine solution (4 mg/mL) for 45 
minutes followed by thorough washing of the surface with 0.22 !lm filtered Mili-Q water to 
remove excess of poly-I-Iysine. The surfaces were then dipped vertically in respective NP 
suspension for 30 minutes. Excessively deposited NPs were washed off with 0.22 ~m 
filtered Mili-Q water followed by air-drying. Topography and phase images of these 
samples were captured simultaneously using N anoscope IlIa Dimension 3100 atomic force 
microscope (Digital Instruments, Santa Barbara, CA, USA). AlI Images were acquired 
using 125 !lm TappingMode™ etched silicon probes (TESP7) with tip radius of 5-10 nm, 
spring constant of 20-100 N/m and resonance frequency of 200-400 kHz. A set-point ratio 
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(ratio of engaged oscillation amplitude to free air oscillation amplitude) between 0.6 and 
0.8 was used for aIl topographic and phase images unless otherwise stated. 
5.3.5.4 XPS analysis 
XPS analysis of powdered NP samples was performed on VG Scientific ESCALAB 
MK II using Mg Ka X-rays (hv 1253.6 eV) and an electron take off angle of 0°. A single 
survey scan spectrum (0-1000 eV) and narrow sc ans for C1s (210-305 eV) and Ols (525-
550 eV) were recorded for each sample with a pass energy of 1 eV and 0.5 eV, 
respectively. Acquisition and data analysis were performed by a VGS 5000 data system. 
Peak fitting of the C1s envelope was as described by Shakesheff et al27 • Chemical shifts 
were referenced to hydrocarbon at 285 eV. 
5.3.5.5 Plasma protein binding 
NPs (5 mg) were incubated with 100 ilL whole human serum for 18 h at 37°C with 
gentle agitation. Loosely bound protein fraction was removed by thorough washing with 
Milli-Q water. Adsorbed proteins were desorbed by incubating with Laemmli samp1e buffer 
(Sigma, St. Louis, USA) and then, analysed by SOS-PAGE on 10% polyacrylamide gel 
performed on a Mini Vertical Gel System (Fisher Biotech, Canada). The gel was run at 150 
V for 1 h and then developed with silver stain. Briefly, the gel was shaken gently by 
soaking in 50% methanol followed by freshly prepared staining solution (1 mL 0.2 g/mL 
silver nitrate added to solution of 5.2 mL 0.36% NaOH and 0.35 mL of 14.8 M ammonium 
hydroxide, volume was made upto 25 mL) for 10-15 min. The gel was further washed with 
deionized water twice for 5 min and then developed for 5-10 min in a development solution 
containing 0.5 mL of 1 % w/v citric acid and 50 ilL of 37% formaldehyde in 100 mL water. 
After washing once in deinonized water, the gel was destained in a mixture of 45% v/v 
methanol and 5% v/v acetic acid. Revealed gels were scanned by exposition to UV light 
using a Chemilmager 5500 imaging system (Alpha Innotech Corp., San Leandro, CA). 
5.3.6 Cell culture 
Macrophage cellline, RA W 264.7 was a kind gift from Dr. Jean-Christophe Leroux, 
(Faculty of Pharmacy, University of Montreal, QC, Canada). The cells were grown in 
Oulbecco's modified Eagle cell culture medium (DMEM) containing 10% (v/v) heat-
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inactivated fetal bovine serum, 100 U/mL penicillin-G and 100 mg/mL streptomycin 
(Invitrogen, Burlington, ON, Canada) in an atmosphere of 5% CO2 and 95% relative 
humidity. The cells were routinely passaged at 90-95% confluence. 
5.3.6.1 Evaluation of cellular toxicity of blank NPs 
Inhibition of cell proliferation was assessed by tetrazolium salt 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Briefly, 5 x 105 
RA W 264.7 cells were seeded in 96-well flat bottom plates (Co star, Coming, NY) and 
allowed to grow for 24 h. The cells were then incubated with increasing concentrations of 
blank NPs for 24 h. Cell layers were washed with cold PBS and further incubated with 10 
ilL of MTT solution (5 mg/mL in PBS) for 4 h at 3TC. Formazan crystals formed were 
then dissolved along with the cell layers and absorbance was measured on microplate 
reader at 570 nm. Cell viability was calculated with respect to PBS as control. 
5.3.6.2 Cellular interaction with RA W 264.7 
RA W 264.7 cells (1 x 105 cells/ well) were plated in 96-well flat bottom plates 
(Co star, Coming, NY) and allowed to adhere overnight in DMEM with 10% serum. Next 
day, the medium was removed and replaced by RPMI 1640 without serum. The cells were 
then incubated with different concentrations of fluorescein-Iabeled PLA or pegylated NPs 
for 3 h at 3TC. The cell monolayers were washed with cold PBS (pH 7.4) and then lysed 
with 0.2% Triton-X 100 in 0.2 N NaOH solution. The fluorescence was measured on 
microplate reader at excitation and emission wavelength of 494 nm and 520 nm, 
respectively. The amount of NPs phagocytosed was calculated from calibration curve of 
NPs under the same conditions. To find the mechanism of cellular entry, cell monolayers 
were incubated with endocytic and metabolic inhibitors as described by Huang et at2s. First, 
the cell monolayers were incubated with different inhibitors for 1 h, followed by NPs (160 
Ilg/mL) for another 3 h. Cell monolayers were then washed four times with cold PBS (pH 
7.4) followed by 100 ilL 5 mM EDTA (pH 5.0) and then lysed with 0.2% Triton-X 100 in 
0.2 N NaOH solution. The fluorescence was measured on microplate reader at excitation 
and emission wavelength of 494 nm and 520 nm, respectively. 
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5.4 Results and Discussion 
5.4.1 Polymer characterization 
a ~ Jl A /PLA-PEG-PLAJ 
PLA-PEG-PLK '-/ l 
o lli2 
o 
lOO-m-x x 
Figure 5.1. Chemical·structures ofmultiblock copolymer (a) and grafted copolymers 
(b) where m=1 and 5 for PEG1%-g-PLA and PEGs%-g-PLA. 
Table 5.1. Polymer characterization by gel permeation chromatography, IH NMR 
and OSC 
PEG* 
TOC" Polymer Mn Mw Mw/Mn 
(mol %) g 
Poly(O,L )Lactide 18222 24844 1.36 41.2 
PEG 1 %-g-PLA 9753 15059 1.54 1.2 47.3 
PEG5%-g-PLA 9245 14363 1.55 7.0 34.8 
(PLA-PEG-PLA)n 5250 6120 1.16 17.8 15.7 
*: Calculated by NMR 
* *: Calculated from second run of OSC 
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Chemical structures of the polymers are shown in Fig. 5.1. The measured molecular 
weight, polydispersity, and thermal properties of synthesized polymers are summarized in 
Table 5.1. Polymers with weIl defined composition and low polydispersities were obtained 
using the employed synthesis route. 
5.4.2 Size and charge of NPs 
Table 5.2 shows the particle size distribution and zeta potential data of NPs. Mean 
diameter of aIl NPs was in the range of 180-195 nm. Zeta potential measurements revealed 
that PLA NPs had lowest negative zeta potential (-2.5 mV) and multiblock copolymer had 
the most negative zeta potential of -22.7 mV (Table 5.2). Zeta potential results of PLA NPs 
are in agreement with Zambaux et al29 who obtained the value of --4 m V for PLA NPs 
prepared with PV A. This low zeta potential for PLA NPs could be attributed to presence of 
PV A on the surface of these NPs. In case of NPs of grafted polymers, lower zeta potential 
can be correlated to the arrangement of PEG groups on the surface of NPs. On the other 
hand, high negative zeta potential of multiblock copolymer NPs was attributed to the 
presence of ester bonds in the structure on the multiblock copolymer where the 
delocalization of negative charges was possible as suggested by Quaglia et at3°. This may 
also mean presence of insufficient amount of PEG and/or unprotected surfaces on these 
NPs. 
Table 5.2. Characterization ofNPs 
Formulation Size (nm) Polydispersity Zeta potential (m V) 
PLA 185 0.359 -2.5 ± 0.61 
PEG1%-g-PLA 180 0.078 -5.97 ± 0.83 
PEGs%-g-PLA 184 0.22 -7.72 ± 1.69 
(PLA-PEG-PLA)n 192 0.019 -22.72 ± 2.06 
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5.4.3 Surafec morphology and phase analysis 
Tapping mode atomic force microscopy (TM-AFM) is a versatile technique, which 
allows probing soft samples such as biological and polymerie materials3 1.32• One recent 
development in TM-AFM is the use of the changes in the phase angle of the cantilever 
probe to produce phase image. This image often provides more contrast than the 
topographie image and has been shown to be sensitive to material surface properties such as 
sti ffncss, viscoelasticity and chemical composition'I .33.3':). In generaL changes in the phase 
angle during scanning are related to energy dissipation during tip-sample interaction,,·3.:). It 
has been shown previollsly that phase contrast images recorded in moderate tapping force 
(rsp = 0.5-0 .7) can be related to sLich properties as viscoelasticity or stiffness33.3':). Although 
AFM has been widely llsed to study the topography of NPs/miccllcs3:i-37, phase image 
ana/ysis has not yet been reported to study the surtàce of NPs to the best of our knowledge. 
We report phase image AFM stlldies of NP samples to exp:l ore the possibility of detection 
of PEG on the surtàce of pegylated NPs due to viscoelastic and/or hydrophilicity 
differences between PLA and PEG chains. 
Figure 5.2. Tapping mode AFM phase images of NPs. all images are acquired in air. 
Scan size: 250 x 250 (nm x nm): PLA (a), PEG lo;o-g--PLA (b), PEG:i ~' o-g-­
PLA (c). PLA-PEG-PLA)n (d) 
The TM-AFM phase images of PLA, grafted and multiblock copolymer NPs 
acquired at moderate tapping force are shown in Fig. 5.2 . It can be seen that PLA particles 
had homogenous surface without any phase separation (Fig. 5.2 a). This may suggest that 
residual PY A coated the surface of PLA NPs very homogcnously. in tum, masking 
negative surface charge (Table 5.2). On the other hand, ail pegylated NPs showed the 
presence of sharp phase contrast (Fig. 5.2 b-d). As PEG has sm aller Young's modulus than 
PLA 3R , PEG molecule is softer th an PLA resulting into darker regions for PEG in the phase 
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images due to negative phase shift. This has aIready been demonstrated for poly(styrene-b-
ethylene oxide) polymer films where softer PEG segments resulted in darker regions 
embedded in lighter polystyrene matrix39. Thus, AFM studies gave a direct visible proof for 
the presence ofPEG on the surface ofpegylated NPs. 
5.4.4 XPS analysis 
XPS analysis was carried out to probe into surface composition of these NPs 
prepared with different polymers and to quantitate PEG/PV A concentration on their 
surface. XPS spectrum of PEG showed one peak corresponding to ether carbons (286.4 eV, 
Table 5.3). PVA polymer showed three main peaks corresponding to C-C/C-H (285 eV), C-
OH (l.3 eV shi ft) and o-c=o (4.2 eV shift) environments. For pure PLA polymer, the best 
envelop fit was obtained using three main peaks corresponding to C-C/C-H (285 eV), C-
OH (l.9 eV shift) and o-c=o (4.0 eV shift) environments (Table 5.3). These results are in 
accordance with Shakesheff et al27. 
Table 5.3. Relative peak areas from XPS surface analysis 
Chemical shift/ Atomic percentage 
Pure materials as reference Nanoparticles 
Functional Multi + group PLA PVA PEG PLA PEG1% PEGs% PLA 
(50:50) 
C-C (PVA) - 0.0/48.5 - 0.0/27.3 0.0/14.7 0.0/8.4 0.0/13.9 
C-C (PLA) 0.0/38.3 - - 0.0/7.8 0.0/16.1 0.0/25.6 0.0/25.8 
C-O(PVA) - l.3/4l.5 - l.3/23.5 l.3/12.7 l.3/7 .3 l.3/1l.9 
C-O (PLA) 1.90/31.0 - - 1.9/6.3 l.9/13.1 1.9/20.8 l.9/2l.0 
C-O (PEG) - - l.45/100 - 1.6/5.5 1.5/9.1 l.5/3.7 
O-C=O 4.2/10.1 4.2/5.8 4.2/3.1 4.2/1.8 4.2/2.9 (PVA) - -
O-C=O 4.0/30.7 4.0/6.3 4.0/12.9 4.0/20.6 4.0/20.8 (PLA) - -
*C-O-C=O - - - l.0/14.9 1.25/9.3 1.25/1.4 -
C-O-*C=O - - - 2.1/8.2 2.1/12.7 2.1/5.0 -
Primary C Is chemical shifts (eV) relative to saturated hydrocarbon (C Is = 285.0 eV) 
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Interestingly, XPS data of PLA NPs could not be fitted using only 3 peaks observed 
in PLA polymer sample. Same results were obtained even though analysis was repeated 
twice and on a different instrument to rule out any sample handling or instrumental error. 
To get the best envelop fit, two additional peaks had to be added corresponding to c-o-
*C=O (2.1 eV shi ft) and *c-o-c=o (1.0 to 1.25 eV shi ft) (Table 5.3). These additional 
peaks obtained in PLA NPs could be the result of chemical interaction between PLA -
COOH end groups and PV A -OH groups during NP formation. It is well-known that a 
fraction of PV A remains associated with the NPs despite of repeated washings and this has 
been attributed to the hydrophobic interactions between vinyl acetate segment of PV A and 
PLAIPLGA core40,41. Presence oftwo additional peaks corresponding to *c-o-c=o and C-
O-*C=O in the XPS spectrum of PLA NPs indicate the possibility of chemical interaction 
between PLA and PV A. This explains the surface homogeneity of PLA NPs as revealed by 
AFM and also supports effective masking ofnegative charge ofthese NPs. 
Analysis of NPs prepared from grafted polymers showed similar results where best 
envelop fit was obtained by addition of two more peaks as that found for PLA NPs, again 
suggesting the similar reaction taking place between available PLA -COOH and PVA -OH 
groups (Table 5.3). This interaction became weaker with increasing PEG grafting 
percentage (total contribution of additional peaks were 22% and 6.4% for PEG1%-g-PLA 
and PEGs%-g-PLA NPs, respectively, Table 5.3). Although multiblock copolymer NPs 
showed presence of PV A, these peaks were absent indicating no chemical reaction between 
the polymer and PV A. This seems logical as synthesis of multiblock copolymer has been 
realized by polymerization between PLA -COOH and PEG -OH groups, first resulting in 
triblock copolymers which are then condensed to form multiblock copolymers. Thus, it is 
clear that number of free -COOH end groups available for reaction with PV A-OH groups 
are much less in multiblock copolymer NPs in contrast to PLA homopolymer and grafted 
polymers. Whatever may be the mechanism of PV A adsorption (physical adsorption or 
chemical reaction), aIl pegylated polymers decreased surface PVA adsorption almost by 
50% as compared to PLA. This is attributed to the enhanced surface hydrophilicity. This is 
consistent with Shakesheff et a127, who reported reduced PVA adsorption for more 
hydrophilic PLGA microspheres than PLA microspheres. 
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XPS analysis also revealed that PEG surface concentration for PEG1%-g-PLA and 
PEGs%-g-PLA NPs was 5.5 and 9.l % respectively, whereas multiblock copolymer NPs 
showed only 3.7% surface composed ofPEG despite ofhigh PEG content in the copolymer 
(17.8 mol% for multiblock copolymer as against 1-7 mol% for grafted copolymers, Table 
5.l and Table SA). This was attributed to the polymer architecture. Peculiar architecture of 
grafted polymers allowed easy migration of PEG on the surface of NPs whereas covalent 
linkage of PEG with two PLA blocks hampered this process in multiblock copolymer, thus 
reducing its surface coverage. Indeed, Rieger et a19 have recently observed that grafted 
copolymers of poly(s-caprolactone) (PCL) and PEG resulted in 70 % PEG available at NP 
surface, compared to 25% in case of diblock copolymer. They proposed grafted copolymer 
to have palm tree like structure where hydrophobic PCL trunk served as anchoring block 
while hydrophilic PEG palms formed denser hydrophilic brush. On the other hand, diblock 
copolymer consisted of only one PEG block resulting in less surface packing in this case. 
Table SA. Relative percentage of monomer from area under the curves from 
respective Cl s peaks 
Nanoparticles Lactide Vinyl alcohol PEG 
PLA 2004 5604 
PEG1% 42.1 30.5 5.5 
PEG5% 67.0 17.5 9.l 
Multi + PLA (50:50) 67.6 28.7 3.7 
ln a nutshell, it can be seen that PLA NPs had more hydrophilic surface (56% 
surface covered with PVA), followed by PEG1%-g-PLA and PEGs%-g-PLA NPs whereas 
multiblock copolymer NPs had highest proportion of PLA on the surface (Table SA). The 
absence of chemical reaction with PV A and low surface PEG coverage of multiblock 
copolymer NPs supports higher negative potential of multiblock copolymer NPs due to 
delocalization of negative charge. 
5.4.5 Plasma protein binding 
Surface properties of a carrier decide the extent and specificity of prote in 
adsorption. With constant research in this area a general assumption was put forth that more 
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prote in adsorbs on to poorly water wettable (hydrophobie) surfaces42 . Nagahama et a143 
have recently shown that 8-anned pegylated polymer had improved resistance to prote in 
adsorption and ceU adhesion than 2-anned linear pol ymer due to their lower water 
absorption capacity. Similarly, Rieger et al9 have shown that PCL-g-PEO copolymers were 
more effective in preventing protein adsorption as compared to PEO-b-PCL diblock 
copolymers. These results are directly correlated to the effective PEG surface density on 
NPs as a consequence of polymer architecture. In accordance with XPS results, multiblock 
copolymer NPs displayed less amount ofPEG and more amount of PLA on the surface and 
hence, they would be less wettable. Indeed, the silver-stained SDS-PAGE profiles in Fig. 
5.3 reveal that PLA and multiblock copolymer NPs adsorbed higher amounts of proteins, 
compared with grafted copolymer NPs. It is worthy to note that only few protein bands are 
visible in grafted copolymer NPs as against PLA and multiblock copolymer NPs. This puts 
forward the fact that surface PEG concentration of any colloidal drug delivery system is 
more important than total polymer PEG concentration in determining their protein resistant 
ability. 
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Figure 5.3. Plasma protein adsorption of different NPs by SDS-PAGE gel 
electrophoresis 
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5.4.6 Cellular toxicity and uptake studies 
PLA is a well-known biodegradable and biocompatible polymer. In our study, NPs 
of all the polymers were well tolerated and exhibited no adverse effects on the cell viability 
as shown by cell proliferation assays (Fig. 5.4). 
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Figure 5.4. Cytotoxicity ofNPs in RA W 264.7 cells by MTT assay. PLA (.); PEGl%-
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In the uptake study by RA W 264.7 cells, reduced uptake was observed for PLA 
NPs. This is the result of high and uniform adsorption of residual PV A on PLA NPs. These 
results are in accordance with Sahoo et al40 and Prabha et al44 who have reported decreased 
cellular uptake and decreased gene transfection efficiency due to presence of PV A on the 
surface ofNPs. Thus, the uptake results of pegylated NPs cannot actually be compared with 
PLA NPs as a positive control. It is interesting to note that grafted polymer NPs resulted in 
lower degree of internalization in macrophages compared to multiblock copolymers NPs. 
This may be ascribed to surface hydrophobicity and charge of the multiblock copolymer 
NPs. Highly anionic surface charge and presence of less PEG (thus, more hydrophobic 
surface) was thought to be the reason for this increased uptake of multiblock copolymer 
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NPs. lndeed, it has been previously found that macrophage uptake of NPs increases with 
surface charge4S,46 and surface hydrophobicity47. Roser et al46 have studied phagocytosis of 
albumin NPs in U-937 cells as well as activated mouse peritoneal macrophages. Their 
results showed that higher negative or positive surface charge of album in particles 
significantly increased their cellular uptake. Fang et al 18 have also shown increased uptake 
of negatively charged poly(hexadecyl cyanoacrylate) NPs in macrophages as compared to 
their less negative pegylated NPs. It has also been reported that negatively charged particles 
are taken up by Kupffer cells by non-specific scavenger receptor-mediated endocytosis 45. 
These results suggest the possibility of use of negatively charged multiblock copolymers 
NPs for their potential application in liver targeting whereas grafted copolymer NPs can be 
used as long-circulating drug carriers for intravenous administration. 
It was further interesting to find out whether this difference in the uptake was 
related to different mechanisms operating at cellular level for different polymer types. 
Hence, cell monolayers were incubated with various metabolic and endocytic inhibitors in 
addition to the NPs. As shown in Fig. 5.5 A and B, the cellular uptake was concentration 
and temperature dependent as reported for poly(lactide-co-glycolide) NPS48 • Further, 
significant inhibition of uptake (35-62%, p < 0.01) of all NPs by metabolic inhibitor 
(sodium azide, O.l%w/v) confirmed active endocytic mechanism oftheir uptaké4. It cou1d 
be seen that grafted polymer NPs showed greater extent of inhibition with sodium azide 
than PLA and multiblock copolymer NPs (Fig. 5.6). Hyperosmotic sucrose (450 mM) 
inhibits fluid phase and receptor-mediated endocytosis49 . A 1 h pretreatment with sucrose 
resulted in drastic decrease in the uptake of all the NPs, especially pegylated NPs (50 to 90 
% inhibition), further confirming fluid phase endocytosis as the major uptake pathway for 
these NPs. Chlorpromazine (10 Ilg/mL) is known to disrupt the assembly and disassembly 
of clathrin by reducing the number of coated pit-associated receptorsSO and it was found to 
reduce uptake of all NPs by 68 to 92%. Thus, all NPs showed fluid phase and clathrin-
dependent endocytosis for their uptake. lnterestingly, incubation of NPs with cytochalasin 
B (10 llg/mL), maneuver known to restrict actin polymerization surrounding endocytic 
vesicle in macropinocytosisSI , did not affect uptake of PLA, PEGs%-g-PLA and multiblock 
copolymer NPs significantly (6-9% inhibition) whereas PEGl%-g-PLA showed significant 
inhibition (42%; p < 0.01) with cytochalasin B treatment. This difference in the results is 
not understood, but may be attributed to the different core/shell structure of NPs. lndeed, 
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Mahmud et a152 have reported similar discrepancy in intemalization mechanism for PEO-b-
PCL micelles having different block length finally affecting their core/shell structure. The 
authors have reported that cytochalasin B inhibited intemalization of 5000-5000 and 5000-
13000 PEO-b-PCL micelles without having any effect on the intemalization of 2000-5000 
and 5000-24000 PEO-b-PCL micelles. They assigned this to the difference in core/shell 
structure 52 . The reason for inconsistency in our results is not clear at this moment and needs 
further investigation. However, it is evident that uptake of pegylated NPs involved different 
endocytic routes and was not by phagocytosis. AIso, polymer architecture resulted in 
change in the surface properties and hence, differences in the uptake of these NPs. 
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Figure 5.5. A. Effect of NP concentration on cellular uptake by RA W 264.7 cells. 
Cells were incubated with NPs at concentrations 40, 80, 120, 160 and 200 
~g/mL at 37 oC for 3 h. Mean ± SD, n = 5; PLA (t); PEG1%-g-PLA (0); 
PEGs%-g-PLA (.); (PLA-PEG-PLA)n (x); B. Effect of temperature on 
cellular uptake of NPS by RA W 264.7 cells. Cells were incubated with 
NPs at 37 oC (open bar) and 4 oC (filled bar) at a dose of20 ~g/mL 
5.5 Conclusion 
NPs were formulated using novel copolymers of PEG and PLA with different 
molecular architecture. AFM phase imaging studies successfully showed presence of PEG 
on the surface of pegylated NPs irrespective of their chemistry. Systematic study of surface 
characterization showed that multiblock copolymer displayed less amount of PEG on the 
surface due to interpenetration of PEG chains inside the core of NPs. This resulted in higher 
negative charge, surface hydrophobicity and less resistance to protein adsorption of 
multiblock copolymer NPs irrespective of its higher total PEG content. On the contrary, 
chemical structure of grafted copolymer favored easy migration of PEG chains on the 
surface of NPs improving their protein resistance despite of low total PEG content of these 
polymers. Covalently linked PEG was always more efficient in preventing protein binding 
as compared to homogenously adsorbed PV A on PLA NPs. Further, cellular uptake studies 
c1early revealed c1athrin dependent active endocytic pathways involved in their 
intemalization. In a nutshell, molecular architecture of the polymer is an important 
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parameter controlling surface characteristics of NPs which in tum determine their prote in 
resistant capabilities and cellular interactions. 
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Figure 5.6. Uptake of fluorescent NPs of different polymers by RA W 264.7 cells at 
37°C in the presence of sodium azide (0.1 % w/v), hyperosmolar sucrose (0.45 M), 
Chlorpromazine (10 Ilg/mL), and Cytochalasin B (10 Ilg/mL) (B), Cells were 
pretreated with the inhibitors for 1 h followed by NPs (160 Ilg/mL) for another 3 h. 
Mean ± SD, n 2: 4; *: values significantly different at P > 0.01. 
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Introduction 
First part of this chapter will focus on the synthesis and characterization of 
biodegradable polymers. Feasibility of use of gas adsorption technique for analysis of 
micropores and effect of formulation factors, especially drug loading on the microporosity 
of formulated NPs will be discussed in the next section. Third section will discuss the 
impact of molecular architecture of polymer in deciding the microstructure of NPs and in 
tum, the release kinetics. Finally, this work will bring about the importance of a 
comprehensive study of various physicochemical surface properties in relation to their 
biological properties like protein resistance, macrophage uptake and its mechanism. 
6.1 Synthesis and characterization of pegylated polymers 
We have deve10ped a rapid synthetic method with high yields for PLA grafted with 
allyl, hydroxy and carboxylic pendant functional groups in our laboratory [1]. Using this 
synthesis method, methoxyPEG was grafted on the hydrophobic PLA backbone at two 
different densities; 1 and 5 mole % oflactic acid monomer, referred henceforth as PEGl%-
g-PLA and PEGs%-g-PLA, respectively. Multiblock copolymer, (PLA-PEG-PLA)n was 
utilized as synthesized in our laboratory [2]. These polymers were characterized for their 
structural elucidation (IH NMR), molecular weight and polydispersity by gel permeation 
chromatography (GPC) (Table 4.1, Fig. 4.1) and thermal properties (DifferentiaI scanning 
calorimetry, DSC) (Table 4.1, Fig. 4.2). 
6.1.1 Chemical structure by tH NMR 
Typical spectra were obtained with peaks at 5.2 ppm corresponding to the tertiary 
PLA proton, peak at 3.6 ppm for the protons of the repeating units in PEG chain, peak at 
4.3 ppm for the PEG connecting unit to the PLA block, and peak at 1.5 ppm for the pendant 
methyl group of the PLA chain. For the multiblock copolymer, additional peak could be 
seen at around 2.7 ppm corresponding to the succinic acid moiety as reported earlier [2]. 
Actual PEG grafting percentage was close to the feed ratio as shown in Table 4.1. AIso, as 
shown in fig. 4.1, peak intensity at 3.6 ppm increased with increase in PEG grafting density 
in case of grafted polymers, while multiblock copolymer showed highest PEG content 
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(17.8 % oflactic acid monomer) when calculated by the ratio of peak intensity at 3.6 ppm 
and 5.2 ppm. AIso, synthesized polymers showed very narrow polydispersities as 
determined by GPC results. 
6.1.2 Thermal properties by DSC 
In addition to molar mass and polydispersity, thermal properties of polymers are 
influenced by their molecular structure. It was clearly seen that changing the percentage of 
grafting resulted in change in the thermal behavior of polymers. AIso, block copolymer 
showed good phase mixing between PLA and PEG blocks with ability to form PEG 
microdomains rapidly on cooling (Fig. 4.2). 
Thus, we could successfully synthesize pegylated polymers with different PEG 
concentrations and different polymer architectures (linear multiblock versus branched graft 
copolymer). Polymer architecture defines the shape of a single polymer molecule, which 
often determines its physicochemical properties [3]. As we see from DSC results, it is clear 
that addition of PEG at 5 mole% of lactic acid monomer, resulted in plasticization effect 
leading to decrease in Tg of the polymer. However, it should be noted that at very low 
grafting PEG concentration, effect of branching predominated with subsequent increase in 
Tg of the PEGl%-g-PLA polymer. Although PEG5%-g-PLA and (PLA-PEG-PLA)n, both 
showed decrease in Tg suggesting improved phase mixing, they also exhibited PEG melting 
endotherm, further stressing the existence of crystalline PEG microdomains (Fig. 4.2). This 
has already been reported for polyanhydride copolymers of poly(1 ,3-bis-p-carboxyphenoxy 
propane-co-sebacic anhydride) [4]. When concentration of one of the block exceeds that of 
other, clear microphase separation could be observed, however, at equal concentration of 
both blocks, there was complete phase mixing. This type of phase mixing or phase 
separation has been reported for various polymer blends or copolymer films. However, it is 
questionable whether these phenomena would occur reproducibly during NP formation. If 
yes, how these polymer chains reorganize during the process of NP formation will further 
decide microstructure of the core as weIl as surface properties of these NPs. 
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6.2 NP preparation and impact of formulation factors on 
their microporosity 
In this study, NPs were prepared' using same polymer, PEG1%-g-PLA and the 
Propafenone hydrochloride (Prop) as a model drug. The amount of triethylamine (TEA) 
added to solubilize hydrochloride salt and drug loading levels were varied. 
6.2.1 Physicochemical properties of NPs 
It can be clearly seen that monodispersed and smooth spherical particles in the size 
range of 178-192 nm were obtained by high-pressure homogenization technique (Table 3.1 
and Fig. 3.1). There was no effect of the amount of TEA or drug loading on the size and 
morphology of these NPs, suggesting complete control of homogenization technique on 
their size. As reported by Kohori and co-workers [5], TEA successfully served the purpose 
of increasing the encapsulation efficiency of Prop. It was proposed that TEA scavenges 
hydrochloride of the salt, thus setting free more hydrophobic Prop base. This led to 
increased encapsulation of Prop base into PLA core, probably due to enhanced hydrophobic 
and/or ionic interactions between the carboxylic groups of PLA and amino groups of Prop. 
To further conflnn this me chanis m, free base generated using TEA was used for drug 
loading experiments. Increase in drug loading of base as compared to hydrochloride salt 
without use of TEA confinned our hypothesis of hydrophobic and/or ionic interaction 
between the drug and polymer playing role in their encapsulation. It is clear that addition of 
1:2 M TEA in situ was more effective in setting free the basic fonn of the drug than 1: 1 M 
TEA, f~voring its interaction with the polymer, thus further increasing its encapsulation 
efficiency (Table 3.1). 
These results are further confinned by thennal analysis of pure drug (both salt and 
basic fonns), pure polymer, their physical mixtures and Prop-Ioaded NPs (Fig. 3.3). 
Retention of the melting endothenns (Tm) of the salt as well as base in both the physical 
mixtures is evident from DSC results. Although encapsulation of Prop in the NPs resulted 
in the disappearance of Tm, shift of Tg of the polymer towards higher temperatures clearly 
supported the interaction between the polymer and drug (Fig. 3.3). Indeed, DSC has been 
successfully used to study the interaction between the drug and the polymer [6, 7]. Okada 
and co-workers [6] have already suggested interaction between carboxylic acid residues of 
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PLA and amme groups of basic drug, resulting in increase in Tg of the formulated 
microspheres. They attributed this to the formation of rigid structures inside the matrix due 
to ionic interaction between the drug and polymer. Similarly, Miyajima et al reported 
increase in Tg of copoly(lactic/glycolic acid) after incorporation of basic drugs [7]. 
6.2.2 In vitro release kinetics 
Although TEA increased the drug loading significantly, it did not have any apparent 
effect on drug release (Table 3.1, Fig. 3.5). On the other hand, initial drug loading affected 
both, the realloading inside the NPs as well as drug release kinetics (Table 3.1, Fig. 3.6). 
Higher drug loading resulted in slower drug release kinetics, irrespective of amount of TEA 
used. This could not be explained just based on the physicochemical properties of the NPs 
as all of them have been prepared from the same drug and the polymer as well as they 
showed comparable particle size distribution (178-192 nm; Table 3.1). AIso, increased drug 
loading did not lead to any evidence of crystallization of Prop inside the polymeric matrix. 
In fact, DSC results confirmed amorphous or disordered crystalline phase of molecular 
dispersion of Prop inside NPs (Fig. 3.3). This implies that release kinetics is controlled by 
the drug diffusivity in the matrix. 
The porous structure of a material is important in both natural phenomena and 
practical applications such as dissolution, adsorption and diffusion of drugs [8]. Lemaire et 
al [9] suggested that, during release, a drug molecule located inside a pore would naturally 
diffuse towards one of the end-points of the pore and eventually reach outside. If a drug 
molecule is present within the network of micro pores, it will have to diffuse towards the 
closest pore to be released outside. The movement of such molecule in the micropore 
network is highly restricted due to the limited space available and due to more important 
interaction between drug molecule present in the micropore and wall of micropore. 
Microporosity also hampers water flux inside such matrix affecting its hydration. Thus, in 
other words, the effective pore diffusion coefficient of drug in microporous network will be 
smaller than the diffusivity in a straig~t cylindricallslit-like pore as a result of the random 
orientation of pores leading to longer diffusion path. This effective restricted diffusion 
coefficient of the drug in the porous media is a function of the diffusivity of drug, porosity 
(f:) and tortuosity Ct) of the matrix. The tortuosity in turn depends on the pore structure, 
pore size and shape distributions [10]. Thus, study of microstructure ofNPs was undertaken 
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to see whether this porous microstructure was responsible for these differences in the 
release kinetics of Prop. To this end, we applied nitrogen gas adsorption technique to 
calculate BET surface area, total pore volume, pore size distribution (PSD) and 
microporosity. Microporosity was studied by Horvath-Kawazoe [11, 12] known as HK 
method. The HK method is based on slit-shaped pore model. Even though this pore model 
may not be appropriate for NPs, it was applied in this thesis accepting the limitation that it 
will still allow comparison between sarnples, since the analysis were carried out under 
identical conditions. 
AlI the pararneters, viz., BET surface area, total pore volume, PSD showed no 
significant difference for the formulations tested (Table 3.2). A c10ser look at microporosity 
of formulations prepared with different arnounts of TEA revealed similar microporosity and 
drug release profiles even though they had different drug loading efficiencies (Fig. 3.4 & 
3.5). Hence, TEA affected neither microporosity nor drug release. However, formulations 
prepared with sarne TEA but different initial drug loading c1early exhibited differences in 
their microporosities and subsequently, drug release profiles (Fig. 3.4 & 3.6). These results 
revealed that formulations having less microporosity (50 and 51:2) always had higher re1ease 
rate than those with higher microporosity (100 and 101:2, respectively). Both these 
formulations with 10% initial loading had comparable encapsulation efficiencies, but 
higher realloading (% w/w) and higher microporosities (Table 3.2). So, question was asked 
if the real loading (arnount of drug present in the matrix at t = 0) was responsible for 
determining the release kinetics. lndeed, formulations 50 and 51:1 as well as 100 and 101:1 
showed no significant differences in realloading and consequently, drug re1ease kinetics. 
However, it is worthwhile to note that formulations, 51:2 and 100 or 101:1 also showed 
comparable real drug loading, but different release kinetics. Why? Answer lies in their 
different microporosities (Fig 6.1). This strongly points out to the fact that real loading 
inside the matrix is not the actual factor determining the drug release rate. Thus, 
microporosity seems to be more important and predictable in determining release profiles 
than other factors. As previously discussed by Lemaire et al [9], more microporosity 
hindered the movement of drug and changed medium flux thereby reducing effective prop 
diffusion coefficient. This in turn slowed down the release phenomena. 
132 
1 
~ 1 
"B 0.01 \ 
';' 1 
e 1 
= \ ë 1 
~ 1 
~0.005 : 
c. 1 
~ \ 
:: 1 
.! \ " ---5 1:2 
= \.li § 0 +-~_r--_----, __ -_--,--_-_1_0---,O 
U 
120 
100 
'Q 
~ 
<Il 80 
= ~ 
~ 
1. 60 0.0 
= 1. 
'Q 40 
~ 5 (1 :2) co 
20 
-"*" - 10 (0) 
0 
o 5 10 15 20 0 200 400 600 
pore width (Â) lime (h) 
Figure 6.1. Microporosity detennines the release; Fonnulations (51:2, 100) having 
same realloading (% w/w), but different microporosity resulted in different release 
kinetics; higher the microporosity (100), slower the release is. 
In conclusion, these studies clearly supported the hypothesis that fonnulation factors 
affect the internaI structure as well as microporosity, influencing drug release kinetics from 
NPs. Also, gas adsorption technique could be successfully used to probe into the 
microporosity ofNPs. 
6.3 Role of polymer architecture: Study on Blank NPs 
As can be seen from the preceding discussion, fonnulation factors resulted in very 
marginal changes in the microporosities of prepared NPs. It was thought that this 
microporosity of NPs may be the result of cavities/void spaces between the same or 
different polymer chains created during the NP fonnation. Further, the question was asked 
if changes in the polymer architecture would be able to magnify such differences. In other 
words, it is quite possible that fonnulation factors considered in the previous study might 
not be able to create big differences in the pol ymer chain folding. However, if the basic 
molecular architecture is changed, it might create big differences in the free volume as well 
as wriggling of polymer chains and probably, microporous structure of their NPs. To 
confinn this hypothesis, homopolymer, PLA and its pegylated copolymers with different 
molecular architecture (graft or linear block copolymer) were used to prepare NPs. It was 
hypothesized that polymers would rearrange differently during NP fonnation depending on 
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their architecture, leading to change in the internaI NP structure. Hence, blank NPs were 
prepared under identical fonnulation conditions to rule out any effect of drug loading or 
fonnulation factors on their internaI structure. 
Nitrogen adsorption studies revealed differences in the microporosity of these NPs 
(Fig. 4.4, Table 4.2). NPs of grafted polymer, PEG1%-g-PLA showed highest nitrogen 
adsorption capacity, microporosity and BET surface area while that of multiblock 
copolymer, (PLA-PEG-PLA)n showed the reverse trend (Fig. 4.4, Table 4.2). Changes in 
BET surface area have been suggested to be due to differences in the partic1e size, texture, 
structural differences, surface irregularities or presence of impurities [13]. Interestingly, all 
the NPs exhibited same partic1e size and size distribution. Thus, change in BET was 
attributed to the microporosity and structural differences in NPs as both these parameters 
followed the same trend. 
To explain this, we proposed a model of polymer chain reorganization inside NPs 
(Fig. 4.6). PLA being hydrophobie will undergo precipitation and NP fonnation once the 
organic solvent is extracted into the external aqueous phase. When hydrophobie PLA and 
hydrophilic PEG chains coexist in the polymer structure, microphase separation is expected 
to take place depending on the concentration of each block and their molecular architecture 
[14, 15]. We proposed that it would be easy for PEG chains to migrate to the surface ofNPs 
in case of grafted copolymer as hydrophobie PLA backbone can easily collapse in aqueous 
external phase leaving PEG on the external surface of emulsion droplet during NP 
fonnation. However, this phase separation would be difficult in case of multiblock 
copolymer because each PEG chain is covalently linked to two blocks of PLA. During NP 
fonnation, there would be competition between gelation of hydrophobie polymerie phase 
and microphase separation between PLA and PEG chains. Faster gelation willlead to sorne 
of the PEG chains being entrapped inside the hydrophobie domain, allowing only few PEG 
chains to be migrated at the external surface of NPs. This will result in NPs of both types 
with hydrophobie PLA core surrounded by hydrophilic PEG corona, except with different 
PEG confonnation on the surface. In case of grafted polymer, NPs will have PEG with one 
end free to move (extended brush) whereas multiblock copolymer will result in mushroom 
confonnation (Fig. 4.6). In addition, multiblock copolymer NPs will have hydrophilic core 
due to entrapment of sorne of the PEG chains inside the NPs. This hypothesis seems quite 
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logical as interpenetration of PEG inside the core would result in blocking of sorne of the 
pores reducing overall microporosity of these NPs as observed with multiblock copolymer 
NPs. 
XPS results further supported this proposed model (Table 4.2). Multiblock 
copolymer NPs showed very less PEG surface concentration even though copolymer itself 
had higher PEG content compared to grafted copolymer. Thus, polymer architecture seems 
to have affected reorganization of polymer chains during NP formation leading to change in 
their microporous structure. It was further interesting to see how this would affect the drug 
release kinetics from NPs. 
6.4 Release kinetics 
6.4.1 Considering conventional factors in the literature 
After addressing the role of polymer architecture in determining the microporosity 
ofNPs, Prop-Ioaded NPs were prepared using PEG1%-g-PLA and (PLA-PEG-PLA)n. Drug 
release kinetics from these NPs was studied along with their microporosity. As discussed in 
the previous chapter, drug release mechanisms from polymeric NPs include diffusion or 
degradation or combination of both. The release profiles of Prop from grafted and 
multiblock copolymers exhibited an initial burst effect followed by slow and sustained 
release over 40 days. The release pattern showed good correlation coefficient (R2 ~ 0.99) 
when fitted to Higuchi equation of diffusion. For grafted copolymer NPs, Higuchi equation 
was Q = 5.33t + 20.62, r = 0.996 and that for multiblock copolymer NPs was Q = 8.48t + 
28.94, r = 0.994, where Q is the percent amount released in time t. The initial fast release 
(28% and 35% respectively for grafted and multiblock copolymer NPs) can be attributed to 
the prop adsorbed on or present near the surface, or even easily accessible to the bigger 
pores open at the surface. After this phase, the release was diffusion controlled. 
Conventional factors affecting release discussed so far in the literature include 
particle size [16, 17], physical state of drug inside the matrix [18], porosity of the matrix 
[19, 20] etc. Both the nanoparticulate systems studied here showed monodispersed size 
distribution (Supporting information, Fig. S3, Chapter 4) and similar particle sizes viz. 205 
± 10 nm for PEG1%-g-PLA and 211 ± 6 nm for (PLA-PEG-PLA)n (Table 4.3). This 
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completely rules out any possible role played by size in detennining the release kinetics. 
From DSC thennograms, Tg of blank NPs was found to be higher than respective polymers 
(Table 4.1 & 4.2). This seems logical as fonnation ofNPs willlead to more rigid structure 
restricting the movement of polymer molecules. Prop incorporation inside PEG1%-g-PLA 
NPs led to decrease in Tg compared to blank NPs suggesting plasticizer effect of drug. 
However, Prop-Ioaded NPs of (PLA-PEG-PLA)n showed further increase in their Tg 
signifying fonnation of more rigid structure [6]. It is interesting that melting endothenn of 
Prop was absent in any of these NPs suggesting that Prop is molecularly dispersed or in the 
amorphous state in the NPs as discussed previously. It is evident from Tg values of prop-
loaded PEG1%-g-PLA and (PLA-PEG-PLA)n NPs that the fonner has higher Tg than latter. 
This partly explains higher rate of release from (PLA-PEG-PLA)n NPs. lndeed, Frank et al 
[21] have proved that the magnitude of diffusion coefficient of drug through PLA and 
PLGA polymers correlated inversely with the magnitude of measured Tg. Therefore, they 
suggested that polymerie system with lower Tg would exhibit increased release rates when 
the release is controlled solely by diffusion. This seems logical as lower Tg means 
increased plasticity, better hydration and hence, higher release kinetics [22]. 
Now coming to the overall porosity of the matrix, it was highly surprising that 
(PLA-PEG-PLA)n NPs had lower total pore volume (0.048 cc/g ± 0.002) as against PEG1%-
g-PLA NPs (0.28 cc/g ± 0.002). AIso, it is weIl known that specifie surface area plays an 
important role in release kinetics. BET surface areas obtained from nitrogen gas adsorption 
for these Prop-Ioaded NPs were 3.79±0.62 and 20.4±1.10 m2/g for (PLA-PEG-PLA)n and 
PEG1%-g-PLA NPs respectively. These values were confinned by krypton gas adsorption 
(Table 4.3). These results would suggest faster Prop release for PEG1%-g-PLA NPs due to 
its higher BET and higher total pore volume which is contradictory to in vitro release 
results (Fig. 4.7). 
6.4.2 Significance of microporosity 
Given the fact that both these systems have similar size and size distribution 
(Supporting infonnation, Fig. S3, Chapter 4), changes in the BET can be attributed to their 
structural and microporosity differences as discussed for blank NPs. It is clear from Fig. S2 
(Supporting infonnation, Chapter 4) that (PLA-PEG-PLA)n exhibited much less 
microporosity than PEG1%-g-PLA NPs. These studies again confinned the results 
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corroborated in our first article (Chapter 3) that microporosity really plays an important role 
in drug release kinetics. Here, size of diffusing molecule like propafenone (16 A as 
calculated from Chemoffice 8.0) is not at all negligible as compared to size of micropores, 
which more logically presents the distance between the closest polymer chains. Probably, 
prop molecules are entrapped / sandwiched between polymer chains during NP fonnation. 
Release of such drug outside NPs will then depend on its interaction with the pore wall as 
well as swelling and/or relaxation of polymer chains to create sufficient space for 
movement of drug molecules as suggested very recently by Zhao et al [23]. This will slow 
down the process of diffusion. Thus, higher microporosity will pose more restrictions for 
movement of drug through the aqueous channels reducing its effective diffusion coefficient 
and thus, the final rate of release [9]. 
6.4.3 Role of polymer chain organization 
It is also important to think why higher total pore volume or higher surface area of 
PEG1%-g-PLA NPs did not result in faster release from these NPs? As discussed before, 
higher BET surface area of PEG1%-g-PLA NPs was a result of higher microporosity, which 
worked against faster release. As far as total pore volume is concerned, it should be 
remembered that nitrogen adsorption studies are carried out in the dry state. What will 
happen when both these systems are put in the aqueous system? Answer lies in the internaI 
structure or pol ymer chain organization inside NPs. Going back to the hypothesis of 
polymer chain organization (Fig 4.6), (PLA-PEG-PLA)n NPs have hydrophilic core due to 
PEG chain interpenetration. This resulted in pore blocking and reduced microporosity in 
dry state as seen by gas adsorption. However, PEG chains of these NPs would take up 
release medium efficiently when introduced in aqueous environment, reversing the pore 
blocking and in turn, creating more aqueous channels for diffusion of drug molecules. This 
would not be the case with PEGl%-g-PLA NPs where the core is composed of hydrophobic 
PLA chains. The diffusion of drug through this system will then depend on the amount and 
accessibility of surface pores as well as restricted diffusion through the micropores. Thus, 
release kinetics also supports the hypothesis about chain organization or self-assembly of 
polymers during NP formation. 
This research clearly indicated significance of the microporosity, internaI structure 
and polymer self assembly for release properties of NPs. This would definitely serve as a 
137 
guideline for drug delivery of not only small molecule but also large molecules like 
proteins. Indeed, it has been suggested that high internaI porosity is essential for release of 
high molecular weight proteins and also, control of internaI morphology might be 
indispensable to adjust the release rates from any carrier [24]. In our opinion, preceding 
research in this dissertation has attempted to address this issue, pertaining more to the 
microporosity as well as internaI morphology of NPs by gas adsorption technique. Further, 
it can not be any more assumed that higher surface area leads to faster drug release; in fact, 
the underlying cause of the increased surface area should always be taken into account 
before any such conclusion. AIso, even if it is seen as drug-polymer interaction, and/or 
individual polymer or drug properties affecting the release kinetics, these macroscopic 
properties may lead to changes in microporosity at a molecular scale and finally, affect the 
drug release rate. Thus, by studying effect of other factors like molecular weight or solvent 
evaporation kinetics on microporosity, we can gain further insight into the molecular 
arrangement of polymer chains inside NPs and then, polymers can be tailor-made to 
achieve more precise drug release kinetics. 
6.5 Characterization of surface properties and Cellular 
interaction of NPs 
In the preceding section of this thesis, we have already seen the effect of polymer 
architecture on the internaI structure and release properties of the NPs. It was further 
interesting to study how polymer architecture affected the surface properties and cellular 
interaction of NPs. Hence, systematic investigation was undertaken to study surface 
structure ofNPs using various techniques like IH NMR, AFM and XPS. AIso, efforts were 
made to correlate the results of surface characteristics with protein binding and cellular 
internalization capacity of these NPs. 
6.5.1 Surface structure 
6.5.1.1 lH NMR ofNPs in D20 
IH NMR studies of NPs in D20 showed presence of methylene protons of PEG 
chains at 3.7 ppm (Fig. 6.2). SignaIs from PLA methyl or methyne protons were absent. 
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This indicates that PLA protons are in solid environment and cannot be detected whereas 
PEG chains must be in mobile state. Similar results have been reported for PLA-PEG 
diblock NPs to confirm their core-shell structure [25]. Similarly, Breitenbach et al [26, 27] 
have found that NPs of comb polyesters ofPVA-g-PLGA in water exhibited reduced signal 
intensity of the more hydrophobic PLGA chain compared to hydroxyl terminated end 
groups. They proposed that hydrophilic pol ymer parts are oriented towards the outer water 
phase during precipitation and NP hardening whereas the more lipophilic polyester residues 
form the inner core. Our results are in accordance with the above-cited references 
suggesting NPs made of PLA core and PEG corona. However, these studies are not 
quantitative to comment whether all the PEG chains constitute the corona. 
PEGs%-g-PLA 
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Figure 6.2. IH NMR ofblank NPs of PLA, PEGl%-g-PLA, PEGs%-g-PLA, and (PLA-
PEG-PLA)n in D20. PEG peaks at 3.6 ppm are encirc1ed. 
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6.5.1.2 AFM image analysis of NPs 
Phase image AFM studies provided additional visual support to lH NMR studies. 
Two separate phases were clearly present in the phase images of pegylated NPs as against 
homogenous surface of PLA NPs (Fig. 5.2). This demonstrates presence of softer (dark 
regions in the phase) PEG segments on the surface of rigid (light regions in phase) PLA 
segments. This has been previously reported for polymer films [28], however, not for NPs 
to the best of our knowledge. 
6.5.1.3 XPS analysis 
Results of XPS brought forward sorne interesting results (Table 5.3). First of aH, 
PVA was found associated with aH the NPs as found by others [29, 30] and amount of 
adsorbed PVA decreased with increased surface PEG concentration [31]. Secondly, XPS 
results confirmed that PEG chains of multiblock copolymer penetrate inside the PLA core 
resulting in reduced surface PEG concentration. On the other hand, grafted copolymer NPs 
exhibited higher surface PEG concentration suggesting ease of PEG migration on the 
surface due to peculiar pol ymer architecture. This was consistent with the results of Rieger 
et al [32] who found higher surface PEG for grafted copolymer than diblock copolymer. 
From the appearance of two additional peaks, XPS results also revealed the 
possibility of interaction between PLA-CO OH and PV A-OH end groups in case of PLA 
homopolymer and grafted copolymers. This reaction was absent in multiblock copolymer 
(PLA-PEG-PLA)n NPs, probably due to unavailability of end -COOH groups in this 
pol ymer structure. In our opinion, these results partly explain the failure of extensive 
washing procedures for removal of NP associated PV A and also effective zeta potential 
reduction of PLA NPs [29-31, 33, 34]. These results also emphasized that association of 
PV A with NPs may not be just due to the hydrophobic interaction between acetate group of 
PVA and hydrophobic polymer chains as suggested previously [29, 30]. 
6.5.2 Plasma protein binding 
From the above surface structure studies, it was clear that grafted copolymers had 
more surface PEG concentration ev en though (PLA-PEG-PLA)n had higher total PEG 
concentration (surface as weIl as core). Protein binding studies revealed trends in 
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accordance with these results. As a general rule, highly hydrophobie or poorly wettable 
surface adsorbs higher proteins [35]. Hence, PLA and (PLA-PEG-PLA)n exhibited higher 
protein binding than grafted copolymer NPs (Fig. 5.3). This can again be attributed to 
polymer architecture as suggested by Nagahama et al [36] where they found 8-armed 
copolymer structure more protein resistant than its linear copolymer. Similar results have 
been reported by Rieger et al [32] for grafted and diblock copolymers of PCL and PEG; 
where grafted copolymers adsorbed less proteins. 
6.5.3 Cellular uptake studies 
Uptake of aIl NPs in RA W 264.7 cells was concentration and temperature 
dependent (Fig. 5.5) as shown earlier for poly(lactide-co-glycolide) NPs [37]. Further, 
differences in their uptake can be explained based on the surface characteristics. In general, 
adsorbed PVA reduced intemalization of PLA NPs as reported previously [29, 38] either 
due to masking the surface charge or rendering the surface more hydrophilic. Interestingly, 
among the pegylated NPs, multiblock copolymer NPs showed highest uptake which can be 
attributed to reduced surface PEG concentration (and hence, more surface hydrophobicity) 
as seen by XPS. Indeed, there are various reports in the literature signifying role of surface 
charge and hydrophobicity in the cellular uptake of particles [39-42]. 
Further mechanistic evaluation of cellular uptake revealed active, fluid phase 
and clathrin- dependent endocytosis for ail NPs. Their uptake was significantly inhibited by 
sodium azide (metabolic inhibitor), hyperosmotic sucrose (fluid phase endocytosis 
inhibitor) and chlorpromazine (reduces clathrin-coated pits) (Fig. 5.6). Cytochalasin B, 
inhibitor of actin polymerization in macropinocytosis affected uptake of only PEG j %-g-
PLA NPs. The exact reason for this discrepancy could not be explained. In fact, Mahmud et 
al [43] have found similar inconsistency in PEO-b-PCL micelles prepared with varying 
length of two blocks, which they ascribed to the different core-shell structure. Further 
studies are needed to explore the exact reason of this effect. 
Thus, this systematic and complete investigation proved that polymer 
architecture plays a definite role in determining the surface chemistry of formulated NPs. 
Further, these surface properties are critical in deciding protein binding and cellular uptake 
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of NPs, which in turn will determine their in vivo stability and biodistribution and 
therapeutic success. 
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Conclusion 
Although introduction of nanotechnology obviously pennitted to step over 
numerous milestones towards the development of the "magic bullet", there are unresolved 
delivery problems to be still addressed. For instance, with the advent of versatile nanoscale 
delivery approaches like nanoparticles, micelles and dendrimers, various polymeric 
architectures are being synthesized for controlled drug delivery applications. Such large 
number of newly synthesized polymers brings a new problem of quickly selecting a 
suitable polymer for a specified drug as its controlled release material. Although drug 
release properties of nanoscale drug delivery systems have been studied in the past as a 
function of various fonnulation parameters, the experiments in this field has addressed only 
the macroscopic behavior of drug release. A paradigm shi ft of current research from 
'micro' to 'nano'scale needs more infonnation on the molecular level diffusion 
mechanisms of drug molecules in polymer matrix. This thesis is an endeavor to probe into 
such mechanisms by correlating differences in microporosity to the drug re1ease kinetics 
and surface properties of polymeric nanoparticles. 
This thesis first puts forward following hypotheses: 
1. Polymer architecture markedly influences pol ymer chains reorganization in the 
bulk of NPs, thus deciding the internaI structure as weIl as surface properties of 
NPs. 
2. Microporosity plays vital role in detennining the drug release kinetics from 
polymeric NPs. 
3. Polymer architecture also affects surface properties of NPs, th us detennining 
their protein resistance as weIl as cellular interaction abilities. This in turn, will 
detennine their in vivo stability and therapeutic efficacy as drug delivery 
systems. 
The importance of microporosity and internaI structure of these nanosized 
polymeric particles has always been overlooked in the past. The first study reported herein 
proposes use of gas adsorption for unraveling microstructure and mechanism of drug 
release kinetics of nanoparticles at molecular scale. Investigations undertaken thereafter 
with different polymer architectures confirm the results obtained in the first study with 
PEG1%-g-PLA NPs, and also support the importance of microporosity in determinihg drug 
release kinetics. Not only this, both these studies clearly question the universally accepted 
common notion that increased specific surface area leads to enhanced drug release kinetics. 
It urges scientists to reconsider the reason of this increase in specific surface area before 
drawing any such conclusion. Higher microporosity can be one of the reasons contributing 
to higher surface area. It reduces effective diffusion coefficient of drug in the polymer 
matrix, decreasing its release rate as in case ofPEG1%-g-PLA NPs. 
According to best of our knowledge, polymer chain organization inside the 
polymeric nanoparticles has been studied for the first time and validated successfully using 
gas adsorption technique as weIl as other surface analysis techniques like XPS. This also 
demonstrated the importance of polymer architecture on the chain arrangement inside NPs. 
Polymer chain arrangement affected not only the internaI structure of the NPs but also their 
surface properties. Multiblock copolymer NPs resulted in hydrophilic internaI core due to 
PEG entrapment inside PLA core. This led to lower glass transition temperature of 
multiblock copolymer NPs as compared to other NPs and faster drug release kinetics. At 
the same time, PEG entrapment inside the core of multiblock copolymer NPs resulted in 
less PEG surface density. This affected their surface properties leading to enhanced prote in 
binding and endocytic uptake by macrophages. On the contrary, chemistry of grafted 
copolymers allowed most of PEG chains to easily migrate to surface covering more NP 
surface despite of low initial PEG content in the polytpers. This resulted in higher PEG 
surface density leading to low protein binding and less macrophage uptake. 
This dissertation also brings about sorne of the novel aspects of pegylated NPs in 
the course of various studies. For instance, direct visible evidence of presence of PEG on 
the surface of NPs has not been provided till date, despite of lot of work in the area of 
pegylated systems. This is due to the difficulty in imaging such small size particles and 
probably, the damage caused to the NPs leading to their deformation. However, we 
successfully used tapping mode AFM phase image analysis of NP surface by carefully 
controlling set point ratio. Pegyhlted NPs clearly showed presence of PEG on the surface of 
NPs. Although this data can be regarded as more qualitative than quantitative, clear phase 
separation between rigid PLA domains and soft PEG domains on the surface of NPs was 
reported for the first time through these studies. 
Another point brought to notice In this dissertation is the mechanism of PV A 
adsorption on PLA NPs. Till now, it has been reported that vinyl acetate segment 
interpenetrated PLA/PLGA core through hydrophobic interactions/hydrogen bonding and 
hence, it was difficult to completely remove surface adsorbed PV A. However, from XPS 
results reported here, we strongly suggest possibility of chemical interaction between PLA 
-COOH end groups and PV A -OH groups. It seems logical to assume that such a chemical 
reaction would hamper any attempt of complete removal of adsorbed PV A from surface of 
NPs even after several washings. 
AIl· the hypotheses put forward have been successfully converted into results 
through systematic design of various experiments. Nonetheless, in our opinion, this work 
has opened a completely new avenue of fine-tuning pol ymer architecture to get the desired 
pharmaceutical and targeting properties of nanoscale drug delivery systems. Very small 
size of such delivery systems urges us to probe at the molecular level. The importance of 
studying molecular drug diffusion mechanisms in polymer matrix is clearly evident by the 
work do ne on microporosity of nanoparticles in this thesis. There are many questions which 
are generated from this work and need to be answered. For instance, effect of various 
formulation factors like method of NP preparation, rate of solvent evaporation, ratio of 
external to internaI phase of emulsion, effect of different drugs on the microporosity of 
given polymeric system will shed more light on their internaI structure and release kinetics. 
Although this study shows definite pol ymer chain rearrangement inside NPs, various 
diverse and novel polymeric architectures such as dendrimers, star block copolymers, 
stimuli-responsive polymers should be studied to gain more insight into polymer self 
assembly. Such studies will also provide in-depth understanding of the factors to control 
bulk and surface orientation of polymeric nanostructures precisely, thus controlling both 
their release as weIl as site-specific intracellular delivery. Once such fine control is 
achieved, the dream of converting these smart drug delivery systems into "magic bullets" 
will soon turn into a realityl 
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